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“I always think that the chances of finding out what really is going on are so 
absurdly remote that the only thing to do is to say hang the sense of it and just 
keep yourself occupied.” Douglas Adams, The Hitchhikers Guide to the Galaxy 
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Summary 
The use of mass spectrometry to study of proteins and their non-covalent 
complexes has grown during the last few decades thanks to the introduction of 
soft ionisation techniques capable of preserving the weak molecular bonds 
present in higher order protein structure. The integration of the shape selective 
technique ion mobility with mass spectrometry has allowed the study of 
conformation and dynamics of native proteins. The work presented in this thesis 
focuses on the use of ion mobility mass spectrometry to investigate both protein 
conformation, and conformational differences induced by mutation. 
Prolyl oligopeptidase family enzymes are proteases characterised by their unique 
function; these enzymes are only capable of digesting short amino acid sections 
of no more than thirty amino acids. These proteins have been implicated in a 
number of neurological disorders and have been targeted as potential drug 
candidates. PREP is an 80.7 kDa monomeric protein that has been targeted as a 
potential drug candidate. PREP has been crystallised in two distinct 
conformations, open and closed, and it has been suggested that the protein exists 
in equilibrium between the two states in solution, with only the open 
conformation allowing substrate entry via a domain separation mechanism. Ion 
mobility mass spectrometry has been used to confirm the presence of both 
conformations, and to investigate the effect of ligand binding on conformation. It 
was found that, at lower energy states, PREP was only capable of adopting a 
single conformation, and that more extended conformations were only present 
following activation of the protein. Binding of ligand appeared to increase the 
relative stability of the protein. DPP IV, is a larger, dimeric, protein from the 
same family. Unlike PREP, DPP IV has only been crystallised in a single 
conformation and it was proposed that small loop movements, rather than 
domain separation, allowed substrate entry. Ion mobility measurements show 
only a single conformation of DPP IV, consistent with no large conformational 
changes, supporting this hypothesis. 
Haemoglobin is the main protein involved in gas transport in mammalian 
systems, taking oxygen from the lungs to the tissues of the body. Disorders of 
haemoglobin represent the most common of all inherited disorders, with an 
xix 
 
estimated 7% of the global population being carriers for a haemoglobin disorder. 
A previous study by Scarff et al used ion mobility mass spectrometry to identify 
conformational differences between normal HbA and HbS, the haemoglobin 
mutant responsible for sickle cell disease. Recent experimental improvements in 
sample preparation, data collection and data processing have been used in this 
research to provide improved experimental information. HbA, HbS and HbC, a 
third haemoglobin variant known to form crystals within erythrocytes, were 
investigated using ion mobility mass spectrometry. Calibration of ion mobility 
data using native protein standards indicated that the structural differences 
between HbA and HbS were smaller than previously reported, and that the CCS 
measurements of the two proteins were similar for the native charge states. The 
HbC molecule does however adopt a smaller conformation. All three proteins 
unfold as a factor of increased protonation, with HbS and HbC showing 
evidence of adopting a more extended conformation at lower charge states when 
compared to HbA, suggesting possible differences in protein stability. These 
stability differences were investigated using collision-induced activation of the 
protein, the results suggesting that HbA is more resistant to unfolding that either 
HbS or HbC. 
Monoclonal antibodies represent a new generation of biotherapeutic capable of 
high specificity and selectivity, with diminished risk of inducing a host immune 
response. Antibodies therapeutics have an added benefit of interacting with host 
cellular systems, promoting host immune response. Engineering of antibodies 
has become well established to improve or diminish antibody-receptor binding 
in order to increase or abolish this interaction. Four antibody Fc variants have 
been studied using a combination of ion mobility mass spectrometry and 
hydrogen deuterium exchange mass spectrometry; a wild type, a TM mutant, a 
YTE mutant and a TMYTE double mutant. Previous studies have shown that the 
introduction of both TM and YTE mutations leads to a decrease in the thermal 
stability of the protein, and it was an aim of the study to provide structural 
information to explain this thermal destabilisation. Ion mobility mass 
spectrometry measurements suggest that there is little change in global 
conformation between the four variants. HDX results show that mutation 
introduces changes in local conformation across the protein, with increases in 
xx 
 
deuterium uptake observed at sites distant to the mutation sites. One region, 
located between the TM and YTE mutation sites, showed a greater than additive 
increase in deuterium uptake in TMYTE mutant compared with either TM or 
YTE mutants, indicating a region that hade become destabilised in the double 
mutant. These changes could be responsible for the observed loss of thermal 
stability.  
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1.1 Mass spectrometry 
1.1.1 Mass spectrometry 
Mass spectrometry (MS) is an analytical technique that measures the mass-to-charge 
ratio (m/z) of gas phase ions. A typical mass spectrometry system shown in Figure 
1-1 consists of an ionisation source for generating ions, a mass analyser to measure 
the m/z of these ions and a detector to register the number of ions at each m/z value, 
with a post-detection computer system which may be used to process and/or interpret 
the data (Cristoni and Bernardi 2003, Heck and van den Heuvel 2004). A number of 
inlet methods may be employed to introduce the sample into the system. 
 
Figure 1-1 – Schematic of a mass spectrometer. 
Ions produced in the source are analysed prior to MS detection. Information collected by the detector 
is processed by a computer system to generate a spectrum. 
A number of possible components may be employed for each element, and by 
varying these components it is possible to construct a mass spectrometry system 
suitable for a wide range of analytical applications. 
1.1.2 Ionisation Sources 
In the ionisation source the sample is ionised prior to introduction into the mass 
spectrometer. Many different ionisation methods are suitable for use with mass 
spectrometry. Some ionisation techniques are highly energetic and transfer a lot of 
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energy to the analyte, leading to fragmentation of the ion, whilst others are softer and 
leave the ion intact (de Hoffman and Stroobant 2007). 
Initial MS instruments made use of ionisation sources employing electron ionisation 
(EI), chemical ionisation (CI) or field ionisation (FI). These methods required the 
analyte to be in the gas phase prior to analysis and thus were only suitable for 
volatile, thermally stable compounds. Due to these limitations early MS analysis was 
rarely used for biological applications (Feng, Liu et al. 2008) 
Modern ionisation sources are capable of transferring an analyte into to the gas phase 
from either the liquid or solid phase as part of the ionisation process. The 
development of electrospray ionisation (ESI) (Wong, Meng et al. 1988, Fenn, Mann 
et al. 1989), a liquid-phase ionisation method, and matrix-assisted laser desorption 
ionisation (MALDI) (Karas, Bachmann et al. 1987, Karas and Hillenkamp 1988, 
Tanaka, Waki et al. 1988), a solid-phase method, revolutionised the MS field since 
these techniques were soft enough to allow the study of biomolecules by MS. Such 
has been the impact of these techniques that the Nobel Prize in Chemistry in 2002 
was awarded to John Fenn and Koichi Tanaka for their roles in their development. 
Electrospray Ionisation 
Electrospray ionisation (ESI) was developed by John Fenn (Fenn, Mann et al. 1989). 
It has since become the principal technique for the study of biomolecules using MS 
since it is considered to be the softest of the ionisation techniques (leading to the 
least fragmentation of the analyte) and because, as a liquid phase technique, it is 
compatible with inlet systems incorporating liquid chromatography (Feng, Liu et al. 
2008), enabling high throughput analysis of complex biological samples. In an ESI 
source, shown in Figure 1-2, an analyte in solution is ejected from a capillary upon 
the application of a strong electric field. A solution containing analyte molecules 
dissolved in a volatile buffer is driven into the capillary at a flow rate of 1-20 
µL/min, depending on the inlet method (Wilm and Mann 1994, Banerjee and 
Mazumdar 2012). Application of a high voltage, typically 2-6 kV (Banerjee and 
Mazumdar 2012), applied to the capillary leads to the partial separation of positive 
and negative electrolyte ions in the solution. In positive ion mode, positive ions 
migrate to the surface of the liquid, whilst negative ions migrate to the centre of the 
capillary. Electrostatic repulsion of positive electrolytes, combined with the effect of 
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the electric field leads to an elongation of the solvent at the tip, generating a 
characteristic cone (Taylor cone). The tip of this cone, the least stable point, 
elongates further to form a liquid filament which breaks up to form the individual 
charged droplets containing the analyte (Kebarle 2000).  
 
Figure 1-2 – Schematic of an ESI source.  
The electric potential applied to the capillary causes the separation of the electrolytes in solution. 
Electrostatic repulsion causes the elongation of the liquid filament and the formation of liquid 
droplets. 
ESI capillaries generate first generation droplets approximately 1-2 µm (Wilm and 
Mann 1996) in diameter, each of which may contain many thousands of analyte 
molecules (Wilm and Mann 1994).  An exact mechanism describing how charged 
ions are produced from these droplets is still under debate, with three main 
mechanisms having been proposed. The ion evaporation method (IEM) (Iribarne and 
Thomson 1976) and the charge residue model (CRM) are the two most accepted 
mechanisms of ion formation., whilst the chain ejection method (CEM) is a more 
recently proposed mechanism (Konermann, Ahadi et al. 2012). These are 
summarised in Figure 1-3. 
Within the source the charged droplets undergo solvent evaporation  (Fenn, Mann et 
al. 1989). In order to assist with the evaporation of solvent ESI capillaries are heated 
to 100-300
o
C (Banerjee and Mazumdar 2012).  
The droplet diameter decreases with evaporation until the Rayleigh limit is reached. 
This is the point at which the coulombic repulsion of surface charges and the solvent 
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surface tension are equal. At this point the droplets undergo coulumbic fission into 
daughter droplets of smaller diameter and lower charge.  
The IEM mechanism states that there is a certain threshold at which the charge 
required for coulombic fission of the droplet is lower than that required for direct 
evaporation of the charged ions from the droplet. At this point the droplets 
themselves remain whilst the charged ions evaporate from the droplet and become 
fully desolvated (Iribarne and Thomson 1976).  
The CRM mechanism, in contrast, suggests that this limit does not exist, and 
indicates that successive coulomb fission and evaporation eventually leads to 
desolvated charged ions (Dole, Mack et al. 1968).  
The CEM mechanism is a more recent proposal based on extensive computational 
molecular dynamics (MD) simulations. In this mechanism it is suggested as a droplet 
approaches the Rayleigh limit the ions within migrates to the surface of the droplet. 
One end of the chain is ejected from the droplet, followed by the sequential ejection 
of rest of the ion by electrostatic repulsion. Unlike the CRM and IEM, the CEM is 
not dependant on droplet size and therefore may occur in any droplet approaching 
the Rayleigh limit (Konermann, Ahadi et al. 2012).  
It is generally accepted that no single mechanism is completely correct; rather that 
each mechanism is applicable to a different subset of molecules. The CRM approach 
best explains the ionisation of larger, globular molecules such as intact proteins 
(Heck and van den Heuvel 2004). MD simulations indicate that, within the charged 
droplet, excess charge migrates to the surface, whilst large, hydrophobic molecules 
cluster towards the centre, supporting the CRM mechanism for proteins. The IEM 
approach best explains the ionisation of smaller, hydrophilic ions, whilst the CEM 
approach best describes the ionisation of longer, disordered molecules such as 
polymer chains or unfolded peptides (Konermann, Ahadi et al. 2012). 
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Figure 1-3 – Overview of the three proposed mechanisms of generating charged ions in the electrospray method. 
In the IEM, the energy threshold for solvent evaporation eventually becomes higher than the ion evaporation energy leading to ion evaporation from the droplet. In the CRM, 
all the solvent evaporates from a droplet, leaving only a single ion. In the CEM the ion is ejected from the droplet in sequential steps along the length of the ion. The CEM 
method occurs as the droplet approaches the Rayleigh limit, and does not always require successive coulombic fission to occur.
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Nanoelectrospray Ionisation 
In 1996 Wilm and Mann first published data on nanoelectrospray ionisation (nESI) 
(Wilm and Mann 1996); a version of ESI scaled down to produce smaller droplets 
from the capillary using lower flow rates. nESI capillaries are far smaller than ESI 
capillaries, with an internal diameter of 1-4 µm and a tip of ~1 µM (Wilm and Mann 
1996) . Droplets are produced from the capillary tip by the same mechanisms as for 
ESI, with the notable exception that the flow rates for a nESI source are far lower 
than that of ESI (1.2-30 µL.hr for nESI compared to up to 30 mL/ hour for ESI 
(Konijnenberg, Butterer et al. 2013). As a result of the lower flow rates and smaller 
capillary spray orifice, nESI droplet size is far smaller than those produced by ESI; 
nESI droplets are approximately 200 nm  in diameter (based on theoretical 
calculations),100-1000 times smaller than the ESI droplets (Wilm and Mann 1996).  
nESI has a number  of benefits over conventional ESI. The smaller droplet size of 
nESI makes solvent evaporation far more favourable, reducing the need for high 
source temperature which can lead to the thermal decomposition of sample 
(Konijnenberg, Butterer et al. 2013). nESI is also more tolerant to non-volatile salts 
and buffers typically present in biological samples (Lorenzen and Duijn 2001).  
Importanly, nESI also requires much lower samples concentrations, and samples 
volumes (as little as 1 µL of sample at a typical concentration 5-10 µM), and is more 
amenable to less volatile solvents, such as water, ammonium acetate or ammonium 
bicarbonate, which makes it ideally suited for the study of biomolecules 
(Konijnenberg, Butterer et al. 2013).  
1.1.3 Mass Analysers 
Once ions have been produced they must be separated, based on their m/z, by a mass 
analyser. There are a number of potential mass analysers available for use in a mass 
spectrometer, each of which uses different methods to measure the m/z of an ion. All 
mass analysers use either static or dynamic electric and magnetic fields, alone or in 
combination, to achieve ion separation and can be divided into two classes: scanning 
mass analysers, which transmit ions of different masses successively over an 
extended timescale or simultaneous transmission analysers, which transmit all ions 
simultaneously whilst achieving separation.  
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Modern mass analysers include quadrupole (Q), ion trap (IT), time of flight (TOF), 
Orbitrap and Fourier transform ion cyclotron resonance (FTICR) based approaches. 
Although they are all capable of measuring m/z, different mass analysers have 
different performance characteristics with some analysers better suited to certain 
fields of research. Many modern instruments contain more than one mass analyser 
(hybrid instruments) allowing them to be used in conjunction to increase instrument 
versatility and provide an option for multiple experimental approaches. 
Quadrupoles 
The development of the quadrupole mass analyser dates back to the 1950’s with 
initial work carried out by Paul and Steinwegen in 1953. Quadrupoles are in the class 
of scanning mass analysers. A quadrupole consists of four parallel circular rods. 
Opposed rods are paired electrically and a radio frequency (RF) voltage is applied 
between the two pairs. Superimposed over this RF field is a direct current (DC) 
voltage.  
 
Figure 1-4 - Representation of a quadrupole mass analyser.  
Opposed parallel rods are paired with a RF field of the same polarity, with a superimposed DC field. 
The relationship between teh RF and DC fileds acts as a m/z filter, with only one type of ion having a 
stable trajectory through the rods, shown by the green line. All other ions have an unstable trajectory 
through the poles and are lost, shown by the red line.  
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Based on the values on the RF and DC voltages applied, only certain m/z ions have a 
stable trajectory through the analyser, based on their oscillation between the poles. 
Ions with little oscillation pass directly through the analysers, whilst those with a 
stronger oscillation may collide with one of the poles and can be lost. This is shown 
schematically in Figure 1-4. Varying the DC and RF voltages changes which m/z 
ions have a stable trajectory allowing a quadruple to be utilised as a mass filter. 
Quadrupoles are typically operated in scanning mode, where DC and RF voltages are 
varied to allow all ions to pass sequentially through to the detector, but may also be 
used in a fixed mode, where only a single m/z species is allowed through to the 
detector (de Hoffman and Stroobant 2007) 
Time of Flight 
TOF mass analysers date back to the late 1940’s, however the first publication 
describing a linear TOF-MS instrument with a resolution high enough to be practical 
was in 1953. Despite their high sensitivity and potentially unlimited m/z range all 
early TOF analysers suffered with problems with resolution, with a few hundred 
being the best resolution observable on these early instruments (Mamyrin 2001). 
TOF analysers separate ions based on their velocities through a free-field region 
called a flight tube. As ions enter the analyser they are accelerated by a potential 
difference towards the flight tube. All ions receive the same kinetic energy, and 
therefore separation occurs based on Equation 1-1, where t is time to traverse the 
flight tube, L is the length of the flight tube, m is the mass, z is the number of 
charges, e is the charge and Vs is the initial acceleration potential. 
𝑡2 =
𝑚
𝑧
(
𝐿2
2𝑒𝑉𝑠
) 
Equation 1-1 
Given that the terms within the parentheses are constant, the time taken for an ion to 
traverse the flight tube is proportional to the square root of the m/z. This indicates 
that molecules of low mass, or high charge, will traverse the flight tube faster than 
large molecules with fewer charges (de Hoffman and Stroobant 2007). 
For many years MALDI was the preferred ionisation method for use with TOF 
analysers, principally due to the significant loss in sensitivity associated with the use 
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of continuous ionisation methods, such as ESI, compared to the MALDI based 
pulsed ionisation method (Mirgorodskaya, Shevchenko et al. 1994). Throughout the 
1980s a number of research groups dedicated time to developing TOF analysers 
capable of analysing a continuous ion beam without losing sensitivity. These new 
systems integrated orthogonal acceleration regions prior to the TOF analyser which 
collected ions prior to their acceleration into the TOF analyser, facilitating their use 
with a number of continuous ionisation techniques (Mirgorodskaya, Shevchenko et 
al. 1994, Guilhaus, Selby et al. 2000).  
A number of factors in early instrument design led to a broad ion packet arriving at 
the detector directly resulting in low resolution. The introduction of delayed 
extraction (DE) and reflectron technology eliminated many of these problems and 
hugely improved the resolution of TOF analysers. 
DE, first explored by Wiley and McLaren (Wiley and McLaren 1955), was designed 
to overcome the effect of kinetic energy differences of ions on resolution. Ions are 
given a short time (hundreds of nanoseconds to a few miliseconds) to expand into 
the field free environment of the source prior to being subject to a voltage pulse. By 
introducing a delayed pulse in this manner, ions of the same m/z are first allowed to 
separate based on their internal kinetic energy before the pulse is applied. Ions with 
higher energy drift further from the source of the pulse and thus receive less of a 
kinetic boost than those closer to the pulse, equalising the kinetic energy differential 
between the ions (Wiley and McLaren 1955). 
The reflectron, developed by Mamyrin, uses a decelerating field that acts as an ion 
mirror slowing ions of the same m/z value and deflecting them back towards the 
detector, as illustrated in Figure 1-5. Ions of higher kinetic energy penetrate deeper 
into the decelerating that ions of lower kinetic energy but same m/z. The additional 
time spent within the field corrects the kinetic differential between the m/z ions, 
much in the same way as a DE, ensuring a narrower ion packet arriving arrives at the 
detector increasing resolution. To a lesser extent a reflectron also increases TOF 
resolution by increasing the length of the TOF flight tube. Reflectrons use two main 
configurations, V-optics, which makes use of a single decelerating field, or W-
optics, which uses two decelerating fields that send ions back and forth, resulting in 
three passes through the field prior to detection. Whilst the latter option improves 
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instrument resolution it can also lead to a loss in sensitivity as a result of ion loss (de 
Hoffman and Stroobant 2007). 
 
Figure 1-5 - Schematic of a time of flight mass analyser with a reflectron.  
Two ions of the same m/z leave the ion source at the same time, but with different kinetic energies. 
The red ion has a higher kinetic energy than the green ion, and therefore penetrates deeper into the 
decelerating field. This serves to normalise the kinetic differences of the ions to ensure they arrive at 
the detector at the same time. 
1.1.4 Detectors 
The final element in an MS system is the detector. Ions separated by an analyser are 
passed into a detector, which converts the ions into a suitable signal to provide the 
experimental output. Ion detection is based on one of three physical properties: mass, 
charge or ion velocity. Of critical importance is that not only the m/z of an ion is 
detected, but also the ion abundance. Modern instruments convert ions detected into 
an electrical current proportional to ion abundance. 
Unlike the developments in ionisation methods there has been no revolution in 
detector design, with advances coming as part of ongoing development to improve 
ion detection. As with all parts of a mass spectrometer, a number of configurations of 
detector are available and the choice of detector used is influenced both by the 
instrument and the analysis required. 
The earliest detectors date back to the initial work performed by J. J Thomson in 
1913. Photoplate detectors in 1913 consisted of luminescent screens which were 
used to visualise particles by means of a fluorescent spot (Squires 1998), although 
these were later replaced with ion sensitive photoplates inserted in the vacuum 
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regions of the MS after the analyser. Since these early days ion detection has become 
more sophisticated.  
One of the biggest challenges associated with ion detection is MS systems is related 
to electrical signal strength. A typical ion beam has a current of subfemto- to 
nanoamphere, which requires significant electronic amplification before it can be 
converted to a voltage for interaction with electronic circuits. 
The multichannel plate (MCP) detector is a variant of the continuous dynode 
electron multiplier (CDEM) detector. The MCP consists of a disk containing a series 
of channels each of which is a few tens of millimetres in diameter and a few 
millimetres in length coated in an electron-emissive surface. Ions strike the surface 
near a channel, resulting in a burst of electrons emitted into the channel. This sets off 
a cascade of electron emissions down the channel, increasing the size of the electron 
cloud until it is detected by an anode at the base of the channel (Koppenaal, Barinaga 
et al. 2005). 
Standard electron multiplier (EM) detectors rely heavily on the velocity of an ion in 
order to generate the electron cloud cascade. Larger ions tend to produce lower 
signals on EM detectors since they have a lower ion velocity. CDEM detectors, like 
the MCP, produce a continuous electric field across its length. This field provides 
ample acceleration for the electron cloud, serving to enhance the signal even for 
larger ions. With the application of mass spectrometry transitioning more towards 
the study of biomolecules, which inherently produce large ions, this form of detector 
has proven invaluable for enhancing signal intensity and sensitivity. 
A mass spectrometer must be able to convert the signal produced by a detector into a 
digital signal capable of being processed by a computer system to create an output 
mass spectrum. Conversion is usually performed by one of two systems; an 
analogue-to-digital converter (ADC) or a time-to-digital converter (TDC). ADC’s 
take the amplified analogue signal produced by a MS detector, filter out the 
background noise and convert to a digital output before transferring it to memory. 
The information content produced from an ADC is proportional to every data point 
across a single MS spectrum and therefore the ADC sampling frequency is 
determined by the scanning speed of the MS instrument being used. TDC’s make use 
of a discriminator to register the analogue electron pulse produced by the detector 
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once it overcomes a certain threshold. The discriminator converts the signal into 
signal pulse which persists for the duration of the electron pulse. The TDC measures 
the duration of the signal pulse and converts it into a histogram to be stored in the 
memory prior to transfer to the computer system. TDC’s are time counting devices 
and therefore make no differentiation between the number of ions striking the 
detector simultaneously from the same flight cycle. If two ions strike the detector 
sequentially the second ion is not registered as the system is unable to register ions 
for a short interval after each ion event. This is known as dead time. As a 
consequence, TDC’s suffer from limited dynamic range, with a deleterious effect on 
mass accuracy for intense ions (de Hoffman and Stroobant 2007). 
1.1.5 Tandem Mass Spectrometry 
Tandem mass spectrometry (MS/MS) refers to any method which involves two 
stages of mass analysis using a dissociation process or chemical reaction between the 
analysers to change the mass or the charge of the ion. Depending on instrument 
configuration it is possible to carry out multiple selection and fragmentation events 
in a process known as MS
n
, where n is the number of generations of ions studied. 
MS/MS can be performed either in space or in time, and the method  used is 
dependent on instrument configuration. 
MS/MS in space uses an initial mass analyser to select and isolate a precursor ion, 
which is then subjected to fragmentation. The fragments are then separated using a 
second mass analyser prior to detection. Typical instrument configurations for 
MS/MS in space are triple quadrupoles (QqQ), aligned time of flight time of flight 
(TOF-TOF) or quadrupole time of flight (QTOF) instruments. Located between the 
mass analysers is a collision cell suitable for fragmenting the ions (Figure 1-6).  
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Figure 1-6 - Schematic of the arrangement of mass analyses in a tandem MS instrument.  
A full ion packet is introduced into mass analyser 1, which is used to select only a single m/z ion; all 
other ions are filtered out and lost. The selected ion is then fragmented within the collision cell. These 
fragment ions are analysed by mass analyser 2 prior to detection.  
Whilst there are a number of potential methods for ion activation and fragmentation 
the most widely applied method is collision induced dissociation (CID). Pioneered in 
the 1960’s by McLafferty and Jennings (McLafferty and Bryce 1967, Jennings 1968) 
CID achieves fragmentation via collisions between the precursor ion and an inert 
buffer gas (usually He, N2 or Ar). In the collision cell the translational energy of the 
ion is converted into internal vibrational energy which leads to ion fragmentation. By 
accelerating the precursor ions as they enter the chamber fragmentation may be 
increased and secondary fragmentation can also be induced (Seidler, Zinn et al. 
2010). This form of experiment has a number of potential applications for biological 
mass spectrometry, which are discussed later. 
1.1.6 Ion Mobility Mass Spectrometry 
Ion mobility spectrometry (IMS) is a technique that separates ions based on their 
velocity when travelling through a certain medium. The first reported use of ion 
mobility was in 1898 by John Zeleny (Zeleny 1898), although the underlying 
principles behind IMS were later described by Langevin in 1903.  Based on this 
initial work it was understood that ions could be separated based on their velocity 
through an inert gas with a superimposed electric field. Ions passing through the field 
have a specific, constant velocity determined by their physical properties (Uetrecht, 
Rose et al. 2010); their size/charge ratio as determined by mass, charge and shape 
(Kanu, Dwivedi et al. 2008). IMS is a rapid technique that has high sensitivity and 
selectivity and for these reasons IMS has been utilised for the analysis of drugs, 
explosives and small molecules for many years (Mesleh, Hunter et al. 1996, 
Guharay, Dwivedi et al. 2008). 
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Most simple IMS systems consist of a single drift cell. In this instrumental set-up 
ions are introduced into the drift tube in packets. The ions traverse the cell, which is 
filled with a neutral inert gas (He, Ar or N2), under the influence of a weak, uniform 
electric field. As the ion packets diffuses through the drift cell larger ions suffer 
more collisions with the buffer gas compared to the smaller ions, their movement 
through the cell is retarded relative to the smaller ions resulting in a longer drift time, 
see Figure 1-7 (Clemmer and Jarrold 1997).  
 
Figure 1-7 - Schematic of a drift time ion mobility cell.  
Ions traverse the cell under the influence of a weak electric field. The cell is filled with an inert buffer 
gas, usually N2 or He, which acts to slow the ions movement through the cell. Smaller ions, those 
shown in blue and green, collide less with the buffer gas and therefore traverse the cell faster than 
larger ions, shown in purple.  
The use of IMS in tandem with MS, known as ion mobility mass spectrometry (IM-
MS) dates back to the 1960s. Over the years IMS has been coupled to most MS 
detectors, starting with magnetic sector instruments, quadrupoles and TOF’s and, 
more recently, moving on to ion traps and FTICRs (Uetrecht, Rose et al. 2010). The 
use of a coupled IMS-MS system creates an extremely powerful analytical tool. IMS 
separates molecules based on their size/charge ratio and MS can be used to 
determine m/z; when used in tandem it becomes possible to investigate an ions 
shape, more specifically its rotationally averaged collision cross section. 
IM-MS has a number of potential applications. Whilst initial experiments focussed 
on the properties of atoms and simple molecules it has subsequently been used as a 
method of separating complex ion mixtures in proteomics (Valentine, Plasencia et al. 
2006) and glycomics (Clowers, Dwivedi et al. 2005). IM-MS has had the most 
significant impact, however, in the field of structural biochemistry for the analysis of 
protein structure and protein complex assembly. The Jarrold, Clemmer and Bowers 
groups have published pioneering work in this field (Clemmer and Jarrold 1997, 
Hudgins, Ratner et al. 1998, Wyttenbach, Kemper et al. 2001)  
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Initial publications were based on data acquired using in-house built drift cell IM-
MS instruments. The first available commercial instrument incorporating ion 
mobility mass spectrometry was the Synapt G1 HDMS system in 2006, followed by 
the Synapt G2 HDMS system in 2009. Since then a number of IM-MS platforms 
have become available including a commercial drift cell instrument from Agilent 
(the Agilent 6560 Q-TOF system) and an optional FAIMS upgrade available for 
instruments from Thermo Scientific. 
Drift cell IM-MS (DCIMS) utilises a convention drift cell, the mode of operation of 
which has been previously described. Drift cell instruments have high IMS 
sensitivity and resolution. The relationship between an ions drift time, mass (m), 
charge (z), rotationally averaged cross section (Ω) and interaction with buffer gas 
under the effects of an electric field of known strength are well understood. A 
DCIMS instrument measures drift time, mass and charge, and since all other 
instrumental conditions remain constant, it is possible to directly calculate Ω for ions 
analysed using this method using Equation 1-2 (Clemmer and Jarrold 1997, Pringle, 
Giles et al. 2007) where N is the background gas density, ze the ionic charge, µ the 
reduced mass of the ion-neutral pair, kb is Boltzmann’s Constant, T the gas 
temperature and K0 is the reduced mobility, the measured mobility corrected to 
273.2K and 760 Torr. 
Ω =  
3𝑧𝑒
16𝑁
(
2𝜋
𝜇𝑘𝑏𝑇
)
0.5 1
𝐾0
 
Equation 1-2 
High-field asymmetric waveform ion mobility spectrometry (FAIMS) exploits the 
differential mobility of gas phase ions at high electric field strengths. At low field 
strengths, such as in DCIMS ion mobility is independent of field, whereas at high 
field strengths mobility becomes a function of field. In this experiment ions are 
allowed to pass through parallel electrodes at ambient temperature and pressure. An 
asymmetric voltage pulse is applied to one electrode to draw ions towards it, whilst 
the other electrode has a continuous voltage applied to it to compensate for the drift 
towards the former electrode. This is known as the correction voltage. Ions require 
different correction voltage strengths to correct their drift towards either plate, 
allowing for ion mobility separation (Barnett, Ells et al. 1999). The theory of FAIMS 
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is currently poorly understood, and the high field strengths can induce structural 
changes making it an unsuitable method for estimating protein structural dimensions 
(Uetrecht, Rose et al. 2010). 
1.1.7 Travelling Wave Ion Mobility  
The first and second generation Synapt HDMS systems make use of travelling wave 
ion mobility (TWIMS) as the IMS method of separation. The IMS cell, shown in 
Figure 1-8, is located between the trap and the transfer cells. 
 
Figure 1-8 – The schematic of the Synapt G1 HDMS system, the first generation commercial mass 
spectrometer with an integrated T-wave ion mobility cell. 
Ions produced by ESI in the source move through the quadrupole into the SRIG region of the 
instrumnet, containing two fragmentation cells (Trap and Transfer) either side of the IMS cell. Follow 
the SRIG region ions are analysed by TOF before detection. 
TWIMS instruments operate under similar principles to DCIMS instruments. The 
difference between TWIMS and DCIMS lies in the use of the stacked ring ion guide 
(SRIG) to generate a voltage wave that propels ions along the cell. 
Ions are introduced into the IMS cell in packets. Each ring in the ion guide has a RF 
field applied and each pair of rings has positive and single negative RF voltages 
applied. The RF field produced serves to radially confine the ions, preventing radial 
diffusion and reducing scattering effects. A transient DC voltage is applied to pairs 
of stacked rings in sequence along the length of the SRIG to create a DC electrical 
wave. Ions are repulsed by this potential wave and are thus propelled through the 
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SRIG. As in a drift cell ions with  larger Ω values undergo more collisions with the 
buffer gas and, as a result, suffer drag which can cause them to slip behind the wave 
front, as depicted in Figure 1-9 (Giles, Pringle et al. 2004, Thalassinos, Slade et al. 
2004, Pringle, Giles et al. 2007), and thus take longer to traverse the cell. This 
method of ion mobility separation has improved speed of data aquisition and 
sensitivity relative to many conventional DCIMS instruments (Scarff, Thalassinos et 
al. 2008) 
 
Figure 1-9 - Schematic illustrating ion mobility through a travelling wave cell. 
As with drift cell IMS, ions are introduced into T-wave cell as a single packet. DC voltages applied to 
pairs of rings create an electrical potential wave, which pushes ions through the cell. Larger ions 
collide more with the inert buffer gas and are slowed in their movement, until they fall behind the DC 
potential wave. These ions are then carried along on the next DC wave until the either fall behind the 
potential wave agian, or they exit the mobility cell. 
Separation using a T-wave is reliant on many of the same factors shown in Equation 
1-2, but also requires the effects of both wave height, determined by DC voltage, and 
wave velocity to be considered. It is not currently possible to calculate absolute Ω 
values from TWIMS data in the same way as DCIMS data, since the properties of 
the electric field are varied across the SRIG (Lanucara 2014). It is possible, however, 
to obtain experimental estimates of Ω values by using reference compounds of 
known CCS to calibrate the data (Scarff, Thalassinos et al. 2008).  
1.1.8 Calibration of Ion Mobility data 
The framework for calibrating TWIMS MS was initially developed by Wildgoose, 
and has been refined and developed by a number of groups (Ruotolo, Benesch et al. 
2008, Scarff, Thalassinos et al. 2008, Williams and Scrivens 2008, Smith, Knapman 
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et al. 2009, Thalassinos, Grabenauer et al. 2009, Michaelevski, Kirshenbaum et al. 
2010). The method described below, and used in this thesis, has been taken from 
Michaelevski et al (Michaelevski, Kirshenbaum et al. 2010). 
Arrival time, measured as scan number (n) relates to the push of the TOF; there are 
200 TOF acceleration pushes registered between the release of each ion packet into 
the mobility cell, resulting in 200 spectra per ion packet. Multiplying the pusher 
time, in milliseconds, by the scan number provides an arrival time (Equation 1-3) 
𝑡𝑑 = 𝑛 ×  𝑝𝑢𝑠ℎ𝑒𝑟 𝑡𝑖𝑚𝑒 
Equation 1-3 
This value is then corrected for m/z dependant flight (t’d), which is the time between 
the transfer cell exit and the TOF pusher. This is achieved by using the enhanced 
duty cycle (EDC) coefficient (c), which is instrument specific, but has a value 
typically between 1.4 and 1.6 (Michaelevski, Kirshenbaum et al. 2010) (Equation 
1-4). 
𝑡′𝑑 =  𝑡𝑑  −  
𝑐√𝑚/𝑧
1000
 
Equation 1-4 
Previous calibrations have corrected for m/z independent flight (time spent in the 
transfer cell after the IMS cell). It has been observed, however, that m/z independent 
flight had little effect on the calculated cross sections and this step has subsequently 
been omitted for simplicity. 
Following correction of drift time of the analyte, each calibrant cross section (Ω) is 
then corrected for ion charge state (z) ion mass (m) and mass of the buffer gas (mg), 
Equation 1-5. Typically the buffer gas is either N2 or He. 
 
𝛺′ =
𝛺
𝑧√
1
𝑚
+
1
𝑚𝑔
  
Equation 1-5 
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From the calculated values, a plot of Ω’ vs t’d for the calibration standards is fitted to 
either a power (y=Ax
N
) or linear (y = Ax + N) series fit, ensuring the R
2
 value is 
≥0.99. Both A and N are then used for the calculation of estimated cross section 
using the power fit, or linear equations. 
𝐶𝐶𝑆 = 𝐴 𝑡′𝑑
𝑁
𝑧 √
1
𝑚
+
1
𝑚𝑔
 
Equation 1-6 
𝐶𝐶𝑆 = [𝐴 𝑡′𝑑 + 𝐵 ] 𝑧√
1
𝑚
+
1
𝑚𝑔
 
Equation 1-7 
As with any analytical technique it is important to ensure that appropriate 
calibrations standards are used for the desired analyte. The Clemmer group published 
a series of measured cross sections of denatured ubiquitin, cytochrome c and 
lysozyme to be used as calibration standards (Shelimov, Clemmer et al. 1997, 
Valentine, Anderson et al. 1997, Valentine, Counterman et al. 1997), whilst some 
groups used other denatured proteins, such as myoglobin (Scarff, Patel et al. 2009) 
as their calibration standard of choice. Using these denatured standards it is possible 
to obtain accurate CCS estimates, assuming both the protein and calibration 
standards are examined under the same experimental conditions (Leary, Schenauer et 
al. 2009). 
Whilst these denatured standards have been shown to provide good estimates for 
many systems, native proteins can have significantly smaller mobilities, and in the 
case of complexes much larger masses, than these unfolded protein calibrants cover. 
Using these standards for estimating intact proteins, and large protein complex, Ω 
values leads to CCS values highly dependent on instrument settings with a larger, 
difficult to estimate, errors. Recent reports have helped rectify this problem by 
providing a number of optional native protein calibration standards, ranging from 
cytochrome c (12 kDa) to the GroEL complex (801 kDa), for use in TWIMS 
experiments (Salbo, Bush et al. 2012). These reports not only outline appropriate 
calibration standards, but also highlight the importance of choosing the correct type 
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of calibrant that closely brackets an appropriate mobility window and mass range for 
the analyte ions, and optimising the instrument parameters for these standards. By 
ensuring these conditions are met it is possible to reduce the instrument dependence 
of the Ω-values recorded. 
1.1.9 Computational modelling of CCS 
In addition to comparing Ω values obtained using TWIMS with those obtained by 
DCIMS it is also possible to calculate Ω vales from published X-ray crystal 
structures. Scarff et al showed that Ω values estimated for a series of protein 
standards using TWIMS correlated well with those calculated from protein data bank 
(PDB) files from both X-ray and NMR structures (Scarff, Thalassinos et al. 2008). 
There are four main methods of calculating Ω values from published PDB data; the 
projection approximation (PA); exact hard sphere scattering (EHSS) method; 
trajectory method (TM); and the more recently introduced projection superposition 
approximation (PSA) method.  
The PA method was first described by Mack in 1925 (Mack 1925), and was adapted 
for the use in modern CCS estimation by the Bowers group (von Helden, Hsu et al. 
1993). 
The PA method replaces an ion cross section with its projection; the ‘shadow’ the 
ion would cast. A number of projections are generated from different angles around 
the ion, and an average is used to generate the cross section. The PA method is the 
least computationally intensive method making it the fastest method available. It 
does not, however, account for interactions between the ion and the buffer gas. 
Whilst this method is suitable for small molecules it has been shown to consistently 
underestimate the Ω value for larger peptides and proteins (Jarrold 1998). 
The TM approach is the most thorough modelling method. It takes into consideration 
many of the interactions between the buffer gas and the ions, and their respective 
velocities and scattering angles. By calculating scattering angles this approach 
assesses the full three-dimensional structure of an ion, including any concave and 
convex regions of the ions surface. Whilst the TM calculation is by far the most 
robust, it is also the most computationally intensive; the algorithm can take several 
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weeks on a standard computer to compute structures that other methods take only a 
few days to compute (Bleiholder, Wyttenbach et al. 2011) 
The EHSS method may be considered as a middle ground between the PA and the 
TM; the EHSS treats the molecule as a single hard sphere for the calculation of 
interactions with buffer gas. This approach does not take into consideration the 
subtle differences caused by an ions surface shape (concave/ convex surface 
elements) like the TM method, but does not completely ignore buffer gas effects like 
the PA method. The result is a method that gives slightly more robust calculations 
than the PA with a fraction of the computational time required for the TM method 
(Mesleh, Hunter et al. 1996, Bleiholder, Wyttenbach et al. 2011).  
The PSA method was developed by the Bowers group to provide an improved 
method for calculating theoretical Ω values for biomolecules, taking into 
consideration size and shape effects like the TM method but with a reduced 
computational demand. The PSA method builds on the PA method – an averaged 
projection area is calculated which is then corrected for any deviation from a perfect 
sphere using a shape factor. The result is a calculation that provides theoretical Ω 
values similar to the TM method but with a computational demand comparable to the 
PA method; for PDB entry 1IHM (a spherical virus capsid) the PSA method takes 
663 minutes to compute Ω, compared to 5 minutes for the PA, 1401 minutes for the 
EHSS and 47 days (67680 minutes) for the TM (Bleiholder, Wyttenbach et al. 
2011). 
1.1.10 Comparing experimental and computational CCS measurements 
In order to validate the experimental Ω values obtained experimentally it is possible 
to compare the CCS obtained from computational methods with those obtained 
experimentally. A number of previous studies have shown that it is possible to obtain 
CCS estimates from T-wave instruments that agree well with those calculated from 
X-ray crystal structures (Ruotolo, Benesch et al. 2008, Bush, Hall et al. 2010, Salbo, 
Bush et al. 2012), if experimental parameters are carefully controlled and a suitable 
calibration curve is produced. It is important when performing this comparison to 
ensure that computationally derived CCS values and experimental CCS values use of 
the same buffer gas, N2 or He, as this can lead to differences in the drift time, and 
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thus CCS measurements (Bush, Hall et al. 2010, Jurneczko, Kalapothakis et al. 
2012).  
This is particularly problematic when using TWIMS, as TWIMS makes use of N2 as 
the buffer gas for IMS separation, whilst all of the computational methods for 
estimating CCS use He. A modified version of the MOBCAL program, which 
performs PA, EHSS and TM methods, configured to use N2 as the buffer gas has 
been developed by Iian Campuzano, but it has been optimised for small molecules 
and drug-like compounds and would not be suitable for protein analysis 
(Campuzano, Bush et al. 2012). 
1.2 Proteins; structure and function 
Proteins, along with lipids, carbohydrates and nucleotides, are biological 
macromolecules that are essential to all life in earth. Proteins have a variety of roles 
within a biological system including catalysis, molecular transport and storage, 
coordinated motion, mechanical support, immune protection, cellular signalling, 
growth and differentiation; proteins are involved in virtually every biological process 
across nature. The key to this diverse functionality lies in in protein structure (Stryer 
2011). 
1.2.1 Protein Structure 
Proteins are polymer molecules comprised of amino acids capable of folding into 
complex three-dimensional shapes. Protein structure can be broken down into four 
categories: primary, secondary, tertiary and quaternary. 
Primary structure refers to the sequence of the amino acids of a protein. There are 
twenty types of unmodified amino acid molecule, each with a conserved core and 
unique R group (see Figure 1-10). 
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Figure 1-10 – The generic depiction of an amino acid. Differences in R group give rise to the 
different amino acids. 
Secondary structure refers to the spatial arrangement of the amino acids in regions 
close in sequence. There are three major secondary structure elements; α-helical and 
β-sheet are regular structural features formed by amino acids linked by hydrogen 
bonding between the amide and carboxyl groups along the peptide backbone. The 
third structural element is a random coil; a disordered structure featuring few 
hydrogen bonds. 
Tertiary structure refers to the spatial arrangement of amino acids close in space but 
not in sequence – it refers to the three-dimensional folding of the primary and 
secondary structure. Tertiary structure also includes consideration of any disulphide 
bonds a protein contains to stabilise the three dimensional structure.  
In many proteins multiple polypeptide chains, each with their own primary, 
secondary and tertiary structure, come together to form the protein complex. Each 
polypeptide chain may be referred to as a subunit, each of which comes together to 
form a functional protein, or protein complex. Quaternary structure refers to both the 
spatial arrangement and the interactions of these subunits (Stryer 2011). 
Ultimately it is thought that a proteins primary structure determines how a protein 
folds into its higher order structure. This was shown by Christian Anfinsen in the 
1950’s (Anfinsen, Redfield et al. 1954, Stryer 2011) and the structure, in turn, 
determines a proteins function. Changes in primary structure can result in variation 
in the manner in which a protein folds. Many inherited diseases are caused as a direct 
result of a DNA mutation which alters the primary sequence of a protein, thus 
altering its three dimensional shape and changing its function. An example of this 
may be found in inherited haemoglobin disorders. It is now becoming apparent that 
misfolded proteins are capable of not only causing, but transmitting disease, such as 
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prion proteins that are thought to be implicated in bovine spongiform 
encephalopathy (Stryer 2011). 
In addition to protein folding, post-translational modifications (PTMs) are an integral 
part of a proteins structure, and play an important role protein function. PTMs take 
many forms including glycosylation, phosphorylation, ubiquitination, lipidation and 
proteolytic cleavage. PTMs can to either to activate or deactivate protein activity, 
determine the cellular localisation of a protein, target the protein for degredation or 
modify the protein structure (Mann and Jensen 2003).  
1.2.2 Methods of studying protein structure  
With protein structure tied closely not only with function, but also with disease, it 
has become vital to study proteins in order to gain an understanding of not only how 
they fold, but also how this relates to their function.  
Proteins, however, are not static structures in solution. They exist as an ensemble of 
structures, by virtue of their ability to flex and move, and it is this inherent flexibility 
that allows many proteins to perform their functions. Changes in the ensemble may 
be as a result of response to external stimuli, such as cooperative binding, or as a 
result of structural changes due to mutation. It is therefore important not only to 
study changes in protein structure but also changes in structural dynamics. There are 
a number of tools available for the study of both protein structure and dynamics. 
Small angle scattering (SAXS) is a solution phase technique suitable for studying 
protein structure. SAXS measures the interference pattern of scattered X-rays to 
provide information on molecular shape. Data is low resolution and therefore is only 
really suitable for studying quaternary and tertiary structure and overall protein 
shape (Kaltashow and Eyles 2005). 
Circular dichroism (CD) utilises the differential absorbance of polarised light by 
chiral molecules to probe protein shape. Specifically, CD is capable of investigating 
secondary structural elements due to the chirality induced by side-chain/ disulphide 
bridge orientation in certain structural elements (Kaltashow and Eyles 2005). 
Vibrational spectroscopy is another low resolution technique suitable for the 
quantification of secondary structure. It exploits the fact that molecules absorb 
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specific frequencies, typically in the infra-red region, that resonate with their 
molecular bonds (Schweitzer-Stenner 2006).  
Whilst these techniques are all capable of studying protein structure the main 
methods of structural elucidation are X-ray diffraction and Nuclear Magnetic 
Resonance, with those techniques mentioned above providing complementary 
information to these high resolution techniques (Schweitzer-Stenner 2006). 
X-ray crystallography is technique capable of providing high resolution (2 - 4Ǻ) 
information regarding a proteins three-dimensional structure. Briefly, crystals are 
grown from a supersaturated protein solution. Crystalline proteins adopt a conserved 
structure which is repeated to form a lattice. X-ray beams are made to diffract off 
these crystals. The diffraction pattern is determined by the atomic positions of the 
atoms, and provides electron density for each repeat unit, or protein molecule, in the 
crystal. The structure of the protein is then calculated from the electron density 
(Keith 2008).  Data quality is unaffected by protein size making it ideal for the study 
of larger biomolecules. It is not, however, without its limitations, foremost being the 
difficulty in obtaining a representative diffracting protein crystal. Optimal conditions 
for growing suitable crystals are unpredictable; screening a number of different 
methods is required for each molecule making the method time consuming for 
routine analysis (Berkowitz, Engen et al. 2012). Optimum conditions typically use 
non-physiological buffers and temperatures that do not adversely affect the protein 
backbone but can alter side chain orientation (Garman 2014). The structure obtained 
by this method is an average of all the protein conformations present within the 
lattice at any given time. Due to the requirement to form a crystalline lattice there is 
a bias in the structural behaviour of a molecule towards a more ordered conformation 
(Garman 2014) and it is possible that the crystal lattice structure is not representative 
of the solution phase structure (Schweitzer-Stenner 2006). Molecules with 
intrinsically disordered regions are often difficult to crystallise due to their inherent 
flexibility, such as Antibody molecules complete with linker regions (Saphire, 
Stanfield et al. 2002).  Despite these limitations X-ray diffraction remains the major 
method used to study protein structure, as evidenced by the inclusion of over 82,000 
protein structures obtained using X-ray crystallography within the Protein Data bank 
(PDB) at the time of writing (PDB 2014). 
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Nuclear magnetic resonance (NMR) has, for many years, been a major method for 
the study of protein structure and dynamics, transient molecular structures, and weak 
interactions. NMR, like X-ray crystallography, is a high resolution technique capable 
of atomic resolution data (Wang, Zhang et al. 2014). NMR is based on the principle 
that atomic nuclei have spin energy levels which split when under the influence of a 
magnetic field. Certain biologically significant atoms (
1
H, 
13
C and 
15
N) with spin 
values of ½ can occupy two spin states, either aligned with or against the magnetic 
field. Application of a radio frequency field causes the atoms to change spin 
alignment. Atoms are then allowed to relax to the ground state, producing a signal, 
which is measured. Resonance frequency is determined by atomic environment and 
the signals provide structural information on atoms linked both chemically, through 
a number of bonds, and through space (Kaltashow and Eyles 2005). NMR suffers 
from a number of experimental limitations. NMR instruments typically have poor 
sensitivity compared with complimentary techniques, requiring milligrams of sample 
to obtain relevant data. NMR is also limited by analyte size; sensitivity and 
resolution are proportional to molecular weight, with molecules of >30 kDa 
suffering from low sensitivity and poor resolution (Berkowitz, Engen et al. 2012, 
Wang, Zhang et al. 2014). There is a need to enrich the isotopic concentration of 
15
N 
and 
13
C and recombinant methods of synthesis are commonly carried out. NMR 
remains a powerful technique for the study of protein structure, with a number 
advances in instrumentation and methods attempting to overcome these limitations 
(Kanelis, Forman-Kay et al. 2001, Wang, Zhang et al. 2014) . 
Hydrogen exchange, or hydrogen deuterium exchange (HDX) as it is now commonly 
known, is a method for studying protein structural dynamics that has historically 
been linked to NMR, but is becoming increasingly associated with mass 
spectrometry.  
HDX is based on the concept that labile hydrogen atoms (
1
H) on a protein may 
exchange with those in solution. Replacing normal protonated buffers with 
deuterated buffers, containing >95% deuterium, ensures that all 
1
H atoms are 
systematically exchanged with deuterium. The kinetics of deuterium incorporation 
may then be measured (Wales and Engen 2006).  
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Whilst all hydrogen atoms have the potential to exchange, HDX studies on protein 
dynamics primarily focus on the backbone amide hydrogens, since more labile 
hydrogen atoms exchange too quickly to be observed (Katta and Chait 1991). The 
chemistry and kinetics of amide hydrogen exchange is now well understood and, for 
unfolded proteins, or polypeptides, it is possible to calculate the intrinsic chemical 
exchange rates (k2, see Equation 1-10) for these backbone amide protons based on 
pH, temperature and neighbouring side chains (Englander 2006). Proton exchange 
may be described using the proton transfer theory (Equation 1-8) (Englander and 
Kallenbach 1983) and is catalysed by the strong acid hydronium (H3O
+
) ion or the 
strong base hydroxide (OH
-
) ion, or their deuterated equivalents.  
𝐴𝐻 + 𝐵 ⇌ (𝐴𝐻 . . . 𝐵 ⇌ 𝐴 . . . 𝐻𝐵) ⇌ 𝐴 + 𝐻𝐵 
Equation 1-8 
Chemical exchange rate is highly dependent on pH and temperature, which are 
rigorously controlled in HDX experiments (Englander 2006). 
The study of folded proteins also takes into consideration both pH and temperature. 
The chemical environment of the backbone amide, determined by adjacent side 
chains, becomes less of a concern in these studies relative to the solvent accessibility 
of the amide and the protection that amide hydrogen has by virtue of hydrogen 
bonding. In a folded protein it is common for many amides such as those on the 
surface of the protein to exchange rapidly, whilst those buried within the 
hydrophobic core exchange more slowly (Wales and Engen 2006). Exchange rates 
between the same amide hydrogen can differ by as much as 10
8
 between folded and 
unfolded protein states (Englander and Kallenbach 1983) as a result of these effects. 
Most amide hydrogens, given enough time, will participate in HX. Even those 
amides buried within the hydrophobic core are capable of exchange as a result of 
local mobility that opens the region up to solvent (Kim, Fuchs et al. 1993). The 
kinetics of exchange, kex, of any amide on a protein can be described using Equation 
1-9 
𝑘𝑒𝑥 = 𝑘𝑓 +  𝑘𝑢 
Equation 1-9 
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Where kex is the sum of the kinetics of exchange of the folded (kf) and unfolded (ku) 
forms of the protein (Kim, Fuchs et al. 1993). kf dominates for those amides not 
participating in H-bonding located towards the surface of the protein, and can further 
be described by using Equation 1-10. 
𝑘𝑓 =  𝛽𝑘2 
Equation 1-10 
where β is the probability factor of exchange (between 0-1), which is a function of a 
number of factors including solvent accessibility and hydrogen bonding 
environment, and k2 is the intrinsic chemical exchange rate for an unstructured 
peptide (as described previously). β values closer to 1 indicate a higher probability of 
water and catalyst presence near an exchanging amide at any given time.  
ku dominates for amides located further from the surface; the kinetics behind their 
exchange is more complex and requires a partial, or complete, unfold of the protein 
for exchange, described in Equation 1-11 
𝐹𝐻   
𝑘1
⇌
𝑘−1
  𝑈𝐻   
𝑘2
→
𝐷2𝑂
   𝑈𝐷  
𝑘1
⇌
𝑘−1
 𝐹𝐷 
Equation 1-11 
where F and U refer to the folded and unfolded forms of the protein, respectively, 
and subscript H and D refer to the protonated and deuterated forms of the protein, 
respectively. The relationship between the rate constants k1, k-1 gives rise to the 
different ku values. In instances where k2 >> k-1 a single unfolding event is sufficient 
for complete amide exchange, thus  
𝑘𝑢  =  𝑘1 
Equation 1-12 
in what is known as EX1 kinetics. Under physiological conditions it far more 
common, however, for k-1 >> k2. In these instances the kinetics of exchange are too 
slow to happen in a single event; the probability of exchange occurring is 
exceedingly low and therefore a number or transitions between folded and unfolded 
states need to occur in order to observe exchange. In these instances ku is described 
as  
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𝑘𝑢 =  
𝑘1
𝑘−1
𝑘2 = 𝑘𝑢𝑛𝑓𝑘2 
Equation 1-13 
where kunf is the constant used to describe the unfolding process (Wales and Engen 
2006). 
Whilst the effects of solvent accessibility and H-bonding are evident, it is not 
possible to differentiate between the two factors using HDX techniques since both 
factors occur in parallel to one another (Wales and Engen 2006). Whilst it was 
initially believed that H-bonding between amides would prevent exchange it is now 
understood that protons participating in H-bonding undergo a transient H-bond 
separation to open the amide to solvent catalysis (Englander 2006). At pH 7 all 
proton exchange is base-catalysed; OH
-
 acts as the catalyst and H2O the source of the 
new proton (or OD
-
 and D2O in the case of deuterated buffer) 
Amide hydrogens have been described as occupying four types of mobility domains 
based on their kinetics; the slow exchange core represents the most protected 
environment and contains the amides that exchange slowest; surface amides that 
exchange rapidly; flexible buried regions, such as loop regions, capable of high 
mobility that exhibit rapid exchange, yet not as rapid as surface amides; and 
secondary structural regions with exchange values between those of the core amides 
and the flexible, buried amides (Kim, Fuchs et al. 1993). 
All of these early kinetic and fundamental studies were carried out using NMR as the 
method of study. Whilst 
1
H has spin ½, and therefore is observable by NMR, 
2
H is 
invisible to NMR, and thus measuring the loss of 
1
H signal gives rise to information 
regarding protein dynamics and kinetics (Kaltashow and Eyles 2005). 
1.3 Biological mass spectrometry 
The advances in technology which were discussed in sections 1.1 Mass 
spectrometry have made it possible to utilise mass spectrometry for the study of 
biomolecules. Over the last 30 years the field has grown to encompass most aspects 
of biological science including the study of DNA, carbohydrates, metabolites and 
proteomes and protein structure (Konermann, Vahidi et al. 2013). 
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1.3.1 Structural mass spectrometry 
Mass spectrometry has unique features amongst the methods described since it can 
be used to answer a number of structural questions; from protein sequence 
information and identification of post-translational modifications to probing 
conformation and dynamics. 
Primary sequence information 
Primary sequence information can be obtained by a using tandem MS approach as 
described in section 1.1.5 Tandem Mass Spectrometry. Typically, peptides 
generated from the protein after proteolytic digestion are analysed within the 
instrument. 
Individual peptides are isolated and subjected to CID; fragmentation occurs along 
the amide backbone generating characteristic ions depicted in Figure 1-11 
(Papayannopoulos 1995) based upon the nomenclature described by Roepstorff 
(Roepstorff and Fohlman 1984). Depending on charge retention the ions are labelled 
on the N-terminal side of cleavage (b-ions) or the C-terminal side (y-ions). CID may 
be performed using Q-TOF, Triple Quad or ion trap instruments typically generate b 
and y ions due to the low energy (10-100eV) used to induce fragmentation  
 
Figure 1-11 - The nomenclature of a CID spectra. Nomenclature is determined by both where the 
fragmentation occurs, and where the charge is retained. Imaged adapted from (Roepstorff and 
Fohlman 1984). 
X
Y
Z
A
B
C
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A typical peptide CID spectrum contains a number of peaks each corresponding to 
different peptide fragmentations. Identification of the mass loss between the peaks 
may be sufficient for identification of primary sequence information, which can 
either be performed manually or computationally. 
Protein Conformation and Dynamics 
There are a number of MS-based experiments capable of probing higher order 
protein structure that utilise native-MS, IMS-MS and HDX coupled to MS (HDX-
MS). 
Native MS 
Native MS is the simplest tool for the study of protein structure since it requires no 
additional instrumentation; it is merely the analysis of a protein, or complex, in its 
native conformational state. As mentioned in section 1.1.2 Ionisation Sources nESI 
is the softest ionisation method and native MS hinges on the low energy transition of 
molecules from solution-phase to gas-phase. During the ionisation process a protein 
is taken from a solvated solution phase environment and transferred to a desolvated, 
gas phase environment. It was initially believed that a protein would not preserve it’s 
higher order structure during ionisation due to the lack of important solvent 
interactions in the gas phase (Wolynes 1995). 
There is increasing evidence that over the timescale of a normal MS experiment a 
protein is able to retain a great deal of the non-covalent interactions it has within 
solution. The evolving structure of a gas-phase protein summarised by Breuker and 
McLaffetry is shown in Figure 1-12 (Breuker and McLafferty 2008). Brueker and 
McLafferty suggest that within a few picoseconds of desolvation the hydrophobic 
side chains collapse onto the protein backbone and self-solvate (Steinberg, Elber et 
al. 2008), and that it is not until a number of milliseconds following self-solvation 
that non-covalent interactions are lost. More recent MD simulations provided by van 
der Spoel indicate that a biomolecule in the gas phase is capable of forming and 
increased number of hydrogen bonds relative to a solution environment. Crucial 
hydrogen bonds between secondary structural elements are preserved in the gas 
phase whilst additional bonds form between the desolvated side chains which would 
normally form hydrogen bonds with the solvent. This data suggests that the 
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structures observed in the gas phase may be kinetically trapped in near solution-
phase conditions (van der Spoel, Marklund et al. 2011). Further evidence for the 
preservation of a solution-like structure has been provided by ion-mobility mass 
spectrometry based experiments. The Bowers group have shown that Ubiqutin 
studied by drift cell IMS-MS has a similar gas phase CCS compared to its solution 
CSS. The same studied also indicated that Ubiquitin retained the same conformation 
in the gas phase for >100 ms following desolvation (Wyttenbach and Bowers 2011).  
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Figure 1-12 - The evolution of gas phase protein structure over time. 
A - The solvent droplet containing solution phase structure protein is produced via nano-ESI. Protein is surrounded by water which (B) begins to evaporate as the ion 
traverses the source region. Water molecules are lost from the bulk of the protein, remaining clustered to the exposed basic sites until (C) eventually all solvent molecules are 
lost, leaving only a gas phase protein ion in a solution phase structure. All of this occurs within the first few nanoseconds of ionisation. Following desolvation (D) the charged 
side chains self-solvate, folding onto the protein backbone. This occurs within picoseconds of desolvation. Over the next few milliseconds the protein undergoes successive 
loss of hydrophobic (E) and electrostatic (F) interactions, forming a stable gas phase structure. Structures A to D can be retained in the gas phase for up to 100 ms 
(Wyttenbach and Bowers 2011). Figure adapted from (Breuker and McLafferty 2008).  
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The preservation of these non-covalent interactions are highly dependent on 
experimental conditions and instrument settings (Skinner, Breuker et al. 2013). 
Optimisation of these parameters is crucial and the effects of these conditions have 
been explored and summarised by a number of groups.  
Small molecule and proteomics applications of MS make use of volatile, organic 
solvents, such as methanol and acetonitrile, commonly containing 0.1-2% organic 
acid. These buffers are unsuitable for native MS as they denature all but the most 
stable proteins. To ensure a protein complex remains in a native state a solution of 
ammonium acetate, or ammonium bicarbonate, with a pH range of 6 – 8 is typically 
used for analysis; both ammonium and acetic acid have high enough volatility to 
allow for the formation of ESI droplets and adequate desolvation (Hernandez and 
Robinson 2007). 
Native protein ions typically have high m/z by virtue of their large molecular weight 
and low charge state.  As a result, these ions are less affected by the normal RF 
methods for radially confining ions during transmission through an MS instrument 
(Benesch, Ruotolo et al. 2007). Ion transmission can be improved by increasing the 
pressure within the interface of the MS system (Tahallah, Pinkse et al. 2001) with 
different pressures proving optimum for different biological molecules (Douglas and 
French 1992). This observation was initially attributed to collisional cooling; the 
increased gas pressure inducing a number of low energy collisions that each served 
to leach energy from the ion, reducing the internal kinetic energy of the ion and thus 
preserve the non-covalent interactions. A more recent study by Krutchinsky et al has 
suggested that the transition between the atmospheric pressure of the source and the 
rough vacuum of the instrument results in the radial expansion of the cloud of ions 
produced by nESI. The rapid axial and radial acceleration of the ions can cause a 
change in the ion trajectory, resulting in fewer ions transitioning into the mass 
analyser (Krutchinsky, Chernushevich et al. 1998). Increasing the gas pressures 
induces a collisional dampening effect whereby ion-neutral collisions reduce the 
axial and radial kinetic energy of the ions and help better focus the ion beam 
(Benesch, Ruotolo et al. 2007).  
Whilst collisional dampening has a positive effect on ion transmission the ion-
neutral collisions convert the axial and radial kinetic energy from ion motion into 
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internal ion energy, effectively increasing the internal ion temperature (Benesch, 
Ruotolo et al. 2007), which can lead to ion activation and fragmentation 
(Konijnenberg, Butterer et al. 2013). Careful control of the ion temperature is vital 
for any native MS experiment, as over excitation of the ion can lead to 
fragmentation, whereas over cooling of an ion can lead to ions forming ‘frozen’ 
clusters with solvent vapour still within the source (Konijnenberg, Butterer et al. 
2013). Ion temperature is carefully controlled by a series of acceleration voltages and 
gas collision, such as those described above.  
Evaporative cooling is another major factor contributing to ion internal temperature. 
Tang and Kebarle observed that the initial temperature of an ESI droplet is always 
lower than the ambient environmental temperature due to the effects of solvent 
evaporation (Kebarle and Tang 1993, Tang and Kebarle 1993). MD simulations by 
Caleman and van der Spoel suggest that solvent evaporation can reduce the droplet 
temperature dramatically over a short period of time; Caleman and van der Spoeal 
report a temperature loss of 65 K over 500 ns for droplets starting at an initial 
temperature of 275 K (Caleman and van der Spoel 2006, Caleman and van der Spoel 
2007). Increased starting temperature has also been shown to increase the rate at 
which the temperature drops (Caleman and van der Spoel 2006).  
Native MS experiments are an inherent compromise between ion cooling and 
excitation. Many publications advocate the use of low source temperatures and low 
voltages to preserve the non-covalent interactions of a protein/ protein complex 
(Hernandez and Robinson 2007, Ruotolo, Benesch et al. 2008, Kirshenbaum, 
Michaelevski et al. 2010, Salbo, Bush et al. 2012), using careful optimisation of the 
acceleration voltages to dissociate any solvent adducts via CID. Whilst it is possible 
to obtain well resolved peaks for native MS spectra it should be noted that native MS 
experiments are not well suited for the observation of accurate mass, and that 
residual hydration can actually further stabilise the protein structure (Patriksson, 
Marklund et al. 2007, Steinberg, Breuker et al. 2007) 
Assuming all required experimental parameters are met, it is possible to gain a great 
deal of information from native MS experiments. The charge state distribution of a 
native protein can provide insight into the structure and conformation of a protein 
(Konijnenberg, Butterer et al. 2013). Native proteins have been observed to have a 
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narrower charge state distribution at higher m/z than unfolded proteins (Katta and 
Chait, 1993); folded proteins have fewer exposed basic sites to protonate as a result 
of their folded structure. Folding of a protein under different experimental conditions 
can be tracked by observing changes in charge state distribution, such as the thermal 
unfolding of heat shock proteins (Benesch, Sobott et al. 2003). 
Information regarding the stoichiometry and subunit composition of protein 
complexes has also been obtained by MS using a number of experimental 
approaches. Using carefully controlled solution conditions it is possible to partially 
destabilise a complex in solution, whilst retaining non-covalent interactions. The 
high electric field gradient associated with ionisation, coupled with the stability 
reduction lost due to removing solvent hydrogen bonding, may result in the complex 
undergoing dissociation during this process, allowing the observation of subunits in 
their native-like states (Rostom and Robinson, 1999). 
Collisional Activation 
Collisional activation, the process of using increased collision voltages to induce 
dissociation, can also be used to study protein complex assembly. Whilst a number 
of activation methods can be used, the most documented method has been CID 
(Benesch, Ruotolo et al. 2007). CID activation of protein complexes follows one of 
two mechanisms; either the complex undergoes symmetric dissociation into equally 
sized subassemblies or, more commonly, the complex undergoes asymmetric 
dissociation, losing a single subunit to form a monomer and a “stripped oligomer” 
(the complex minus one monomer) (Benesch, Aquilina et al. 2006). Interestingly, in 
these instances the charge distribution on dissociation also appears to be asymmetric, 
with the departing monomer taking many additional charges from the main complex 
despite its significantly smaller size (Benesch, Ruotolo et al. 2007)Collisional 
activation using the skimmer cone can also lead to collisional activation, and follows 
a similar mechanism of dissociation as CID activation (Benesch, Ruotolo et al. 
2007) 
Ion Mobility Mass Spectrometry  
The underlying principles of IMS-MS, including estimating collision cross sections 
for native proteins and complexes, has already been discussed in sections  1.1.7 
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Travelling Wave Ion Mobility and 1.1.8 Calibration of Ion Mobility data. 
Typically IMS-MS is used as a tool to investigate protein conformation at low 
resolution. A protein is assumed to retain solution phase conformation(s) upon 
transfer to the gas phase for the timescale of the mobility experiment (ms). IMS-MS 
can be used to separate conformations based on Ω and m/z, providing information on 
the conformation ensemble of a protein, represented by arrival time distribution 
(ATD). Where a protein adopts multiple conformations, these will manifest as a 
single charge distribution on the m/z scale, but multiple arrival times on the drift 
time scale. 
In the same way that changes in charge distribution are suggestive of unfolding, 
changes in a molecules ATD can be used to study the effect of solvent, 
thermal/collisional heating, mutagenesis or ligand binding on the protein 
conformation.  
Hydrogen Deuterium Exchange Mass Spectrometry 
As outlined in section 1.2.2 Methods of studying protein structure HDX is a 
solution phase technique, which has been used to study changes in protein 
conformation and dynamics. Much of the early work on HDX was performed using 
NMR, however since the work by Katta and Chait (Katta and Chait 1991) in the 
early 1990’s HDX has been increasingly coupled to MS. HDX-MS brings together 
both hydrogen deuterium exchange and mass spectrometry to create an analytical 
technique sensitive to minor changes in protein conformation, with the speed and 
broad sample applicability of mass spectrometry (Jaswal 2013). Recent advances 
have seen the development of automated HDX-MS techniques (Waters 2014) which 
have seen HDX-MS employed by a number of groups. HDX-MS is typically used to 
study the effects of ligand binding, protein-protein interactions and proteins with 
intrinsic disorder (Balasubramaniam and Komives 2013, Jaswal 2013). Whilst 
observing changes in deuterium uptake at a whole protein level can provide 
information on conformational change, the crucial step in any HDX-MS experiment 
is the localisation of the regions of deuterium uptake. This is achieved by means of 
proteolytic digest of a labelled protein, followed by LC-MS detection of the labelled 
peptides (Pan, Han et al. 2012) Since the LC-MS system operates using protonated 
buffer a great deal of work has gone into optimising the instrument conditions to 
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limit the degree of proton exchange that occurs during proteolysis/chromatographic 
separation. HDX kinetics are well understood, and it has been shown that rates of 
exchange are lowest at pH 2.5 and 0°
 
C (Englander, 2006). Following the labelling 
step, samples are quenched to these conditions to reduce any additional exchange 
with proteated buffer, and to denature the protein prior to proteolysis. Since quench 
conditions require low pH for reduced enzyme kinetics, Pepsin is used as the 
proteolytic enzyme of choice since it retains its activity in acidic conditions (Smith, 
Deng et al. 1997, Wales and Engen 2006, Zhang, Chien et al. 2010, Konermann, Pan 
et al. 2011) Identification of a number of redundant peptides helps improve the 
spatial resolution, and supplemental fragmentation in the mass spectrometer can 
improve spatial resolution up to single amino acid exchange data (Rand, Zehl et al. 
2009, Landgraf, Chalmers et al. 2012). Following the acquisition of peptide/ amino 
acid resolution exchange data, exchange information can be mapped onto a protein 
crystal structure to visualise regions of exchange/ change. 
1.4 Aims and Objectives 
The aim of this project was to use MS based techniques to investigate the structural 
and dynamics differences in a number of different proteins. The principal method 
used was native ion mobility mass spectrometry; a technique capable of probing 
disruptions in the proteins overall conformation. Three protein systems were 
investigated; prolyl oligopeptidase (Chapter 3) in collaboration with Dr Dean Rea 
and Dr Vilmos Fulop at the University of Warwick, haemoglobin (Chapter 4) and 
antibody Fc domains (Chapter 5) as part of a CASE funded research project with 
MedImmune. 
The main aims of the research project were: 
1) To use ion mobility mass spectrometry to probe the conformation of prolyl 
oligopeptidase and other related family enzyme to provide information 
regarding the mechanisms of substrate binding, and to study changes in the 
conformation as a result of ligand binding. 
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2) To use recent improvements in sample preparation and ion mobility mass 
spectrometry to further our understanding of the structural differences 
between haemoglobin variants known to cause disease 
 
3) To use a combination of ion mobility mass spectrometry and hydrogen 
deuterium exchange mass spectrometry to study the conformational 
differences between four IgG Fc domains engineered for different functions. 
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2.1 Materials 
2.1.1 Protein samples 
Prolyl oligopeptidase (Prep) and dipeptidyl peptidase IV (DPP IV) were provided by 
collaborators within the School of Life Sciences. Both samples were supplied at a 
concentration of 7.5 µM. Prep and DPP IV inhibitor, a ZPP-like inhibitor, was 
provided at a concentration of 100 mM in 10 mM sodium phosphate, 150 mM 
sodium chloride. 
Samples of fresh whole blood containing heterogeneous normal (HbA), sickle (HbS) 
and haemoglobin C (HbC) were supplied by University Hospitals Coventry and 
Warwickshire NHS Trust.  
Four fully human intact antibodies were provided by MedImmune (Cambridge, UK). 
Antibodies were expressed by Chinese hamster ovary cell lines and purified using 
protein A as the primary capture step, followed by established polishing steps to 
remove any remaining impurities. IgG-WT, IgG-TM and IgG-YTE were formulated 
in 50 mM sodium acetate, 100 mM sodium chloride, pH 5.5. IgG-TMYTE was 
formulated in 25 mM histidine, 7% sucrose, pH 6.0.  
Commercially-available lyophilised haemoglobin A and haemoglobin S, cytochrome 
C (equine heart), serum albumin (bovine), Avidin (egg white), Alcohol 
Dehydrogenase (saccharomyces cerevisiae), β-lactoglobulin (bovine milk) and 
glutamate dehydrogenase (bovine liver) were purchased from Sigma Aldrich LTD 
(Gillingham, UK). 
2.1.2 Reagents 
High-grade chemical reagents, including high purity water and acetonitrile, were 
obtained from J.T. Baker (Phillipsburg, NJ, USA) and Sigma-Aldrich (Gillingham, 
UK). Sodium acetate, caesium iodide, sodium iodide, diisoproply fluorophosphate, 
sodium chloride, sodium phosphate monobasic, sodium phosphate dibasic, 
endoproteinase lys C (Lysobacter enzymogenes) were all supplied by Sigma-Aldrich 
(Gillingham, UK). Deuterated water was obtained from Cambridge Isotope Labs 
(Tewksbury, MA, USA). 
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2.2 Methods 
2.2.1 Sample Preparation 
Chapter 3: Preperation of Prolyl oligopeptidase for MS analysis 
500 µL of Prep and DPP IV were spun at 13,000 rpm for 15 minutes in centrifugal 
filter units with a 10 kDa cut-off (Amicon
®
 Ultra 0.5 mL 10 K, Millipore, Ireland) to 
concentrate to a final volume of 50 µL. Sample retained on filter was diluted to 500 
µL using 200 mM ammonium acetate. This process of concentration and dilution 
was repeated a further five times (six spin steps in total) to desalt the protein.  
Following incubation with ZPP-like inhibitor, the sample was subject to a further 
two centrifugal filtration steps, using the same conditions as above, to remove the 
salts and inhibitor prior to MS analysis. 
Chapter 4: Preparation of whole blood samples 
Whole blood samples were prepared by diluting 20 µL aliquots to a final volume of 
500 µL in 10 mM ammonium acetate pH 6.8. 500µL of protein sample was spun at 
13,000 rpm for 15 minutes in centrifugal filter units with a 10 kDa cut-off (Amicon
®
 
Ultra 0.5 mL 10 K, Millipore, Ireland) to concentrate to a final volume of 50 µL. 
Sample retained on filter was diluted to 500 µL using 10 mM ammonium acetate. 
This process of concentration and dilution was repeated a further five times (six spin 
steps in total) to desalt the protein. 
Chapter 5: Preparation of IgG Fc’s for MS analysis.  
Proteolytic digestion of mAb to Fc constructs 
In order to obtains Fc fragments the intact IgG molecules were subject to partial 
proteolytic cleavage using endoproteinase lys C. The protocol used was optimised 
based on protocols published in Lau et al (Lau, Pace et al. 2010), Masuda et al and 
(Masuda, Yamaguchi et al. 2000) Kleeman et al (Kleemann, Beierle et al. 2008). 
IgG1 samples were buffer exchanged into phosphate buffered saline (PBS) – 10mM 
sodium phosphate, 150 mM NaCl, pH 7.4. Endoproteinase lys C was added in a 
400:1 IgG: enzyme ratio. The reaction was performed at room temperature and 
terminated after 30 min with addition of proteinase inhibitor diisopropyl 
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fluorophosphate (DIFP). DIFP was made up to 1 M and added in a 1:1 ratio (by 
volume) with the lys C to ensure complete lys C inhibition. 
Purification of Fc’s from Fc/ Fab mixtures. 
Purification of the Fc’s were attempted using two different approaches; Protein A 
extraction and CaptureSelect affinity purification. 
CaptureSelect affinity purification 
CaptureSelect affinity purification kits contain an immobilised 13kDa llama 
antibody V-domain which shows binding affinity to a wide variety if IgG Fc 
domains, including human IgG1, as the affinity matrix.  
CaptureSelect affinity spin columns were equilibrated using 10 mM sodium 
phosphate, 150 mM NaCl at pH 7.4. Fc/ Fab mixture was added to the pre-
equilibrated columns and incubated by end-over-end mixing at room temperature for 
30 minutes. Fab was eluted from the column by centrifugation. To ensure complete 
elution of Fab, the column was washed further three times using 10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4. Fc’s were eluted from the column using 200 mM 
glycine buffer, pH 2.8. 
Protein A Purification 
Purification was performed using a Freedom EVO Liquid handling robot (TECAN). 
MabSelect SuRe resin (GE Healthcare Life Sciences), an immobilised Protein A 
resin, prepacked in MediaScout columns (Attol) was used as the affinity matrix. 
Columns were equilibrated with 50 mM sodium phosphate, 150 mM NaCl pH 6.6 
prior to sample loading. Unbound Fc was eluted in three PBS washes, and protein 
non-specifically bound to the resin was released using a detergent wash. Fc was 
released from the column using 50mM sodium acetate, pH 3.6. The pH of the eluent 
was adjusted to pH 5.5 using 500mM sodium acetate, pH 6.6 for storage prior to 
analysis. 
Following elution from the columns, Fc fragments were analysed using LC-MS to 
confirm identity. 
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IgG Fc [protein A] elutions obtained from endoproteinase digestion were buffer 
exchanged into 200 mM ammonium acetate, pH 6.8, prior to native  MS analysis. 
500µL of protein sample was spun at 13,000 rpm for 15 minutes in centrifugal filter 
units with a 10 kDa cut-off (Amicon
®
 Ultra 0.5 mL 10 K, Millipore, Ireland) to 
concentrate to a final volume of 50 µL. Sample retained on filter was diluted to 500 
µL. This process of concentration and dilution was repeated a further five times (six 
spin steps in total) to desalt the protein. All centrifugation was performed in a chilled 
centrifuge set at 4 
o
C. 
Preparation of calibration standards for ion-mobility mass spectrometry 
All lyophilised protein standards used for collision cross section estimation were 
prepared at concentrations of 1 mg/mL in 200mM ammonium acetate pH 6.8. 500µL 
of protein sample was spun at 13,000 rpm for 15 minutes in centrifugal filter units 
with a 10 kDa cut-off (Amicon
®
 Ultra 0.5 mL 10 K, Millipore, Ireland) to 
concentrate to a final volume of 50 µL. Sample retained on filter was diluted to 500 
µL with 200mM ammonium acetate. This process of concentration and dilution was 
repeated a further five times (six spin steps in total) to desalt the protein.  
2.2.2 Sample analysis  
Instrumentation 
All native MS and IM-MS experimental data was acquired on a Synapt G1 
instrument (Waters, Manchester, UK) commercially modified with a 32K 
quadrupole RF generator to allow selection of high m/z ions. All samples were 
introduced into the source region of the Synapt G1 by direct infusion using nano-ESI 
by means of fused silica nanospray needles (Waters, Manchester, UK). The ion 
mobility separation gas used in for analysis was nitrogen (N2) 
Confirmation of digestion and purification of the Fc was assessed by means of LC-
MS. Separation was achieved using an ACQUITY UPLC system (Waters 
Corporation), with spectra acquired on a Synapt G1 HDMS system (Waters, 
Manchester, UK) fitted with a standard 8k quadrupole RF generator.  
Hydrogen deuterium exchange was performed using a CTC PAL sample handling 
robot (LEAP Technologies) with online digestion and peptide separation using an 
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HDX Manager (Waters, Manchester, UK.). Peptides were analysed using a Synapt 
G2 HDMS instrument (Waters, Manchester, UK). 
Calibration of TOF 
In all cases, the TOF mass analyser was calibrated using 2 mg/mL caesium iodide in 
50% aqueous propan-2-ol over a suitable mass acquisition range, usually 1000-
10000 m/z for native MS experiments, and 500-5000 m/z for denatured MS 
experiments. 
Chapter 3: Mass spectrometry analysis of PREP and DPP IV 
The capillary voltage was varied between 1.0-1.1 kV, sampling cone voltage was set 
to 100V and the source temperature 40
o
C. The Trap and Transfer acceleration 
energies were set at 4kV. The backing pressure was maintained between 1.8 and 2 
mBar, the Trap DC bias was increased to 30kV to increase desolvation.  
Ion mobility separation experimental values were optimised for POP enzymes, and 
kept constant. Wave velocity was set to 300 m/s, wave height was set to 10 V and 
IMS gas pressure was set to 0.443 mBar.  
During IMS experiments cone voltage was varied between 60 V and 200 V in order 
to provide activation energy and investigate differences in dynamics. 
Chapter 4: Mass spectrometry analysis of haemoglobin variants 
For denatured mass spectrometry aliquots of HbA, HbS and HbC from whole blood 
were diluted 1/1000 in 50 % ACN, 0.5 % HCOOH and infused into the mass 
spectrometry. Data obtained for each sample were deconvoluted over an appropriate 
m/z range for the species using the MaxEnt1 processing algorithm, within the 
MassLynx™ (v4.1) software, to provide an estimate of molecular mass. 
For native mass spectrometry, instrument acquisition conditions were based on the 
previously established conditions used by Scarff et al (Scarff, Patel et al. 2009). The 
capillary voltage was set to 1.2 kV, sampling cone voltage of 60 V, trap and transfer 
acceleration voltages set to 10 kV and 4 kV respectively. Source temperature was set 
to 37
o
C. 
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The effects of source pressure on calibration and on estimated CCS/ arrival time 
were studied  and varied between high pressure (6.6-6.8 mBar) and low pressure 
(3.6-3.7 mBar). 
Ion mobility separation experimental values were based on those taken from Scarff 
et al (Scarff, Patel et al. 2009) and kept constant. Wave velocity was set to 400 m/s, 
wave height was set to 18 V and IMS gas pressure was set to 0.542 mBar. 
Chapter 5: Mass spectrometry analysis of antibody Fc domains 
Confirmation of digestion and purification of the Fc was assessed by means of LC-
MS. 2 µg of protein was loaded onto a reverse-phase BEH300 C4 analytical column 
(2.1 x 50 mm, 1.7 µm). Elution was performed at a flow rate of 0.150 mL/min by 
increasing the solvent concentration from 5-42% over 18 minutes. Solvent A 
composition was 0.01% TFA, 0.1% FA in Water, solvent B composition was 0.01% 
TFA, 0.1% FA in acetonitrile..  
For native MS analysis, capillary voltages were set at 1.0 kV. Source temperature 
was set at 30
o
C to reduce protein unfolding in the source. Sampling cone voltage was 
100 V, extraction cone voltage was set at 10 V, Trap and Transfer acceleration 
voltages were set at 15 V to assist with collisional cooling. The source pressure was 
increased to 2.6 mBar. Trap DC bias was optimised to achieve a balance between 
desolvation and signal intensity, and a value of 10 V selected. 
Ion mobility separation values used were optimised for IgG Fc-WT and kept 
constant for all other mutants. The IMS wave velocity at 300 m/s and wave height 
was set at 10 V, IMS gas pressure set to 0.437 mBar. 
Hydrogen/ deuterium exchange MS 
Hydrogen/ deuterium exchange was initiated by 20-fold dilution of IgG1-Fc (10 μM, 
in protonated aqueous buffer, 10  mM sodium acetate, pH 5.50) into deuterated 
buffer (10  mM sodium acetate, pD 5.50) at 293 K. After between 10 s to 24 h 
incubation, hydrogen-exchange was quenched by mixing 1:1 with pre-chilled quench 
buffer (100 mM sodium acetate, 1.0 M TCEP, 8 M urea) to a final pH of 2.55 at 274 
K. Sample was immediately digested using a pepsin-agarose column (Porozyme) and 
the resulting peptides separated on a C18 column (1x100 mm ACQUITY BEH 1.7 
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μm, Waters, Manchester, UK.) with a linear gradient of acetonitrile (3-40 %) 
supplemented with 0.1 % formic acid at 273.5 K. Peptides were analysed using a 
Synapt G2 mass spectrometer (Waters, Manchester, UK.). Peptides were identified 
by MSE fragmentation (2 of 3 replicates with 0.3 fragments per amino acid). Key 
hinge peptides were confirmed using targeted MS/MS fragmentation. 
Deuterium incorporation was measured in DynamX (Waters Corp.) by subtracting t0 
peptide 
2.2.3 Estimation of rotationally averaged collision cross section 
Calibration of the data, protein cross section estimation and theoretical cross-section 
calculations were performed as detailed in 1.1.8 Calibration of Ion Mobility data. 
Protein standards were analysed under the same experimental conditions as those 
used for the analyte molecules.  Protein calibration standards were chosen based on 
the drift time through the ion mobility cell. Standards with drift times which 
bracketed the drift time of the analyte ionswere selected in each case. 
For PREP and DPP IV avidin (egg white), alcohol dehydrogenase (saccharomyces 
cerevisiae) and glutamate dehydrogenase (bovine liver) were found to be suitable 
calibration standards 
For Hb variants cytochrome C (equine heart) and serum albumin (bovine) were 
found to be suitable calibration standards 
For the mAb Fc domains cytochrome C (equine heart), β-lactoglobulion (bovine 
milk), and alcohol dehydrogenase (saccharomyces cerevisiae) were used as T-wave 
calibrants. 
2.2.4 Computational Modelling 
Generating computationally derived CCS estimates using MobCal. 
Four computational methods were used to create CCS models from X-ray diffraction 
crystal structures; PA, EHSS, TM and PSA. For the PA, EHSS and TM methods 
MOBCAL, created by the Jarold group, (Mesleh, Hunter et al. 1996, Shvartsburg 
and Jarrold 1996) was used. MOBCAL requires files to be converted from .PDB to 
.mfj file format for the software, which was achieved using in-house software. The 
PSA method, introduced by the Bowers group (Bleiholder, Wyttenbach et al. 2011) 
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uses a web-based form to submit structures for analysis. Data files must be submitted 
as .xyz coordinate files. OpenBabel was used for the conversion of .pdb files to .xyz 
files. All computationally derived CCS estimates from all methods were obtained 
using helium (He) as the buffer gas. To compare He computational CCS values with 
N2 CCS estimates, He values have been corrected from PA, EHSS, TM and PSA to 
PA’, EHSS’, TM’ and PSA’. Correction factor was determined by comparing the 
molecular weight of the analyte protein with an appropriate calibration standard 
protein from Bush et al, based on the observation that the differences between He 
and N2 CCS values obtained from drift cell data is dependent on molecular weight 
(Bush, Hall et al. 2010).  
For Chapter 3 - Conformational studies of Prolyl Oligopeptidase family enzymes, a 
correction factor of 9% has been used for PREP, and a correction factor of 7% has 
been used for DPP IV. 
For Chapter 4 - : Investigating the structural differences in haemoglobin variants, a 
correction factor of 10% has been used for Hb tetramer, and a correction factor of 
12% has been used for the Hb dimer. 
Generating the crystal homology model for HDX data output 
Homology models for Fc-WT, Fc-TM, Fc-YTE and Fc-TMYTE were built using 
Discovery Studio software from Biovia (formerly Accelrys Software Inc.). These 
were constructed from crystal structures of 3AVE (Fc-WT), 3C2S (Fc-TM) and 
3FJT (Fc-YTE) which served as templates for the different Fcs. The Trastuzumab 
(Herceptin) model structure was used as the template for the hinge region (Brandt, 
Patapoff et al. 2010). Models were assembled as shown in Table 2-1. Sequence 
alignments are shown in Appendix A. 
Model name 3AVE 32CS 3FJT Trastuzumab 
Fc-WT     
Fc-TM     
Fc-YTE     
Fc-TMYE     
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Table 2-1 – A table showing the different crystal structures used to create the Fc homology models. 
Multiple sequence alignments were made between template and target sequences 
using ClustalW and are shown in the appendix. 100 homology models were 
generated with a random seeding of deviation from initial atomic co-ordinates. Each 
model was energy minimised and two scores were calculated: DOPE and PDF N-
total. Models were ranked by PDF N-total and then DOPE and the top model for 
each mutant was selected. 
HDX data fitting 
Data normalisation was calculated between mutant and wild type data sets using in-
house software written by Dr Jonathan Phillips (MedImmune, Cambridge, UK) in 
MatLab (Mathworks) and Python. Structural representations were generated with 
PyMol (Schrödinger LLC) and plots in Figure 5-33 - 5-37 prepared with Prism 
(GraphPad).  Hydrogen/deuterium-exchange was represented in Figure 5-32 by 
calculating the mean deuteration level per amino acid, according to Equation 2-1.  
?̅?𝑗 =
1
𝑛
∑
1
𝑞
∑ (𝑚𝑖
𝑡 − 𝑚𝑖
0)
𝑡
0
𝑛
1
 
Equation 2-1 
M̅j is the mean deuteration level at amino acid j, n is the number of overlapping 
peptides, q is the number of exchangeable amides for peptide species i, mi
t is the 
isotopic weighted midpoint at time t and mi
0 is the midpoint at time 0 (undeuterated). 
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3.1 Introduction 
There are a number of reasons why a protein or peptide may be digested from 
polypeptide to individual amino acids; many proteins are broken down as a result of 
digestion of food matter; some intracellular proteins are only permitted within cells 
for a small period of time before degradation; defective proteins or peptides, created 
as a result translation errors or protein misfolding, are sometimes targeted for 
destruction before even entering the cytosol (Stryer 2011). All proteins are digested 
by proteolytic enzymes known as proteases, commonly referred to as peptidases. 
Approximately 2% of all proteins are peptidases (Rea and Fulop 2006). It was 
initially believed that these peptidases only played a role in nonspecific digestion of 
ingested protein matter, but it has since become apparent that peptidases can also 
play a pivotal role in protein post-translational modifications. Peptidases have been 
implicated in a number of biological processes including fertilisation, embryonic 
development, cell cycle regulation, immune response and apoptosis (Stryer 2011). 
Peptidases, like many enzymes, may be subdivided into families based on sequence 
homology. Families may then be further subdivided into clans based on shared 
tertiary structural motifs, suggestive of a common ancestral heritage. Enzymes may 
also be given a tag relating to their catalytic mode of action; there are six tags 
relating to four mechanisms of peptidase catalytic activity (A, C, M, S for the 
aspartic, cysteine, metallo and serine mechanisms, respectively), a mixed catalytic 
type (P) and an unknown type (U) (Barrett and Rawlings 1995). 
Prolyl oligopeptidase (POP) family enzymes are clan SC peptidases that share a 
conserved catalytic domain which adopts an α/β-hydrolase topology; a protein fold 
found in a number of enzymes including esterases, lipases, thioesterases and 
hydroxynitrile lyases (Holmquist 2000). The active site forms around a catalytic triad 
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compromised of an aspartate (Asp), histidine (His) and serine (Ser). This catalytic 
triad is also found in at least four other serine proteases, suggesting a conserved 
catalytic mechanism. 
Prolyl oligopeptidase, formally known as prolyl endopeptidase (PREP), is a key 
enzyme in the POP family and has been the subject of numerous studies. It is larger 
than other serine peptidases; PREP is an 80 kDa protein whereas trypsin and 
subtilisin, both serine proteases, are only 25 – 30 kDa. PREP is only capable of 
digesting short amino acid sequences of approximately 30 residues in contrast with, 
for example, trypsin which acts on whole proteins (Rea and Fulop 2011). Selective 
digestion on these short peptides is determined by the size exclusion of larger 
peptides and proteins from the active site, (Fülöp, Böcskei et al. 1998) discussed in 
more detail below. PREP has also been implicated in a number of diseases. Whilst 
PREP is widely distributed across the body, it is particularly concentrated in the 
brain and has been linked to several psychiatric disorders, including depression, 
mania and bulimia as well as neurodegenerative disorders including Parkinson’s and 
Alzheimer’s (Rea and Fulop 2011). PREP has been identified as a potential drug 
candidate, and has been extensively characterised structurally. 
The crystal structure of porcine PREP (PDB:1QFM) is shown in Figure 3-1. 
 
Figure 3-1 - The crystal structure of porcine Prolyl Endopeptidase (PDB 1QFM). 
β-propeller domain is highlighted in blue, catalytic α/β beta-hydrolase domain is highlighted in red. 
The active site is located in a central cavity between the two domains. Access to the active site is 
therefore size restricted, with only short peptide sequences able to gain access to the active site.  
180o 180o
A B C
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PREP is an 80.7 KDa monomeric protein comprised of two discrete domains; 
residues 1-72 and 428-710 make up the α/β-hydrolayse catalytic domain whilst 
residues 73-427 make up a 7-bladed β-propeller (Rea and Fulop 2006). β-propeller 
domains are found in a number of proteins, and are formed by a repeating four-
stranded antiparallel β-sheet motif that comes together to form the propeller. Many 
proteins with this motif have evolved a manner in which to close the full circle of the 
propeller (known as the Velcro of the propeller).  In G-proteins the N- and C-
terminal strands come together to form a single blade of the propeller, creating a 
number of H-bonds which close the circle (Fülöp and Jones 1999).  PREP was the 
first protein discovered that exhibited an open-topology; the only interactions 
stabilising the first and last blade were hydrophobic interactions between blades 1 
and 7 (Figure 3-2). This has been commonly referred to as open-Velcro topology. No 
descriptions of the specific hydrophobic interactions have been described (Fülöp and 
Jones 1999). 
 
Figure 3-2 - The open topology of the PREP β-propeller. The first (N-terminal) blade, shown in blue, 
is held together with the seventh (C-terminal) blade, shown in red,  by virtue of hydrophobic 
interactions only. 
The active site residues lie in a central cavity located between the α/β-hydrolase and 
β-propeller domains. This cavity is approximately 8500 Å2 in size (Rea and Fulop 
2011) making it able to accommodate large peptides. Despite this, PREP’s 
distinguishing catalytic feature is its ability to digest smaller peptides of 
approximately 30 residues. The presence of the β-propeller protects the active site 
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and acts to prevent larger, or more structured, peptides accessing the active site. 
There is a small opening at the base of the propeller, shown in Figure 3-2, of 
approximately 4 Å in diameter, and it was initially suggested that this pore, although 
too small to allow a small peptide (typically 6-12 Å in size) through, could widen to 
allow substrate passage into the active site. This was consistent with previous studies 
on PREP kinetics which suggested a conformational change was the rate-
determining step in PREP catalysis (Polgar 1991, Polgar 1992, Szeltner, Rea et al. 
2004). Given the unique topology of the β-propeller in PREP, it was initially 
believed that the separation of the first and seventh blades could widen the pore size 
enough to allow substrate entry (Fülöp, Böcskei et al. 1998). Mutagenesis 
experiments which introduced disulphide bridges between blades one and seven 
supported this theory, indicating that, under reducing conditions, the mutant enzyme 
was active, but it could be selectively deactivated by employing oxidising conditions 
(Polgar 1992). 
This mechanism was commonly accepted until 2005 when a bacterial PREP was 
crystallised in an open conformation (Figure 3-3) (Shan, Mathews et al. 2005), 
suggesting that an alternative mechanism of substrate entry may be possible. 
 
Figure 3-3 – The crystal structure of PREP in the open topology, from PDB file (1YR2) 
In this mechanism, the loops which connect the two domains are thought to act as a 
hinge, allowing the two domains to separate for substrate entry and refold following 
ligand binding. Interestingly, it was observed that PREP in complex with a substrate-
180o
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homologue could not be crystallised in an open conformation, suggesting an induced 
conformational stability following ligand binding.  In a study by Li et al (Li, Chen et 
al. 2010)it was shown that PREP, crystallised in an open conformation, could be 
made to adopt the closed conformation upon treatment of the crystals with substrate 
and inhibitor, strongly supporting an induced fit mechanism. Additional information 
provided by NMR studies suggests that both these open and closed structures exist in 
equilibrium in solution, supporting a mechanism based on domain separation 
(Kichik, Tarragó et al. 2011) 
 
An alternative mechanism of substrate entry has also been suggested, based on 
molecular dynamic (MD) simulations. MD simulations indicated that the mechanism 
involving blades one and seven of the β-propeller moving apart to widen the 
propeller pore is not favoured given the stability of the interactions (Fuxreiter, 
Magyar et al. 2005); this was corroborated by conventional biochemical techniques, 
in which the β-propeller domain was purified independently of the α/β-hydrolase 
domain and found to be stable even when isolated (Juhász, Szeltner et al. 2005). MD 
simulations suggest that there is a potential for substrate entry via a tunnel in the 
inter-domain region of PREP: small loop movements in residues 1-72 of the α/β-
hydrolase domain and residues 192-205 of the β-propeller domain may create a 
tunnel capable of allowing a peptide into the active site (Kaszuba, Rog et al. 2009). 
This mechanism was supported by electron microscopy (EM) data showing a small 
side opening near the regions identified by the MD calculations (Bastos, Grellier et 
al. 2005, Fuxreiter, Magyar et al. 2005). 
The mechanism of substrate entry may be considered in the context of other POP 
family proteins, such as dipeptidyl peptidase IV (DPP IV). DPP IV belongs to the 
POP subfamily S9b (Rea and Fulop 2006). Like PREP, DPP IV has raised a degree 
of pharmaceutical interest due to its implications in canerogenesis (Busek, Malik et 
al. 2004). DPP IVs specific physiologic role is difficult to determine due to the 
number of DPP IV-like enzymes (Rea and Fulop 2006). It is believed to play a role 
in peptide degradation and amino acid scavenging (Tiruppathi, Ganapathy et al. 
1990, Suzuki, Erickson et al. 1993), T-cell signalling (Ansorge, Buhling et al. 1997, 
Kahne, Lendeckel et al. 1999), and chemotaxis (Ludwig, Schiemann et al. 2002). 
DPP acts as a peptidase, removing X-Pro dipeptides from the N-terminus of peptides 
containing Pro as the penultimate residue (Cunningham and O'Connor 1997). 
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Unlike PREP, DPP IV is a homodimer (Elovson 1980) is post-translationally 
modified with an N-linked glycan (Aertgeerts, Ye et al. 2004) and exists in one of 
two forms; a soluble protein and an integral membrane protein (Durinx, Lambeir et 
al. 2000)). Each monomeric subunit of DPP IV is marginally larger than that of 
PREP; DPP IV monomers consist of 766 residues compared to 710 residues in the 
PREP monomer (Rea and Fulop 2006). Structurally PREP and DPP IV monomeric 
units show a high degree of homology. Each subunit consists of an α/β- hydrolase 
domain containing the catalytic triad (Ser630, Asp 708, His 740) and a β-propeller 
domain (Figure 3-4), with the active site located between the two domains.  
 
Figure 3-4 – The crystal structure of the dimeric DPP IV; the β-propeller domain is highlighted in 
blue, catalytic α/β beta-hydrolase domain is highlighted in red. Created from PDB: 1NU8 
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Despite the conserved open-Velcro topology of the DPP IV propeller domain, it 
contains a number of differences when compared to the PREP propeller domain. 
These are illustrated in Figure 3-5. 
 
Figure 3-5 – The crystal structures of A) the 7-bladed PREP propeller and B) the 8-bladed DPP IV 
propeller, highlighting the structural differences between the two related proteins.  
The DPP IV propeller domain consists of eight blades rather than the seven found in 
PREP. This extra blade results in the DPP IV adopting a more significantly ellipsoid 
shape compared to that seen in PREP, highlighted in Figure 3-5, which leads to a 
larger pore being formed in the centre (7 Å in width, 14 Å in length). DPP IV shows 
pronounced bending of blade 1 (dark blue in Figure 3-5) and more subtle bending of 
blades 2 – 4 (cyan, light green and forest green) which may lead to a larger side 
opening between the domains. This increase in pore size supports the hypothesis that 
substrate entry may occur through one of these openings; consistent with a DPP IV 
crystal structure showing an interaction between the side opening and a substrate 
(Engel, Hoffmann et al. 2003)There is currently no clear understanding as to through 
what pore substrates may  enter and exist the active site.  
 
The observation of a POP family enzyme capable of allowing substrate access to the 
active site through either the propeller pore, or via a side channel, suggests that the 
potential for this mechanism may occur in PREP, adding to the discussion 
surrounding the possible mechanisms of substrate entry in PREP. Whilst X-ray 
diffraction is an established method for studying protein structure, it is clear that 
additional experimental approaches are required to provide additional data. The aim 
of this study was to utilise TWIM-MS to probe the solution phase structure of 
A B
69 
 
mammalian PREP, both isolated and in conjugation with a ligand analogue, to 
identify if mammalian PREP was capable of adopting both open and closed 
conformations in solution, and to investigate potential conformational changes 
induced as a result of ligand binding. DPP IV was analysed by the same methods in 
order to confirm that it is only capable of adopting a single, closed, conformation in 
solution supporting the suggested mechanistic divergence in substrate entry between 
PREP and DPP IV. 
3.2 Results and Discussion 
3.2.1 Prolyl Endopeptidase 
Mass Spectrometry 
Figure 3-6 shows the native-MS spectra of PREP and PREP in conjugation with 
ZPP-like ligand at a cone voltage of 100V.  
 
Figure 3-6 - The MS spectra of PREP and PREP with ligand (cone voltage 100 V). 
Binding of the ligand by PREP causes a shift in the charge state distribution, suggesting either a 
change in conformation of PREP, or the blocking of a protonation site in PREP. 
The spectra in Figure 3-6 show relatively broad peak widths of 25 amu and 34 amu 
for PREP and PREP with ligand, respectively, indicating a high level of solvent 
adducting on the protein. This indicates the MS settings and sample preparation 
would benefit from further optimisation. The inhibitor was provided in a high salt 
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content buffer and the observed increase in the peak width may be attributed to 
increased salt adducts in the ligand-bound PREP spectrum. Both spectra show 
evidence of two species of similar molecular weights, based on the overlapping 
charge distributions. For PREP, the two species have molecular weights of 85649 Da 
and 85924 Da whereas for PREP with ligand the species have molecular weights of 
86230 Da and 86499 Da. This increase of approximately 270 Da between species 
one and two is suggested to be due to of incomplete desolvation of the protein.  
The expected theoretical mass of PREP based on the sequence is 80769.5 Da, which 
differs from the observed molecular weight of 85649 Da by approximately 4800 Da, 
which equates to 6% of the total mass. Sobott and Robinson (Sobott and Robinson 
2004) observed a mass difference of 4000 Da for GroEL. This mass increase was, 
however, only 0.5% of the total GroEL molecule (GroEL molecular weight is 
approximately 800,000 Da) which is much smaller than the 6% observed here. A 
possible explanation for the increase in mass may result from the proteins natural 
structure. PREP has been shown to have an internal cavity of approximately 8500 Å
2
 
in size (Rea and Fulop 2011). It is possible that this cavity remains solvated 
following elevation to the gas phase, and the retained solvent contributes to the 
observed mass increase. An internal cavity of 8500 Å
2
 PREP is could potentially 
retain enough solvent to contribute to the 4800+ Da mass increase observed. 
Following ligand binding there is an observed mass increase of 581.4 Da for the first 
species and 575.4 Da for the second species. The mass of the ligand is 380.44 Da. 
The observed mass increase in consistent with the binding of ligand, with the 
remaining mass proposed to be the binding of extra salts/ solvent within the binding 
cavity.  
It has been proposed that the PREP in solution exists in equilibrium between its open 
and closed states, and that substrate binding shifts this equilibrium towards the 
closed state (Li, Chen et al. 2010).  Figure 3-6 shows that PREP and PREP with 
ligand share the 20
+
  16+ charge states, suggesting that a population of the proteins 
share a similar conformation. Addition of ligand causes a shift in the charge state 
distribution of the protein from the 16
+
  20+ in the ligand-free state to the 15+  
20
+ 
in the ligand-bound state. It has been shown that a proteins charge state 
distribution can be related to its conformation (Konijnenberg, Butterer et al. 2013) 
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with higher charge states relating to a more open conformation (Katta and Chait 
1993) arising from more available protonation sites. It is therefore possible that the 
binding of the ZPP-like inhibitor results in a conformational change that disrupts the 
available protonation sites. The ZPP-like inhibitor binds to the catalytic serine of 
PREP (Kaszuba, Rog et al. 2009). Serine is a polar, non-charged amino acid and 
therefore not a proton acceptor in solution. Inhibitor binding to this serine would not 
result in a change in charge distribution by removing one of the protonation sites of 
sites. It is possible, particularly given the poor MS resolution, that multiple copies of 
the ligand are binding the protein at other sites which may affect the charge 
distribution. Whilst this shift supports the theory that binding of ligand may induce a 
conformational change in the protein, further evidence is required to strengthen the 
theory.  
Ion mobility mass spectrometry 
Figure 3-7 shows the arrival time distributions for PREP protein and PREP with 
ligand analysed using a low cone voltage activation energy of 60 V for the charge 
states observed in both species (the 16
+
  20+ charges). Drift time chromatograms 
presented here are obtained from summation of the whole peak, including solvent 
adducts, since there was insufficient MS resolution to separate the peaks into 
separate species. 
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Figure 3-7 – Arrival time distributions for PREP and PREP + ligand (cone voltage 60 V). 
16
+ 
(green), 17
+
 (blue) and 18
+
 (red) charge states show only a single conformation in both PREP and 
PREp with ligand. 19
+
 (black) and 20
+
 (brown) charge states show evidence of an additional extended 
conformation, which appears at a higher relative intensity in the PREP with ligand ATD compared to 
PREP. 
Under low energy activation conditions both PREP, and PREP with ligand show 
only a single observed conformation at charge states 16
+
  18+. This observation 
may suggest that PREP substrate entry occurs via small loop movements, rather than 
via large domain separation. Lower activation energies lead to less desolvation 
(Sobott and Robinson 2004), and it has been observed that additional solvent adducts 
can stabilise native protein structures (Steinberg, Breuker et al. 2007, Patriksson, 
Marklund et al. 2007). It is therefore possible that the additional solvent adducts are 
helping to stabilise the single conformation. Figure 3-7 shows that, with increasing 
charge, both PREP and PREP with ligand can adopt an additional more extended 
73 
 
conformation consistent with a more open conformation. As with Figure 3-6, Prep 
shows a higher relative intensity of the 19
+
 and 20
+
 conformations, suggesting it may 
more readily unfold compared with Prep with ligand. The intensity of the second, 
extended conformation of the 19
+
 and 20
+
 charge states is also higher in Prep when 
compared with Prep with ligand, again suggesting that PREP with ligand may less 
readily unfold. This is consistent with previous observations of PREP with ligand 
favouring a more closed conformation compared to PREP (Li, Chen et al. 2010). 
Samples were analysed using IMS at a higher cone voltage of 100 V to investigate 
these perceived stability differences, the result are shown in Figure 3-8. Drift time 
chromatograms presented here are obtained by summation of the whole peak, 
including solvent adducts, since there was insufficient MS resolution to separate the 
individual peaks 
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Figure 3-8 – Arrival time distributions for PREP and PREP + ligand (cone voltage 100 V). 
16
+
 (green) charge states show only a single conformation in both PREP and PREP with ligand. 17
+
 
(blue) and 18
+
 (red) 19
+
 (black) and 20
+
 (brown) charge states show evidence of additional extended 
conformations, which appears at a higher relative intensity in the PREP with ligand ATD compared to 
PREP. 
The MS spectra shown in Figure 3-6 indicates that even at this relatively elevated 
energy level there is still a high degree of solvent still bound to the protein. At the 
lowest charge state, 16
+
, there appears to be only a single conformation, in 
agreement with the low energy data from Figure 3-7. The lowest charge state of a 
protein observed by mass spectrometry is thought to be most representative of the 
native, solution phase structure (Grandori 2003, Samalikova and Grandori 2003). 
Both PREP and PREP with ligand show evidence of only one conformation at both 
low (60V) and high (100V) cone voltages for the 16
+
 charge state, suggesting that 
mammalian PREP may only have a single conformation in solution. 
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With increasing charge a more extended conformation appears in both the PREP and 
PREP with ligand samples for the 17
+
  18+ charge states. As with the 60 V data, 
this extended population is observed at an increased intensity in the PREP sample 
compared to PREP with ligand sample. At elevated cone voltage the trend is even 
more pronounced; PREP with ligand shows predominantly compact conformation 
with the major charge state presenting at 18
+
. Prep without ligand shows and 
significantly more intense extended conformations for the 18
+
, 19
+
 and 20
+
 charge 
states compared to Prep with ligand. Proteins are known to unfold as a factor of 
charge in the gas phase as a result of columbic repulsion (Thalassinos, Slade et al. 
2004). The higher relative intensity of the extended conformations observed for the 
PREP sample suggests the protein is able to more readily adopt an extended 
conformation in the gas phase at the same change states when compared to ligated 
Prep. Similar to the 60 V IMS data, this suggests a stability difference between the 
two samples, supporting the observations made by Min Li (Li, Chen et al. 2010) that 
attachment of the ligand may induce more compact conformation.  
The 17
+
 and 18
+
 charge states show evidence of an intermediate peak located 
between the compact and extended conformations, suggesting an additional 
conformation of PREP present in both ligand-free and ligand-bound states. This 
conformation could represent a partially extended closed PREP structure, consistent 
with a minor degree of protein unfolding, or may represent a solvent stable 
intermediate between the open and closed structures shown in Figure 3-1 and Figure 
3-3. At the higher charge states a number of different conformations become 
apparent as the protein beings to unfold and form a number of stable gas phase 
structures.  
Figure 3-6 shows two potential species of PREP which were proposed to be different 
solvated forms of the protein. IMS was used to study these separate species and 
identify if they correspond to the same, of different species, based on their drift time. 
Under IMS conditions the MS spectrum showed reduced resolution, making it 
difficult to fully separate the different species observed in the PREP sample (Figure 
3-9). The selection of different section of the board MS peak, shown in Figure 3-9, 
allowed for the analysis of the different solvated states of PREP. By performing this 
analysis the different species were pseudo-resolved from broad MS peak.  
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Figure 3-9 – An analysis of the different protein conformations in the broad 18+ charge state of 
PREP. Sections A, B, C and D represent differently solvated forms of the same charge state. 
Comparison of the arrival time distributions suggests that as the amount of solvent adducts increase, 
the relative intensity of the extended conformation decreases.  
Closer inspection of the 18
+
 charge state of PREP, shown in Figure 3-9, suggests that 
it is made up of four distinct regions labelled A  D, where A is proposed to be 
related to the 85649 Da species, and B the 85924 Da species. C and D represent 
additional solvated regions. Comparison of the arrival time distribution presents by 
sections A, B, C and D allow the effects of excess solvent and salt adducts on the 
conformational distribution to be investigated. The lowest molecular weight species, 
A, seems to be capable of adopting three major conformations; a compact, an 
intermediate and an extended conformation.  As the amount of solvent adduct 
increases (B and C), the intensity of the intermediate and extended conformations 
decrease until there is only compact conformation remaining (D). It has been 
observed that excess solvent can stabilise the native conformation of a protein 
(Patriksson, Marklund et al. 2007, Steinberg, Breuker et al. 2007). The data 
presented here suggests that the presence of solvent adducts can alter protein 
conformation, with additional solvent favouring a more compact, native 
conformation. The observation of only a single conformation of PREP at more 
highly solvated states (Figure 3-9, insert D) supports the theory that PREP in 
solution can only adopt a single conformation.  
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CCS Estimation 
Estimated CCS values obtained experimentally have been compared with those 
calculated from PDB files. The calibration curves for the estimation of CCS from 
experimental data are shown in Figure 3-10, and were acquired at a 100 V cone 
voltage.  
 
Figure 3-10 – The calibration curve for the estimation of the CCS of PREP and PREP with ligand. 
The data points refer to avidin (red), alcohol dehydrogenase (green) and glutamate dehydrogenase 
(blue) and bracket the arrival time window of both PREP and PREP with ligand samples. 
The calibration curve shown in Figure 3-10 shows an R
2
 value of >0.99 (Scarff, 
Thalassinos et al. 2008). PDB entries 1QFM (Figure 3-1) and 1YR2 (Figure 3-3) 
were used for estimation of protein cross sections for the unligated PREP samples. 
Collision cross sections were calculated using projection approximation and exact 
hard sphere scattering methods. Following CCS estimate, collision cross sections 
were corrected to account for the differences between N2 and helium buffer gases. 
Computational CCS values were increased by 9%, based on the observed differences 
between He and N2 CCS value of BSA and concanavalin A obtained experimentally 
in Bush et al (Bush, Hall et al. 2010).  
A comparison between experimentally estimated CCS values and the 
computationally calculated CCS values for PREP and PREP + ligand are shown in 
Figure 3-11, respectively. 
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Figure 3-11 – Estimates of the CCS of PREP, and PREP with ligand determined experimentally 
compared to the open (double solid line) and closed (dotted line) CCS values obtained from crystal 
structures 1YR2 (open) and 1QFM (closed).  
Ligand free and ligand bound PREP shows similar CCS estimates experimentally, illustrating the 
limited effect ligand binding has on conformation. The experimental difference between the extended 
and compact conformations evident in the 18
+
 and 19
+
 charge states suggests these may correspond to 
the open and closed conformations observed in crystal structures. 
Figure 3-11 suggests that the experimental CCS measurements for the native 16
+
 
charge state of PREP and PREP with ligand, which is proposed to represent a closed 
form of PREP, is between the PA and EHSS values. The PA method is known to 
underestimate CCS values for proteins (Scarff, Thalassinos et al. 2008), and whilst 
the EHSS is known to not be the most robust method for CCS calculation it does 
provide a good compromise between computational demand and speed.  The Barran 
research group have observed that, in a number of proteins, the lowest charge state is 
consistently smaller than the CCS value obtained from the crystal structures 
(Jurneczko and Barran 2011), consistent with the observation reported here.  The 
strong agreement between all data points for PREP and PREP with ligand illustrate 
the limited effect ligand binding has on the CCS of PREP.  
The theoretical CCS measurements provide information on the expected magnitude 
of the CCS change between Open and Closed states of PREP. Based on the PA and 
EHSS CCS values the difference in open PREP and closed PREP is approximately 
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6-8%. The 18
+
 and 19
+
 charge states both have two major conformations which have 
been proposed to represent Open and Closed forms of the protein. The two 
conformations of the 18
+
 charge state show a difference in CCS of 9%, whilst the 
two conformations in the 19
+
 charge state show a difference of 10%. The magnitude 
of the change is similar between the experimental and theoretical, and the increased 
size difference observed in the experimental data may be attributable to charge 
effects. This data suggests that the two conformations may represent open and closed 
conformations of PREP. 
3.2.3 Dipeptidyl peptidase IV 
Mass Spectrometry 
Figure 3-12 shows the native MS spectra of DPP IV with and without ligand.
 
Figure 3-12 – The MS spectra of DPP IV with and without bound ligand.  
Ligand binding appears to have a limited effect on the charge distribution, evident only in a reduction 
in the relative intensity of the 30
+
 charge state, suggesting a limited effect on conformation following 
ligand binding. 
The 27
+
  31+ charge states of DDP IV are observed at the 5200-6400 m/z range of 
the MS spectrum. Compared to PREP, DPP IV shows a shift to both a higher m/z 
region of the spectrum, and in the number of observed charges, consistent with the 
presence of a larger molecule. There was no evidence for any monomeric species in 
the spectrum, suggesting that non-covalent interactions are preserved upon elevation 
to the gas phase. The accurate mass obtained from the native-MS spectrum of DPP 
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IV shown in Figure 3-12 was calculated at 166,530 Da, which agrees with the 
theoretical mass of 166,528 Da to within 2 Da (or 0.001%). Following incubation 
with ligand there is an observed mass shift of approximately 660 Da, consistent with 
the binding of two molecules of the ZPP-like inhibitor at 280 Da each. The peak 
width of the DPP IV with ligand spectra increases from 21 amu to 30 amu, 
suggesting a possible overlap of peaks. This may indicate that, whilst the majority of 
the DPP IV molecules have acquired two molecules of inhibitor, there may be a 
subpopulation with only one molecule. Any future experiments should ensure that a 
higher concentration of inhibitor is used. 
The accurate mass for DPP IV calculated from the native MS spectra shows a good 
agreement to the theoretical mass, which is in contrast to the poor agreement 
between the experimentally observed and theoretical masses of PREP. It has been 
suggested that the mass discrepancy observed with the PREP sample was a result of 
solvent trapped within the inner cavity of PREP. The low mass difference observed 
for DPP IV may suggest that DPP IV is more easily desolvated, than PREP, 
suggesting a possible difference in the conformation and dynamics between DPP IV 
and PREP.  
Following ligand binding there is a minor shift in the charge distribution. This shift 
is less than prominent that observed in the PREP analysis as there is no change in 
observed charge states, but a shift in intensity. This may be due to a minor 
conformational change in the protein following ligand binding, or may indicate that 
the bound inhibitor serves to block protonation sites in the active site; given the 
current theories regarding ligand entry into the active site of DPP IV the latter 
suggestion is more likely. This is in agreement with the PREP observations of ligand 
binding, and serves to reinforce the hypothesis of a ligand-dependant blocking of 
protonation in the active site as a result of binding. 
Ion mobility mass spectrometry 
The drift time chromatograms for DPP IV are shown in Figure 3-13. 
81 
 
 
Figure 3-13 – The drift time chromatograms for DPP IV acquired at the same conditions as PREP.  
All charges states show only a single conformation. Ligand binding appears to have no effect on 
ATD, indicating ligand binding has no effect on conformation 
The drift time chromatograms for DPP IV at all charge states show only a single 
observable conformation. This suggests that DPP IV is only capable of adopting a 
single conformation at each charge state, and is resistant to unfolding as a factor of 
charge. This is in contrast to PREP, which showed clear evidence of undergoing a 
conformational change to a more open state as a factor of charge at intermediate 
charge states, followed by larger scale unfolding at higher charge states. This data 
supports the hypothesis that substrate entry in DPP IV can occur through either the 
side pore or the β-propeller pore, but not via a domain-opening mechanism.  
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Following ligand binding there is no observed change in the arrival time distribution 
of DPP IV.  
CCS Estimation 
The CCS estimates from DPP IV are shown in Figure 3-14. Computationally derived 
CCS measurements have been corrected based upon published cross sections taken 
from Bush et al (Bush, Hall et al. 2010). A correction factor of 7% was used, based 
on the observed differences between He and N2 values of alcohol dehydrogenase. 
 
Figure 3-14 – Experimentally derived CCS estimates of DPP IV with and without ligand compared 
with computationally derived CCS values obtained from PDB entry 1NU8. 
Both DPP IV and DPP IV with ligand show a single conformation. CCS differences suggest no 
change in conformation as a result of ligand binding 
As observed with PREP, the DPP IV data falls between the corrected EHSS and PA 
calculated values. It is known that obtaining a good agreement between CCS 
estimated from TWIMS data and computer models is highly dependent on which 
calibration standards are used (Salbo, Bush et al. 2012). It is possible that the lower 
m/z calibration standard (Avidin, molecular weight 64 kDa) is distorting the CCS 
estimate, leading to an underestimate of experimental CCS relative to the theoretical 
CCS. 
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As with PREP, there is no significant change in the CCS of DPP IV with ligand 
compared to that of the ligand free sample, consistent with previous studies on DPP 
IV with substrate. 
3.3 Conclusions 
The aim of this work was to utilise MS and IMS approaches to investigate the 
solution phase dynamics of two POP family enzymes with a proposed difference in 
the mechanism of allowing substrate into the active site. Bacterial PREP has been 
crystalised in an open conformation in solution, suggesting a whole-domain 
separation as a mechanism for substrate entry. IMS data suggests that procine PREP 
is capable of adopting a more extended conformation when unfolding is induced as a 
factor of charge, and that at higher cone voltages this extended conformation is more 
readily adopted as a factor of charge. A comparison of the CCS values from the x-
ray crystal structures of PREP in its open and closed conformation show agreement 
with the experimentally obtained CCS estimates, suggesting that the dominant 
compact conformation is the closed state whilst the more extended conformation is 
related to the open state.  
Whilst it is clear that PREP is capable of adopting these conformations when 
activated by cone voltage/ charge, it is also observed that native charge states, those 
with the lowest levels of energy, contain only a single observed conformation in both 
low and high energy experiments. The observed increase in the closed conformation 
with additional solvent supports the suggestion that open-PREP is a non-
physiological conformation induced as a result of gas phase unfolding rather than a 
second solution phase conformation adopted by PREP. The most likely explanation 
is that, following collision/ charge dependant activation, the salt bridge connecting 
the two domains is induced to break, allowing the domains to separate and adopt an 
open conformation in the gas phase. 
DPP IV was suggested to undergo no large conformational change for substrate 
entry, which is supported by this work. DPP IV shows only a single conformation 
across all charge states, suggesting the molecule is far more resistant to unfolding, 
possibly as a virtue of size, when compared to PREP. 
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Ligand bound versions of both DPP IV and PREP showed little observed structural 
difference to their ligand-free forms. Some small differences were observed between 
PREP and ligated-PREP in terms of the intensity of the extended conformations, 
suggesting that the binding of ligand may have a small effect of the overall stability 
of the PREP closed conformation, which supports the finding of Min Li (Li 2010). 
These observed changes were minor, representing a 5-10% shift in intensities, and 
further work would be required to investigate stability differences induced as a result 
of ligand binding. 
Future work 
Whilst we have suggested that the discrepancy observed between the observed and 
theoretical PREP masses is as a result of solvent, this needs further investigation. It 
is possible that errors in transcription/ translation have led to a protein containing 
additional amino acids which could affect its structural properties. In order to 
identify any of these errors PREP should be analysed under denaturing conditions in 
order to obtain the true mass of the monomer. It is clear that native PREP conditions 
require further optimisation in order to improve MS resolution. Given the 
observations presented here, this may prove difficult since PREP seems to readily 
adopt an open conformation upon activation, making the balance of activation vs 
cooling/ focussing a difficult process. 
Whilst the computational methods used here for the estimation of PREP/ DPP IV 
CCS have provided good agreement with experimental data, there are additional 
methods available. The computationally demanding TM method would provide the 
most robust estimate of CCS value, whilst the novel PSA method would also provide 
a better estimate than that of the PSA. There are currently a number of issues with 
the PSA method regarding molecular size and compatibility which has resulted in 
some erroneous calculations (Sobott 2014). Future iterations of the algorithm may 
provide the speed and accuracy required to allow improved comparisons between 
experimental and theoretical CCS values. 
This work has suggested there may be a small difference in the overall stability of 
PREP following the binding of inhibitor/ ligand. Following optimisation of the 
instrument conditions, further experiments with more subtle variation between 
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acceleration voltages, and improved reproducibility, could be performed to confirm 
the experimental significance of these observations. 
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Chapter 4 : Investigating the 
structural differences in 
haemoglobin variants 
 
 
 
 
 
 
 
 
 
 
4.1 Introduction 
Hemoglobin is the protein in erythrocytes responsible for the transport of both 
oxygen molecules from the lungs to tissues, and carbon dioxide from tissues to the 
lungs (Thein 2011). It is the most abundant protein in mammals and, due to its high 
abundance and vital role in gas transport, is one of the most well characterised 
proteins on the planet. The three dimensional structure of haemoglobin has been 
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solved using X-ray crystallography, and the structural changes and kinetics 
associated with oxygen binding have been extensively investigated and characterised 
(Buxbaun 2007).  
The haemoglobin molecule, shown in Figure 4-1 is a heterotetramer consisting of a 
two pairs of chains.  
 
Figure 4-1 – The crystal structure of normal adult haemoglobin containing two α-chains (red) and 
two β-chains (green), each bound to a single haem group. 
All haemoglobin molecules consist of two identical copies of both an α-like chain 
and a β-like chain each containing a prosthetic haem group located in a small pocket 
in the protein (Table 4-1). It is the haem group that affords oxygen binding function 
to the molecule (Buxbaun 2007). During human embryo development different 
haemoglobin tetramers are present in the blood. These are determined by the 
different expression of α-like and β-like genes at each of these stages. There are two 
α-like globin chains, α and ζ, and four β-like globin chains, β, δ, γ and ε (Thein 
2011). These different globin chain variants have different oxygen binding affinities, 
with those chains expressed during the embryonic stages of development, α-like ζ –
globin and β-like γ- and ε-globin, having the highest affinity for oxygen. In adult 
humans 96-98% of all haemoglobin is haemoglobin A (HbA), consisting of two α- 
and two β-globin chains. A minor haemoglobin, haemoglobin A2 (HbA2), consisting 
of two α- and two δ-globin chains, is also present at minor concentrations 
(approximately 2% in adult erythrocytes) (Bain 2006). 
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Alpha 
Chain 
VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGS
AQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSH
CLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR 
Beta 
Chain 
VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPD
AVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENF
RLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH 
Table 4-1 – The sequences of haemoglobin α-chain and β-chain, the two major chains present in adult 
haemoglobin 
Disorders affecting haemoglobin, known collectively as haemoglobinopathies, are 
some of the most common of all inherited disorders; it is estimated that ~7% of the 
global population are carriers for an inherited haemoglobin disorder. 
Haemoglobinopathies are subdivided into two main groups: thalassemias, disorders 
relating to the quantitative levels of one or more of the protein chains, and 
haemoglobin structural variants, disorders resulting from mutations to the genes that 
manifest as amino acid substitutions in the protein primary sequence. Whilst there 
are a wide range of different haemoglobin variants the vast majority have no 
significant effect on haemoglobin properties and cause no clinical problems (Bain 
2006). 
Over 1000 structurally different haemoglobin variants have been described. The 
most debilitating of these is the HbS variant which leads to sickle-cell anaemia. First 
described by Pauling in 1949 (Pauling, Itano et al. 1949), and later characterised by 
Ingram in 1956 (Ingram 1956), HbS is a β-chain variant characterised by a single 
amino acid substitution at the 6
th
 position of the β-chain (Glu  Val). This mutation 
induces a conformational rearrangement in the tetramer that facilitates molecular 
stacking. Deoxygenated HbS polymerises via this stacking mechanism, leading to 
the erythrocytes adopting cresentic disc shape as opposed to the normal biconcave 
disc (Murayama 1967). Fortunately, sickle-cell anaemia is only present in people 
homozygous for the HbS gene and is benign in heterozygous individuals. 
HbC is another clinically significant structural mutant of haemoglobin. First 
described by Hunt and Ingram in 1958 (Hunt and Ingram 1958), HbC is β-chain 
variant characterised by a single amino acid substitution at the 6
th
 position of the β-
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chain (Glu  Lys). As with HbS, HbC allows the formation of a condensed phase of 
haemoglobin (Vekilov, Feeling-Taylor et al.); oxygenated HbC is capable of forming 
intraerythrocytic crystals which contribute to the pathology of the disease (Lessin, 
Jensen et al. 1969). As with HbS, HbC is benign in individuals heterozygous for the 
disease but leads to disease in patients homozygous for the mutation (Lawrence, 
Fabry et al. 1991). HbC can also lead to disease in patients that are heterozygous for 
both HbS and HbC; in these cases patients exhibit the oxy-HbC crystals found in 
normal homozygous HbC patients (Nagal and Lawrence, 1991). 
The use of mass spectrometry for the analysis of haemoglobin has been well 
documented. Clinical diagnosis of haemoglobinopathies uses a number of different 
techniques (Clarke 2000, Shimizu, Nakanishi et al. 2006) with ESI-MS and MS/MS 
approaches rapidly becoming one of the preferred choices due to low sample 
consumption and the potential for high-throughput, automated data when coupled to 
HPLC (Witkowska, Lubin et al. 1991, Clarke 2000, Wild, Green et al. 2001, Daniel, 
Turner et al. 2005, Shimizu, Nakanishi et al. 2006).  Mass spectrometry has also 
been used to study the mechanism of assembly and disassembly of the haemoglobin 
tetramer (Griffith and Kaltashov 2003, Griffith and Kaltashov 2006, Boys and 
Konermann 2007, Scarff, Patel et al. 2009)  
The work by Scarff et al made use of ion mobility mass spectrometry to study the 
gas phase structures of the tetramer, and its constituents, and compare them with 
solution phase structures elucidated from x-ray diffraction crystal structures. Since 
the publication of that work in 2009 a novel set of calibration standards have become 
available for native protein calibration standards (Bush, Hall et al. 2010). 
Developments in the field of native mass spectrometry have also refined the 
protocols for both protein preparation and MS analysis. 
The focus of this work is to revisit the Scarff et al research using these new 
developments in native mass spectrometry, and also to make use of the previously 
unavailable PSA method for calculating protein cross sections, in order to study the 
gas phase structures of normal haemoglobin A and the mutant haemoglobin S and 
haemoglobin C variants. 
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4.2 Results and Discussion 
4.2.1 Identification of Haemoglobin variants  
Denatured MS spectra 
Prior to any native analysis the integrity of HbA, HbS and HbC samples obtained 
from whole blood samples were confirmed by MS. Spectra representative of HbA, 
HbS and HbC analysed using ESI-TOF-MS under denaturing conditions (50% 
MeOH, 0.1% HCOOH) are shown in Figure 4-2. HbA is comprised of two chains; 
the α- chain, which has a theoretical mass of 15126.2 Da in the apo form, and the β-
chain, which has a theoretical mass of 15867.2 Da in the apo form (based on amino 
acid sequence). The HbS mutation of glutamate  valine introduces a mass change 
of -30 Da (glutamate mass 147.13 Da, valine mass 117.15 Da) to the beta chain, 
whilst the HbC mutation of glutamate  lysine (lysine mass 146.19 Da) introduces a 
mass change of -1 Da. This mass shift can be observed in the spectra shown in 
Figure 4-2, where the β-chain peaks show a minor shift in the HbS spectra (for the 
15
+
 charge state expected shift is 2 m/z, observed shift is 2 m/z). This shift is present, 
but less prominent, in the HbC sample as a result of the smaller mass difference (15
+
 
charge state expected shift 0.0667 m/z, observed shift 0.141). 
Important to note is that all three samples contain two major charge state 
distributions, supporting the view that each sample contains a homozygous Hb 
protein for HbS, HbC or HbA.  
Both the observed mass differences and the presence of only two major chains are 
highlighted in the deconvoluted mass spectra Figure 4-3. Deconvolution of the mass 
spectra to true mass scale indicates that HbA, HbS and HbC all contain only two 
major species All masses show agreement to within 2 Da of theoretical masses. For 
HbS, this is a sufficient mass accuracy for identification of the α- and β- chains. For 
HbC this is not, as the error is larger than the expected change in mass as a result of 
mutation. The α- chain in all patient samples should have the same mass and can 
therefore be used as an internal standard. α-chain masses in all cases were corrected 
to 15126.2 Da, and the same correction factor applied to the β-chain. Using the α-
chain in this manner it was possible to identify the and 1 Da mass shift between HbA 
and HbC, supporting the view that the sample is homozygous HbC 
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Figure 4-2 – A - The ESI-MS spectra for HbA (blue), HbS (green) and HbC (red) in denaturing conditions. 
All three species contain two charge state distributions; the α-chain, labelled in orange, which is consistent between the three samples and the β-chain, which is labelled in 
blue for HbA, green for HbS and red for HbC. B – a magnification of the 16+ charge state of the α- chain and the 17+ charge state of the β-chain illustrates the m/z differences 
within the β-chain molecular weight for HbA and HbS and HbC chains. 
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Figure 4-3 – The deconvoluted MS spectra for HbA (blue), HbS (green) and HbC (red), obtained from the data shown in Figure 4-2.  
All samples show a conserved peak, relating to the α-chain and a variable peak, relating to the β-chain. Peaks are labelled with the experimentally observed masses, and the 
corrected masses based on the mass correction of the α-chain. 
Observed: 15869.5
Corrected: 15867.2
Observed: 15868.5
Corrected: 15866.2
Observed: 15839.0
Corrected: 15836.7
Observed: 15128.5
Corrected: 15126.2 
Observed: 15138.5
Corrected: 15126.2 
Observed: 15128.5
Corrected: 15126.2 
HbA
HbS
HbC
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Native MS spectra 
Spectra representative of HbA, HbS and HbC analysed by means of ESI-TOF-MS 
under native-like conditions are shown in Figure 4-4. The data for the tetramer 
region were deconvoluted to give masses of 64,455.5 Da for HbA, 64,395.4 Da for 
HbS and 64,452.3 Da for HbC. These agree well with the theoretical masses of 
64,453.2 Da and 64,393.4 Da for HbA and HbS (Ofori-Acquah, Green et al. 2001) 
and 64,451.2 for HbC. Figure 4-4 shows peak broadening, consistent with solvent 
adducts and incomplete desolvation. The effect of residual solvation of a protein has 
been explored and has been shown to stabilise the native complex (Steinberg, 
Breuker et al. 2007, Patriksson, Marklund et al. 2007). Accurate mass is less 
important than the assessment of structure and conformation in these experiments, 
since the identities of the samples have already been confirmed by denatured MS, 
and therefore optimisation of conditions for improved resolution was not carried out. 
The spectra in Figure 4-4 show the presence of the Hb tetramer, α2β2 complete with 
four prosthetic haem groups, the Hb dimer, αβ with two haem groups, and the apo- 
and holo- forms of the momoneric α- and β- chain. Consistent with previous studies, 
there is no evidence of a trimeric species or higher oligomeric species, giving 
confidence that the protein is being studied in its solution phase conformation.  
The observed charge state distribution for HbA, HbS and HbC tetramers in this study 
span the 14
+
 → 18+ charge states, centred at the 16+ charge state. This is a significant 
change to that shown in Scarff et al, in which major charge state distribution spanned 
the 15
+
 → 18+  species, and Ofori-Acquah et al, in which major charge state 
distribution spans the 17
+
 → 19+  species (Ofori-Acquah, Green et al. 2001, Scarff, 
Patel et al. 2009). A shift towards a lower, narrower charge state distribution is 
indicative of a more folded structure, suggesting a more native-like conformation. 
This observation may suggest the hypothesis that a desalting approach using only 
Amicon centrifugal filter units for buffer exchange, in preference to using ion-
exchange resin beads, is a gentler method for desalting proteins. 
In 2000 J. Fernandez de la Mora identified a relationship between the number of 
charges a protein can acquire and its shape in solution.  Proteins with a globular, 
folded, shape are unable to acquire more charges than the Rayleigh limit of a solvent 
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droplet of equal size, determined by Equation 4-1 (Fernandez de la Mora 2000), 
where ZR is the maximum number of charges, and m is the mass of the protein. 
𝑍𝑅 = 0.0778√𝑚 
Equation 4-1 
For haemoglobin ZR = 20, which would suggest that all previous investigations have 
retained a globular structure for haemoglobin. It is therefore likely that the changes 
in sample preparation simply lead to a better observation of the lower charge states 
of haemoglobin, rather than changing proteins structure. 
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Figure 4-4 - The ESI-MS spectra for HbA (blue), HbS (green) and HbC (red) in native conditions. 
All three samples show evidence of monomer peaks, labelled in purple, dimer peaks, labelled in orange, and tetramer peaks labelled in blue (HbA), green (HbS) and Red 
(HbC). 
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All three samples also show evidence of a low intensity species distinct from the Hb 
tetramer charge state present at 3900-4600 m/z. Deconvolution of these low intensity 
peaks suggests they are the 15
+
-17
+
 charge states of an approximately 66.5 kDa 
species. It is unlikely that this species is formed as a result of fragmentation/ adduct 
formation of the Hb tetramer given the observed molecular weight. All samples used 
in this analysis were obtained from whole blood, and therefore it is possible that this 
charge series corresponds to human serum albumin (HSA). HSA is the most 
abundant protein in human plasma, and has a molecular weight of 66.4 kDa, 
although this may be higher dependant on post-translational modifications (Putnam 
2012).  The observed charge state distribution of 15
+
-17
+  
is also
 
consistent with the 
observed charge state distribution of bovine serum albumin (Bush, Hall et al. 2010), 
the bovine homologue of HSA. Deconvolution of the denatured Hb data (Figure 4-2) 
over a wider mass range showed no evidence for the presence of HSA, however this 
may be due to high intensity Hb α- and β- chain signals masking the ions. 
4.2.2 Investigating the effect of source temperature on protein structure 
With native-like MS experiments careful optimisation of the instrument parameters 
is important for retention of protein structure. The intent of this study was to revisit 
data previously published by Scarff et al (Scarff, Patel et al. 2009) in light of recent 
improvements in to native MS experiments. Previous publications on native 
haemoglobin used elevated source temperatures which could lead to partial 
denaturation. The effect of temperature of the source on the structure of HbA and 
HbS were investigated using a combination of native MS and IMS-MS. The results 
are shown in Figure 4-5. 
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Figure 4-5 – Native MS spectra of HbA illustrating the effect of varying source temperature on the 
MS spectrum. Increasing the source temperature appears to increase the relative intensity of the 
monomer and dimer compared to the tetramer, suggesting dissociation of the tetramer oligomers 
Figure 4-5 shows an increased peak width at half maximum (PWHM) for all samples 
compared with spectra shown in Figure 4-3. This peak width increase arises as a 
result of increased pressures throughout the system induced by operating with IMS 
separation on and a source pressure of 6.8 mBar (consistent with Scarff et al (Scarff, 
Patel et al. 2009)). It can be observed, however, that as the temperature increases the 
PWHM narrows. This improved resolution comes from improved desolvation 
induced at elevated temperatures. Figure 4-5 also suggests that at increased 
temperatures the relative intensity of the αholo monomer 7+ charge state increases, 
most prominently at 80
o
C and 100
o
C. This observation could be explained as by 
dissociation of the dimer. At 80
o
C there is, however, also an increase in the relative 
intensity of the dimer suggesting that at elevated source temperatures there is either 
better transmission of the dimer ions, or disruption of the tetramer to generate more 
monomer/ dimer ions.  
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There also appears to be a minor increase in relative intensity of the T
18+
 charge state 
with an increase in temperature, coinciding with a minor decrease in the intensity of 
the T
14+
 charge state. This is also observable in the dimer; as temperature increases 
so does the relative intensity of D
12+
 compared to D
10+
. As a protein unfolds more 
basic sites become exposed, leading to an increase in the number of sites available 
for protonation on the molecule. A previous study by Justin Benesch (Benesch, 
Sobott et al. 2003) explored the thermal unfolding of a protein by using a heated 
capillary to unfold a protein in solution prior to electrospray analysis. It was 
observed that with increasing capillary temperature TaHSP16.9, a dodecamer, 
thermally dissociated into monomeric and dimeric subunits. It was also observed that 
for monomeric lysozyme, increasing the capillary temperature led to a wider charge 
state distribution. The data presented here shows a similar trend, supporting the 
theory that increasing the source temperature adversely affects the folded state of the 
protein. It should be noted, however, that heating a sample using a thermally-
controlled capillary results in a higher degree of dissociation of the complex 
compared to varying the temperature of the source region, suggesting that source 
temperature has a limited effect on structure. 
Figure 4-6 shows the effect of source temperature on an HbS sample. 
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Figure 4-6 - Native MS spectra of HbS illustrating the effect of varying source temperature on the 
MS spectrum. Increasing the source temperature appears to increase the relative intensity of the 
monomer and dimer compared to the tetramer, suggesting dissociation of the tetramer oligomers 
Figure 4-6 shows a similar trend to that shown in Figure 4-5. With increasing 
temperature the intensity of monomer and dimer peaks increases, suggesting a 
temperature-dependant dissociation of the tetramer. There is also an observed shift in 
charge state distribution, for both the tetramer and the dimer, towards more extended 
conformations, consistent with unfolding of both species. The increase in intensity of 
the T
18+
 ion is more pronounced in the HbS sample than for HbA, suggesting a 
possible difference in thermal stability. 
It is likely that the observed low mass peak shouldering observed in both Figure 4-6 
and Figure 4-7 is as a result of the peak broadening of the proposed HSA peaks via 
solvent adduct formation. 
Ion mobility mass spectrometry 
Figure 4-7 shows the arrival time distributions of HbA charge states 14
+
 to 17
+
. The 
ATD for the 18
+
 charge state is not included since it had a poor signal to noise ratio 
under these experimental conditions.  
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The 14
+
 charge state, which is proposed to be representative of the native 
structureshows that with increasing temperature there is no major change in the drift 
time, suggesting that the protein undergoes no large conformational changes as a 
result of temperature. There is evidence, however, of an increase in the ATD for the 
14
+
 charge state with increasing temperature, with broadening occurring beyond 
50
o
C. Increased peak broadening is consistent with an increase in the number of 
conformations a protein is able to adopt, suggesting an increased flexibility with the 
molecule, consistent with a higher degree conformational freedom. 
For the 37
o
C data, increasing charge leads to a decrease in arrival time, as a more 
highly charged molecule traverses the mobility cell faster, as well as increased 
tailing of the peak until a shoulder appears at 17
+
. Peak shouldering is consistent 
with the emergence of an additional conformation as a result of partial unfolding of 
the protein. 
Looking at both sets of the data together, increasing temperature leads to a minor 
increase in drift time, followed by a decrease in drift time across all charge states. 
These observations suggest an expansion followed by a relaxation of the protein in 
the gas phase. Interestingly, the decrease in drift time coincides with an increase in 
the proteins ATD suggesting that the relaxation that occurs may facilitate the protein 
adopting a wider range of conformations. Increasing both source temperature and 
charge leads to peak broadening and shouldering to an increased amount when 
considered together. The effects of both temperature and charge have an additive 
effect of destabilising the protein to the point that, at the 17
+
 charge state at 50
o
C, 
80
o
C and 110
o
C HbA has two distinct peaks in its ATD consistent with two distinct 
conformations. 
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Figure 4-7 – The arrival time distributions for the 14+  17+ charge state of HbA at four different temperatures: 37oC, 50oC, 80oC and 110oC. 
Increasing the temperature appears to have a limited effect on the arrival time distributions of the 14
+
 and 15
+
 charge states. 16
+
 and 17
+
 charge states show evidence of 
increased peak shouldering, consistent with the appearance of an additional conformation, suggesting that elevated temperatures may have a deleterious effect on the 
conformation of the higher charge states. 
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Figure 4-8 shows the observed ATD’s for HbS. There is evidence for increased peak 
broadening of each charge state with increased temperature consistent with an increase in the 
dynamics of the protein at higher temperatures. There is also evidence for a more extended 
conformation of HbS observable at higher charge states, suggested by the shouldering present 
in 16
+
 and 17
+
 charge states at all temperatures. 
Whilst the trend shown by the HbS data is similar to that observed for HbA, there is evidence 
to suggest that HbS is affected to a greater degree by charge and temperature effects. Both 
HbS and HbA show changes in the drift time profile of the 14
+
 charge state; HbA shows a 
minor increase, followed by a decrease. HbS, however, shows a significant decrease in drift 
time, consistent with a gas phase collapse of the protein. Both HbA and HbS also show 
increased peak broadening as a factor of temperature; HbS shows a much more severe peak 
broadening at FWHM compared to HBA suggesting that it is more susceptible to 
temperature-dependant effects. Both proteins show evidence of peak shouldering as a factor 
of charge, again with HbS showing a greater extended profile than HbA. 
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Figure 4-8 - arrival time distributions for the 14
+
  17+ charge state of HbS at four different temperatures: 37oC, 50oC, 80oC and 110oC. 
Increasing the temperature appears to have a limited effect on the arrival time distributions of the 14
+
 and 15
+
 charge states. 16
+
 and 17
+
 charge states show evidence of 
increased pear shouldering, consistent with the appearance of an additional conformation, suggesting that elevated temperatures may have a deleterious effect on the 
conformation of the higher charge states. 
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4.2.3 Investigating the effect of backing gas pressure on protein structure 
The effects on increasing the pressure in the source are discussed in detail in Section 
1.3 Biological mass spectrometry. Briefly, changing the backing pressure serves to 
a provide collision focusing effect on the ions which helps to improve transmission 
of protein complex ions through the mass spectrometer. Optimum conditions are 
protein dependant, and must be carefully controlled as high pressures can lead to 
collisional activation of a protein complex. 
The backing gas pressure was reduced from 6.8 mBar to 4.7 mBar to investigate the 
effect of pressure on the observed MS spectra. Based on the observations outlined 
above, and literature suggestions (Kirshenbaum, Michaelevski et al. 2010, Salbo, 
Bush et al. 2012), source temperature was reduced to 37
o
C to minimise the effects of 
temperature on protein conformation, dynamics and complex activation. The effects 
of this pressure change on MS peak shape and drift time/ CCS values are compared 
below. 
Native MS 
Figure 4-9 shows that at the reduced pressure of 4.7 mBar, there is a significant 
improvement in the observed peak shapes of HbA across the whole mass range; 
FWHM changed from 43.85 amu at 6.8 mBar to 5.42 amu at 4.7 mBar for the T16
+
 
ion, 12.39 amu to 1.23 amu for the D11
+
 ion and 1.5 amu  to 1.2 amu for the αh7+ 
ion. This is consistent with previous observations of increased peak width at higher 
pressure as a result of gentler desolvation conditions throughout the instrument 
(Sobott and Robinson 2004, Hernandez and Robinson 2007).  
Comparison of the relative intensities of the dimer and tetramer suggests that 
lowering the pressure from 6.8 mBar to 4.7 mBar negatively effects the transmission 
of Hb tetramer, D11
+
 intensity is higher than T16
+
 in the 4.7 mBar spectra compared 
to the 6.8 mBar spectra, where dimer intensity is lower than that of tetramer. It is 
possible, however, that the observed loss of intensity is as a result of peak 
broadening, and not of a loss of ion transmission. A comparison of the integrated 
peak area of the T16
+
 peak and D11
+
 peak, representative of the number of ions 
transmitted by the instrument, indicates a D11
+
:T16
+
 ratio of 1:5.2 at 6.8 mBar 
compared to 1:4.1 at 4.7 mBar. Whilst this does indicate a minor loss of ion 
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transmission with changing backing pressure, it is not as significant as first 
suggested based on ion intensity. 
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Figure 4-9 – Native MS spectra of HbA illustrating the effect of varying backing pressure on the MS spectrum between low pressure (4.7 mBar) and high pressure (6.8 
mBar). At increased source pressure relative intensity of the monomer appears much higher, and relative peak width increases. This suggests a worse signal-to-noise ratio for 
the tetramer, and may suggest some degree of collisional activation of the haemoglobin dimer/ tetramer to produce monomer.  
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Figure 4-9 also indicates an increase in the relative intensity of monomer at 6.8 mBar 
is higher than that observed at 4.7 mBar. Increasing the gas pressure in the cell 
induces a number of low energy collisions which serve to reduce the axial and radial 
kinetic energy of the ion (Benesch, Ruotolo et al. 2007). The optimum gas pressure 
is known to be protein specific, based on a proteins physical properties, (Tahallah, 
Pinkse et al. 2001), and increasing the pressure can increasing the internal kinetic 
energy, or temperature, of the ion to the point that collisional activation can occur 
(Konijnenberg, Butterer et al. 2013). It is therefore likely that the increase in 
monomer is as a result of the activation of either the dimer or the tetramer. 
Interrogation of the spectra provided no evidence for the presence of an Hb trimeric 
species, suggesting additional monomer is formed from the activation of the dimer. 
Comparison of the estimated collision cross sections  
As can be seen in Figure 4-10, dropping the pressure significantly improves the 
quality of the CCS calibration. At lower pressures we see a shift in the corrected drift 
times of the calibration standards; the drift time window changes from 3.1 – 7.5 ms 
to 1.6 – 4.51 ms. This shift is as a result of a reduction in the collision focusing; 
fewer gas collisions results in ions with a higher axial kinetic energy which allows 
them to traverse the mobility cell faster. There is also an observed shift in the values 
observed for the cytochrome C ions. At higher pressures the cytochrome C ions 
behave in a different manner, illustrated by the negative correlation between the ions 
seen in Figure 4-10 B, compared with Figure 4-10 A. This suggests that, at higher 
pressures, the monomeric cytochrome C may be undergoing gas phase activation as 
a result of the increased collisions, affecting its structure.  
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Figure 4-10 - Calibration curves obtained using cytochrome C (red) and bovine serum albumin (blue) 
at the A) 4.7 mBar and B) 6.8 mBar 
The result of the reduced pressure sees the quality of fit of the calibration curve 
increase from 0.83 to 0.95, making it far more suitable for obtaining CCS estimates. 
A comparison of the CCS estimates for HbA obtained using the calibration at each 
pressure is shown in Figure 4-11. 
 
Figure 4-11 – a comparison between the CCS estimates of HbA obtained using the calibration 
standard shown in Figure 4-10. At 4.7 mBar the better calibration leads to a minor increase in the 
estimated CCS values. 
The improved calibration leads to CCS estimates consistently higher for the 14
+
 - 
17
+
 charge states of HbA. The two data sets do, however, show similar trends 
suggesting that there is no major change in the conformational ensemble of the 
proteins as a result of changing the pressure. A poor signal-to-noise ratio, as a result 
of improper desolvation at the higher pressures, resulted in poor data for the 18
+
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charge state at 6.8 mBar. By changing the pressure regime is possible to resolve this 
peak and estimate a CCS value.  
4.2.4 Validating the collision cross sections  
Haemoglobin tetramer 
A comparison between four computational methods PA, EHSS, PSA and TM 
(discussed in more detail in 1.1.9 Computational modelling of CCS) and the 
experimentally estimated CCS values (obtained using 4.7 mBar source pressure and 
37
o
C source temperature) is shown in Figure 4-12. PDB entry 4HHB was used to 
create the computational CCS values (crystal structure shown in Figure 4-1). The 
computational CCS value produced was obtained using He as the buffer gas. To 
make it more applicable to the experimental dataset the computational model has 
been corrected to represent a pseudo-N2 value. An increase in CCS of 10% was 
chosen as the correction factor, based on the observed differences in the He and N2 
experimental data shown in Bush et al (Bush, Hall et al. 2010). Previous groups have 
reported the use of molecular dynamics to energy minimise X-ray crystal structures 
prior to performing CCS estimations (Ruotolo, Benesch et al. 2008). Due to the 
computational demands of MD modelling, no energy minimisation has been 
performed on these models.  
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Figure 4-12 – A comparison of the CCS values for HbA estimated from experimental data and 
calculated from PDB entry 4HHB. PA’, EHSS’, TM’ and PSA’ computational methods all represent 
the CCS increased by 10% to represent pseudo-N2 theoretical models. 
The experimental CCS calculated for the 14
+
 charge state is lower than the computational methods, 
consistent with previous reports. With increasing charge, the CCS estimate increases, consistent with 
protein unfolding as a result of charge. 
The TM method is the most robust method of CCS estimation, and therefore 
represents the best computational CCS value. The data shown in Figure 4-12 shows 
a difference between the CCS estimate of the 14
+
 ion and the TM’ CCS value is 9%, 
indicating a significantly smaller CCS in solution. The 18
+
 charge state of HbA 
shows good agreement with the calculated TM’ CCS value (0.25%) suggesting that 
under these experimental conditions the 18
+
 charge state represents a less compact 
and possibly more native-like conformation than the lower charge states.  
As seen previously, the PA method underestimates cross section values for HbA. 
The TM method is regarded as the most robust computational method, but it is by far 
the most computationally demanding. For HbA tetramer the TM method took 
approximately 6 days to complete the calculation using a standard desktop PC of 
modest computational power (Intel Dual Core CPU, 2.8/2.8 GHz and 2.98 Gb 
RAM). The EHSS method took approximately 6 hours to complete and provided a 
CCS which showed a 2% difference to the experimental CCS; the PSA method took 
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approximately 12 hours to complete and provided a CCS which agreed to 1.1% with 
experimental values.  
Whilst the TM method is thought to be the most robust computational method, its 
computational time makes it unsuitable to use if speed is a key factor in analysis. The 
PSA method, which has been applied here to haemoglobin for the first time, shows a 
good agreement with the TM method. The PSA would therefore be considered a 
good alternative to the TM method.  
Experimental CCS values for HbS were compared with computational values 
obtained using all four methods. PDB entry 2HBS, Figure 4-13, was used to generate 
the computational models. As can be seen in Figure 4-13, PDB entry 2HBS consists 
of a dimer of the two tetramers.  
 
Figure 4-13 – The crystal structure of PDB entry 2HBS 
Of these two tetramers, only one of the pair contains coordinates for the prosthetic 
heme groups. Pymol was used to remove the atomic coordinates for the tetramer 
containing no heme (in blue) to create a file with only a single haemoglobin 
molecule. These atomic coordinates were then used to create the CCS estimate. As 
before, no molecular modelling has been performed on the PDB files and the 
computational values have been corrected by +10%. 
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Figure 4-14 – A comparison of the CCS values for HbS estimated from experimental data and 
calculated from the modified PDB entry 2HBS using PA’, EHSS’, TM’ and PSA’ based on the 
corrected computational CCS values. 
The experimental CCS calculated for the 14
+
 charge state is lower than the computational methods, 
consistent with previous reports. With increasing charge, the CCS estimate increases, consistent with 
protein unfolding as a result of charge. 
As with the HbA data, Figure 4-14 shows that the CCS estimate of the 14
+
 charge 
state of HbS exhibits a large difference to that of the computational models. Once 
again there is a strong correlation between the 18
+
 experimentally estimated CCS 
value and TM CCS values, with a 0.5% difference, suggesting this may represent a 
more native-like conformation. Once again the PSA method for HbS provided a CCS 
value in good agreement (with a difference of 1.81%) the TM method. 
Computational times for HbS for the four methods were similar to as those presented 
for HbA. 
Haemoglobin dimer 
Atomic coordinate data for the αβ-dimers were created using Pymol to remove half 
the atomic coordinates from the intact tetramer, leaving only a single αβ-dimer with 
prosthetic heme groups (see Figure 4-15). As with Hb tetramer data, CCS estimates 
were corrected to account for the differences between He and N2 buffer gases. A 
correction factor of 12% was applied for Hb dimers. This is based on the observation 
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that proteins with smaller molecular weight/ Ω-values show larger differences 
between He and N2 observed Ω obtained on a drift cell instrument (Bush, Hall et al. 
2010). 
 
Figure 4-15 – The crystal structure of the HbA αβ-dimer (from PDB: 4HHB) 
The HbA dimer CCS data, Figure 4-16, shows a similar trend to the tetramer data; 
the lowest charge state (10
+
) shows a poor agreement with the computational CCS 
values, differing by 15%, whereas the 12
+
 charge state shows better agreement with 
the EHSS method (2.7%) and the TM method (1.3%). This again suggests a gas-
phase compaction of the dimer, consistent with previous observations for the 
tetramer.  
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Figure 4-16 – A comparison of the CCS values for HbA dimer estimated from experimental data and 
calculated from the modified PDB entry 4HHB using PA’, EHSS’, TM’ and PSA’ based on the 
corrected computational CCS values. The experimental CCS calculated for the 10
+
 charge state is 
lower than the computational methods, consistent with previous reports. With increasing charge, the 
CCS estimate increases, consistent with protein unfolding as a result of charge. 
The estimated HbA dimer CCS is, however, larger than half that of the tetramer. The 
tetramer CCS value is 4304±17 Å2 compared to 2660±17 Å2 for the lowest charge 
states (dimer is 61% of the monomer). It may be expected that this difference would 
be approximately 50%, given that the dimer is half the size of the tetramer. 
Haemoglobin dimers have an extensive overlap when they come together to form the 
tetramer, shown in Figure 4-17. This overlap means the diameter of the tetramer at 
its largest point, the value obtained when performing any CCS measurement, would 
be expected to be less than the sum of the diameter of two dimers. 
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Figure 4-17 – The crystal structure on HbA (4HHB) showing the two dimers (blue and green), 
highlighting the overlap at the interface site. Heme cofactors are coloured in red. 
For the HbS dimer the observations are similar (Figure 4-20). 
 
Figure 4-18 – A comparison of the CCS values for HbS dimer estimated from experimental data and 
calculated from the modified PDB entry 4HHB using PA’, EHSS’, TM’ and PSA’ based on the 
corrected computational CCS values.  
The experimental CCS calculated for the 10
+
 charge state is lower than the computational methods, 
consistent with previous reports. With increasing charge, the CCS estimate increases, consistent with 
protein unfolding as a result of charge 
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The 10
+
 charge state of HbS shows a worse agreement with computational models 
(approx. 12% difference between experimental and EHSS, TM and PSA) than the 
12
+
 charge state (approx. 1.5% difference between experimental and EHSS, TM and 
PSA), consistent with previous observations. 
Both HbA and HbS tetramer and dimer show large differences between the lowest 
charge state and the computational models. The Barran group have reported that for 
a number of proteins the CCS of the lowest charge state is consistently lower than 
that of the CCS measurement obtained from crystal structures (Jurneczko and Barran 
2011), which is consistent with the observations in Figure 4-13, Figure 4-14, Figure 
4-16 and Figure 4-18. It has also been observed, however, that higher charge states 
tend to have experimental CCS values higher than CCS values obtained from crystal 
structures. The highest charge state observed here is in good agreement with the 
computational CCS values, suggesting some form of error. It has been observed that 
ion mobility CCS measurements can be dependent on both TWIMS conditions and 
molecular CCS (Bush, Hall et al. 2010, Michaelevski, Eisenstein et al. 2010). 
Michaelevsi et al suggest that optimum T-wave conditions are 300-400 m/s wave 
velocity and 7-10 V wave height. This data set makes used of a wave velocity of 400 
m/s and a wave height of 18 V, based on the original Scarff et al publication (Scarff, 
Patel et al. 2009). It has previously been suggested that higher wave height voltages 
can lead to gas phase compaction of a protein (Michaelevski, Eisenstein et al. 2010). 
Whilst this observation has been challenged more recently (Salbo, Bush et al. 2012), 
Salbo et al did not perform any experiments at such high wave height voltages. It is 
possible that the observed discrepancy between the calculated CCS values and the 
experimental CCS values are as a result of a wave height-dependant effect on the 
CCS.  It is also possible that the choice of calibration standards is having an adverse 
effect on the estimated CCS value. Salbo et al recommend the use of calibration 
standards that carefully bracket the masses and drift time of the analyte (Salbo, Bush 
et al. 2012). Whilst care was taken to ensure calibration standards were chosen that 
bracket the drift time of the tetramer, calibrants were also chosen which bracketed 
the dimer. Cytochrome C, the low mass calibration standard, may be distorting the 
CCS estimates as a result of its low mass and drift time, leading to an 
underestimation of the CCS.  
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4.2.5 A comparison on normal haemoglobin with mutant variants 
Experimentally derived arrival time distributions and estimated CCS values for HBA 
were compared to those obtained from HbS and HbC in order to investigate any 
structural differences between the proteins. A comparison of the native MS spectra, 
shown in Figure 4-4, suggests that these proteins have a similar structure and 
conformation, based on the charge distribution, and therefore any changes to 
structure as a result of mutation would likely be subtle, such as a minor compaction/ 
expansion that would not disrupt the overall surface area of the protein (and thus, its 
ability to obtain charge from the solvent). 
Figure 4-19 shows the arrival time distribution data for the three proteins at each of 
the 14
+
 – 18+ charge states observed on the MS spectra. 
At the 14
+
 charge state HbA and HbS show the similar times, suggesting a similar 
conformation. There is, however, a noticeable increase in the FWHM of the peak – 
HbS has a 0.2 ms wider ATD than HbA suggesting that, whilst the two variants 
adopt a similar conformation, HbS may have a higher degree of structural flexibility 
within that conformation. The 14
+
 charge state in HbC, by comparison, has a lower 
drift time (4.1 ms) than either HbA or HbS (4.36 ms) suggesting a more compact 
conformation. HbC also has the broadest ATD (0.9 ms compared to 0.5 ms and 0.7 
ms for HbA and HbS, respectively) suggesting that it may have a higher degree of 
conformational flexibility. The nature of the mutation may provide some insight into 
this increased destabilisation. In HbA the β6 amino acid is the negatively charged 
glutamic acid. In HbS this glutamic acid has been mutated to neutral valine, whereas 
in HbC the glutamic acid has been mutated to positively charged Lysine. The change 
from a negative side chain in HbA to a positive side chain in HbC is likely to have a 
significantly larger impact on protein structure than the mutation to a neutral side 
chain (HbS), since it will change the electrostatic interactions occurring at the local 
environment. 
As the charge on the protein is increased all three molecules show a decrease in 
observable drift times through to 18
+
. The observed peak broadening in HbS and 
HbC remains consistent with increasing charge, supporting the theory that these two 
variants have increased flexibility as a result of the mutations. There is an observed 
peak shouldering in all three samples at 15
+
, suggesting the emergence of a second, 
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more extended, conformation. This shoulding appears more prominent in HbA by 
virtue of the narrower FWHM in the HbA sample. 
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Figure 4-19 – A comparison of the arrival time distributions of HbA, HbS and HbA at the different charge states. 
HbA and HbS 14
+
 charge states shows simialr drift times, whilst HbC shows a a smaller drift time, suggesting HBC may adopt a more compact confromation. HbA, HbS and 
HbC show evidence of ATD shouldering at higher charge states, consistent with the emergence of additional, extended, conformations. The relative intenisty of the 
shouldering is higher in HbS and HbC samples, suggesting a potential difference in gas phase stability. 
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For the 17
+
 charge state there is a shift in the arrival times of HbS and HbC; both 
proteins exhibit a larger drift time than HbA suggesting a shift to a more extended 
conformation in the mutants relative to HbA. For the 18
+
 charge state both HbS and 
HBA show similar arrival times, suggesting a shared conformational ensemble, with 
the HbC ion having a slightly longer arrival time than the other two mutants. All 
three proteins, at this stage, show clear signs of a secondary conformational 
ensemble; in the HbS sample this is most evident by observation of a second peak 
with an arrival time of 3.33 ms, but it can also be seen by the prominent peak 
shouldering in HbA and HbC. This additional species is at a higher intensity in HbC 
than in HbA, but cannot be fully resolved in either sample. The presence of these 
extended conformations illustrates the ability of the protein to unfold and form 
stable, gas phase structures (Scarff, Thalassinos et al. 2008). 
Using the calibration curve shown in Figure 4-10 arrival times were converted to 
CCS values to provide enable direct comparison. CCS values were calculated for the 
most intense drift times present in Figure 4-19 for all charge states. A comparison of 
HbA and HbS CCS values is shown in Figure 4-20, a comparison of HbA and HbC 
is shown in Figure 4-21, a comparison of HbS and HbC is shown in Figure 4-22. 
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Figure 4-20 – A comparison of the experimental HbA and HbS CCS values.  
Both HbA and HbS show increased CCS with charge, consistent with previous observations. HbA 
and HbS show no differences in CCS at all charge states except the 17
+
 charge state. This may 
suggest differences in the gas phase stability, as HbS more readily adopts a more extended 
conformation. 
Figure 4-20 indicates that both HbA and HbS have similar cross sections in the 14
+
 
charge states. This is in contrast to the work previously published (Scarff, Patel et al. 
2009) which indicated HbS had a larger cross section than HbA. The data presented 
here suggests that, whilst the two proteins have a similar CCS within experimental 
error, HbS estimates are still marginally larger than those of HbA. It has already 
been shown that the improved calibration framework and sample preparation 
methods provide CCS estimates closer to those predicted by computational methods. 
Based on this observation, it is likely that the small differences observed here were 
amplified as a result of the previous calibration.  
With increasing charge we observe an increase in cross section, consistent with 
previous publications (Scarff, Thalassinos et al. 2008, Scarff, Patel et al. 2009) 
indicating that with increasing charge a protein begins to unfold. Whilst HbA and 
HbS exhibit similar CCS values for the 14
+
, 15
+
, 16
+
 and 18
+
 charge states, there is a 
significant difference in the 17
+
 charge state. HbS has a significantly larger CCS 
value than HbA at the 17
+
 charge state consistent with the increase in drift time 
shown in Figure 4-20. This suggests that, at the 17
+
 charge state, HbS may adopt a 
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more extended gas phase structure than HbA, however at the 18
+
 charge state we 
observe similar CCS values again. Whilst HbA and HbS do follow a similar gas 
phase unfolding pathway, suggested by broadly similar drift times/ arrival time 
distributions and CCS estimates, HbS is able to adopt this extended conformation 
more readily.  
 
Figure 4-21 – A comparison of HbA and HbC CCS value. 
Both HbA and HbC show increased CCS with charge, consistent with previous observations. HbC 
appears to have a smaller CCS than HbA at the 14
+
 charge state, suggesting a more compact 
conformation. As with HBS, there is an observed difference between HbC and HbA at the 17
+
 charge 
state. This may suggest differences in the gas phase stability, as HbC more readily adopts a more 
extended conformation. 
A comparison of HbC with HbA suggests that the 14
+
 charge state of HbC has a 
smaller CCS value, consistent with the lower drift time observed in Figure 4-21. 
With increasing charge the cross section of HbC increases, consistent with the HbA 
and HbC data. Interestingly, HbC also exhibits a larger cross section than HbA at the 
17
+
 charge state. From Figure 4-22 illustrates that HbC 17
+
 charge state adopts a 
similar cross section to that of HbS at the 17
+
 charge state, indicating a potentially 
shared conformational ensemble. This suggests that both HbS and HbC follow a 
similar gas phase unfolding pathway when unfolding due to increased charge. For 
the 18
+
 charge state HbA and HbC have similar CCS values, suggesting they both 
occupy similar conformational ensembles at higher charges. 
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Figure 4-22 – A comparison of HbC and HbS CCS value.  
HbC appears to have a smaller CCS than HbS at the 14
+
 charge state, suggesting a more compact 
conformation. HbS and HbS appear to have the same CCS at the 17
+
 charge state, suggesting a 
shared, extended gas phase conformation. 
The effects of mutation were also investigated on the dimers and the results are 
shown in Figure 4-23 and Figure 4-24. Both Figure 4-23 and Figure 4-24 indicate 
that conformational differences observed in the tetramer are not observed in the 
dimer for either the native state, or as a result of unfolding due to increased charge. 
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Figure 4-23 – A comparison of HbA and HbS CCS value for the dimer species. 
Bothe HbA and HbS dimers have the same CCS at all charge states, indicating no conformational 
differences 
 
 
Figure 4-24 – A comparison of HbA and HbS CCS value for the dimer species. 
Bothe HbA and HbS dimers have the same CCS at all charge states, indicating no conformational 
differences 
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4.2.6 Collisional activation of haemoglobin tetramer 
In order to investigate the observed differences in the unfolding transitions of 
haemoglobin collisional activation was used to induce unfolding in the protein. 
Collision activation is described in more detail in Introduction section: Collisional 
Activation but in summary, increasing the acceleration voltage of the protein as it 
enters various regions of the cell results in a number of higher energy collisions 
which can induce dissociation. In this study the aim was not to induce dissociation, 
but to increase the internal kinetic energy of the protein via these collisions in order 
to induce unfolding much in the same way as temperature could be using to induce 
unfolding. The voltage to the skimmer cone was systematically increased between 
60V and 200V; the results for HbA are shown in Figure 4-25.  
It has already been observed that increasing the skimmer cone voltage leads to 
collisional activation and dissociation in a similar manner to that of CID (Benesch, 
Ruotolo et al. 2007), and that is evident in Figure 4-25 as increasing the cone voltage 
leads to a loss of intensity of the HbA tetramer, and an increase in the relative 
intensities of the dimer and monomer species.  
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Figure 4-25 – The native MS spectra of HbA at varying cone voltages.  
With increasing cone voltage the relative intensity of the tetramer (orange) decreases, and the intensity of the dimer (blue) and monomer (red) increases. At cone voltages 
higher than 120 V a number of additional peaks begin to appear, resulting from the fragmentation of the protein backbone by CID.  
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Figure 4-26 - The native MS spectra of HbS at varying cone voltages. 
With increasing cone voltage the relative intensity of the tetramer (orange) decreases, and the intensity of the dimer (blue) and monomer (red) increases. At cone voltages 
higher than 120 V a number of additional peaks begin to appear, resulting from the fragmentation of the protein backbone by CID.  
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Figure 4-27 - The native MS spectra of HbC at varying cone voltages. 
With increasing cone voltage the relative intensity of the tetramer (orange) decreases, and the intensity of the dimer (blue) and monomer (red) increases. At cone voltages 
higher than 120 V a number of additional peaks begin to appear, resulting from the fragmentation of the protein backbone by CID.   
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Figure 4-26 and Figure 4-27 show results for HbS and HbC, respectively that are 
similar; HbS and HbC spectra show a far higher degree of fragmentation, based on 
the intensities of the multiply charged ions observed below 2500 m/z. From this is 
can be concluded that these both HbC and HbS more readily fragment than HbA, 
however which oligomeric state is fragmenting cannot be accurately determined 
without further experiments. These results are in agreement with those previously 
observed for the reduction of stability in the diseased variants of haemoglobin 
relative to normal haemoglobin.  
Figure 4-27 – 4-29 show that tetramer intensity drops off with increasing charge. It is 
also clear that above 160 V, the native-like 14
+
 ion of the tetramer has a significant 
of signal intensity; reducing to below 10% in all cases. At these values the peak has a 
very poor signal: noise ratio making it difficult to analyse the ion mobility data for 
the ion. The arrival time distributions of the 14
+
 ions for HbA, HbS and HbC were 
therefore compared for 60 V  160 V and are shown in Figure 4-28. 
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Figure 4-28 - The drift time chromatograms for HbA (blue), HbS (green) and HbC (red) showing changes in arrival time distributions with increasing cone voltage for the 
14
+
 charge state.  
Increasing cone voltage results in the emergence of a number of additional, extended conformations. The relative intensity of these extended conformations in more intense in 
the HbS and HbC ATDs relative to the HbA ATD  
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The HbA data shows a single conformation at 60 V for the 14
+
 ion, consistent with 
previous observations. As the skimmer cone voltage increases a shoulder appears on 
the ATD, starting at 80 V but shown most prominently at 100 V, suggesting the 
presence of a more extended conformation that cannot be fully resolved from the 
native conformation. At 120 V this extended conformation is fully resolved and is 
itself showing evidence of shouldering, suggesting a number of further unfolded 
subpopulations. By 140 V and 160 V this large peak further extends, resulting in a 
number of smaller unresolved peaks. The data suggests that, with collisional 
activation, HbA can be made to undergo gas phase unfolding to form first one, and 
then a number of extended gas phase structures. Each of these extended populations 
have broad ATDs, indicating dynamic conformations; consistent with a less folded 
structural state. Interestingly, for HbA the native conformation, present at 60 V, 
remains the dominant peak at all cone voltages, indicating that there is incomplete 
unfolding of the HbA. Increased collisional activation may push the equilibrium of 
folded: unfolded protein towards the unfolded state, but at 160 V there is still not 
enough energy to completely force the equilibrium towards the unfolded. There are 
still some changes evident in the native conformation. At the higher energy levels 
(140 V and 160 V) the native conformation shows a small increase in drift time, 
suggesting the equilibrium may be shifting towards a more extended conformation, 
and the ATD is broader, suggesting the conformation has become more dynamic.  
HbS shows a similar trend to that observed for HbA. At 60 V the ATD is broader, 
consistent with the previous data. The shouldering observed in the HbA sample at 80 
V and 100 V is also present, as is the additional peak at 120 V. In HbS, however, 
each of these features appears at higher relative intensities than in the HbA sample, 
suggesting they are more easily induced in HbS.  At 140 V and 160 V there are 
multiple, unresolved peaks which are observed at a higher relative intensity in HbS 
than in HbA. These observations support the previous suggestion that HbS is more 
readily able to unfold compared to HbA.  
HbC shows a similar trend to that observed for HbA and HbS; the formation of a 
shoulder in the ATD at 80V 100 V which becomes a resolved peak by 120 V. This 
extended population has a higher relative intensity in HbC compared to both HbA 
and HbS suggesting that HbC is the most easily unfolded of the three proteins. This 
is most evident at 120 V where the native conformation is no longer the dominant 
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peak in the ATD, having been replaced with the more extended conformation. At 
140 V and 160 V it appears as if the intensity of these extended conformations is 
lower than in the previous examples. Whilst the intensities are lower, the overall 
arrival time window of all the conformations of HbC is wider, suggesting that HbC 
may adopt a more dynamic extended conformation at a lower intensity at these 
higher activation energies. This is consistent with the suggestion that HbC more 
readily unfolds than HbA or HbS. 
Figure 4-29 – 32 show the same unfolding data for the 60 – 200 V unfolding for the 
15
+
 - 18
+
 charge states. 
 
Figure 4-29 – The drift time chromatograms for HbA (blue), HbS (green) and HbC (red) showing 
changes in arrival time distributions with increasing cone voltage for the 15
+
 charge state.  
Increasing cone voltage results in the emergence of a number of additional, extended conformations. 
The relative intensity of these extended conformations in more intense in the HbS and HbC ATDs 
relative to the HbA ATD 
The 15
+
 charge state (Figure 4-29) shows a similar trend to that observed for the 14
+
 
charge state. All three proteins show a similar ATD as a factor of unfolding, with the 
HbS and HbC samples showing higher intensity of the extended conformations 
relative to HbA. The same is true of the 16
+
 (Figure 4-30) and 17
+
 (Figure 4-31) 
charge states. At 17
+
 charges the HbS and HbC samples show evidence that more 
extended conformations are more intense than the more compact. This supports the 
previously shown data which discussed the differences between the HbA CCS and 
both the HbS and HbC CCS values (Figures 4-20, 4-21 and 4-22).  
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Figure 4-30 - The drift time chromatograms for HbA (blue), HbS (green) and HbC (red) showing 
changes in arrival time distributions with increasing cone voltage for the 16
+
 charge state 
Increasing cone voltage results in the emergence of a number of additional, extended conformations. 
The relative intensity of these extended conformations in more intense in the HbS and HbC ATDs 
relative to the HbA ATD 
 
Figure 4-31 - The drift time chromatograms for HbA (blue), HbS (green) and HbC (red) showing 
changes in arrival time distributions with increasing cone voltage for the 17
+
 charge state.  
Increasing cone voltage results in the emergence of a number of additional, extended conformations. 
The relative intensity of these extended conformations in more intense in the HbS and HbC ATDs 
relative to the HbA ATD 
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Figure 4-32 - The drift time chromatograms for HbA (blue), HbS (green) and HbC (red) showing 
changes in arrival time distributions with increasing cone voltage for the 18
+
 charge state 
Increasing cone voltage results in the emergence of a number of additional, extended conformations. 
The relative intensity of these extended conformations in more intense in the HbS and HbC ATDs 
relative to the HbA ATD 
The 18
+
 charge state shows the largest differences between the HbA and both HbC 
and HbS samples. Up until this point the data has suggested that, whilst normal and 
diseased haemoglobin unfolded at different rates, they ultimately followed a similar 
unfolding pathway based on the observed similarity between the CCS values and the 
ATDs. The 18
+
 data suggests that, when unfolded due to increased charge, the three 
proteins show a similar ATD profile, and therefore have a similar CCS value, as 
indicated by Figures 4-20, 4-21 and 4-22. When the 18
+
 charge state is unfolded by 
collisional activation there are some key observed differences between the samples. 
In this instance, the HbA sample seems more readily able to unfold; the most 
compact conformation is lost by 120 V and is replaced by three dominant extended 
conformations. In contrast, HbS and HbC both show evidence of this more compact 
18
+
 structure throughout the activation process, with evidence of the compact 
shoulder persisting until 200 V. In contrast to previous observations, HbC retains 
this compact structure to the greatest degree. In addition, HbS appears to be able to 
adopt a number of different extended conformation which do not appear to a lesser 
extent in HbA, and at different intensities to those of HbC; these differences are is 
most evident at 120 V. 
HbA Collision Heating with cone - Cone V 200HbA Collision Heating with cone - Cone V 200
Time
-0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 16.00 17.00 18.00 19.00 20.00 21.00 22.00 23.00 24.00 25.00
%
0
100
HbS Normal IMS mode Cone V 200 Normal Improved SprayHbS Normal IMS mode Cone V 200 Normal Improved Spray
Time
-0. 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.0 11.0 1 .0 13.0 14.0 15.0 16.00 17.00 18.00 19.00 20.00 21.00 22.00 23.00 24.00 25.00
%
0
100
HbC 1/40 Normal settings IMS mode cone V 200HbC 1/40 Normal settings IMS mode cone V 200
Time
- .00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 16.00 17.00 18.00 19.00 20.00 21.00 22.00 23.00 24.00 25.00
%
0
100
18+
60 V
80 V
100 V
120 V
140 V
160 V
HbA HbS HbC
180 V
200 V
138 
 
4.3 Conclusions 
Ion mobility mass spectrometry has become a useful tool for studying protein 
structure and dynamics. Since commercialisation a number of groups have worked 
on methods for improving the experimental data, and it was the aim of this study to 
revisit a previous publication by Scarff et al from 2009, and apply recently described 
improvements in experimental protocols to that study. By using gentler sample 
preparation and lower source temperatures and pressure it has been possible to obtain 
spectra of haemoglobin with lowest observed charge states and a better resolution, 
obtaining accurate masses to within a 2 Da of the theoretical.  
This improved sample preparation method has been used to analyse the two 
previously studied haemoglobin variants, HbA and HbS, alongside HbC which has 
not previously been analysed by native MS or IMS. The data presented here 
indicated that differences between HbA and HbS initially reported were limited by 
the extrapolation of calibration employed, and the cross sections these two protein 
adopt may be similar than initially reported. HbC does however have a significantly 
smaller estimated CCS value than HbA or HbS, suggesting a more compact 
conformation.  
All three proteins show an increase in CCS as a factor of charge, however HbS and 
HbC show larger CCS values for the 17
+
 charge states than HbA suggesting a 
possible stability difference between normal and diseased protein. The variants may 
more easily adopt unfolded structures. All three haemoglobin samples do share 
similar CCS values at the 18
+
 charge state suggesting a possible shared mechanism 
for gas phase unfolding. This has been further investigated using collisional 
activation. The data obtained supports the inferences obtained from the CCS 
estimations; HbS and HbC do indeed appear to unfold more readily in the gas phase, 
adopting similar conformations to HbA but at a higher relative intensity. It can be 
suggested that HbA, HbS and HbC follow broadly similar unfolding pathways. 
There does appear to be some differences for are ions at higher internal suggesting 
this shared mechanism may diverge at a certain point. 
The results suggest that the β6 mutations causing HbS and HbC induce 
conformational changes in the protein. For HbC these are more immediately 
obvious, but for HbS they only manifest as differences in stability. Nevertheless, ion 
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mobility mass spectrometry has proven useful as a tool for identifying and 
investigating these differences in molecules with strong structural homology; 
differences that would not be easily studied using other techniques. 
Future perspectives 
Collisional activation experiments focused primarily on the changes in the ATD of 
the haemoglobin tetramer and not the dissociation of the tetramer into its subunits. 
The molecular assembly of haemoglobin was one area of the 2009 Scarff et al paper 
that has not been reinvestigated here. Given observed stability differences between 
HbA and HbS it would be interesting to characterise the dissociation energy 
thresholds of the protein using collisional activation in order to see if there are any 
changes to the protein-protein interaction strengths induced by the mutations; the 
data presented here suggests that this may be possible but it is unclear as to whether 
this is due to monomer-monomer interactions or dimer-dimer interactions.  
This leads to two other possible future considerations; self-assembly and collisional 
activation. All collisional activation in work here has been achieved using the 
skimmer cone, which is a relatively blunt method of activation. Future work could 
compare activation using the cone with activation in the instrument collision cell in 
order to draw parallels and investigate the selectivity of the two activation 
techniques. With regards to self-assembly, both HbS and HbC are diseases of self-
assembly and it would be of interest to look at this mechanism. Collisional activation 
could also play a role; inducing dissociation of the aggregate may not only provide 
information regarding assembly mechanisms but also provide an insight into the 
conformation the protein adopts within the aggregate, allowing an observation of a 
possible link between stability differences and self-association.  
Haemoglobin has only been investigated here in the deoxygenated state whereas in 
biological systems there is constant flux between oxygenated and deoxygenated 
states. It would be interesting to investigate conformational and stability differences 
between the two states. This is of particular interest for HbC since it is only capable 
of forming pathological crystals in it oxygenated state. 
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5.1 Introduction 
5.1.1 Immunity, Antibodies, Structure and History 
The Immune Response 
The world is full of microorganisms capable of causing disease. These 
microorganisms are collectively known as pathogens. In order to survive, mammals 
have evolved a number of strategies capable of preventing a pathogen from causing 
disease within the body and to purge the pathogen from the body. This response is 
known as the immune system, and may be broadly separated into two distinct 
mechanisms based on the types of cell that act to clear the pathogen; the innate 
immune response and the adaptive immune response. The innate immune response is 
immediately available to combat pathogens, and is responsible for control of a 
number of common, less virulent, infections. More aggressive or less common 
infections, however, are more challenging to overcome. The adaptive immune 
response has evolved to allow the rapid selection, evolution and proliferation of 
specialist cells which can specifically target and destroy a single pathogen. The 
adaptive immune response also confers long-lasting immunity against infection. The 
two systems do not operate in isolation, but in tandem in order to best combat 
infections; the innate immune system is responsible for the triggering of the adaptive 
response which, in turn, targets the pathogen for destruction by the cells of the innate 
immune response (Janeway 2005).  
There are a number of cells and biomolecules that are vital to the immune response. 
White blood cells, or leukocytes, are the main cell type involved in the immune 
response, and can be subdivided based on functional differences. The innate immune 
response is principally comprised of granulocytes and macrophages, which directly 
destroy pathogens via cellular ingestion, or by the release of toxic agents capable of 
destroying parasites. The adaptive immune system is principally comprised of 
lymphocytes, which can be further subdivided into either T-lymphocytes (thymus-
derived) or B-lymphocytes (bone-marrow-derived). T-lymphocytes, or T-cells, have 
two main functional roles; the triggering of apoptosis in cells expressing viral 
proteins (cytotoxic T-cells) or the activation of additional immune cells (helper T-
cells). B-lymphocytes, or B-cells, which, when activated, rapidly differentiate into 
plasma cells capable of secreting antibodies. Antibody mediated immune response is 
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also known as the humoral immune response (Janeway 2005). Antibodies (Ab) are 
vital biomolecules in the immune response, and form the main focus of this research 
due to their biological, medical and economic impact. 
The antibody molecule 
In 1890 Emil von Behring discovered that it was an antibody that carried immunity 
to a given pathogen within the blood of an individual (Von Behring and Kitasato 
1890). In 1973 M. Edelmann and R. R. Porter were awarded a Nobel Prize for their 
contributions in elucidating the structure of antibodies (Nobelprize.org 1972).Their 
early work focussed on the analysis of proteins and protein fragments obtained from 
myelomas which turned out to be antibodies. In 1959 R. R. Porter published the first 
X-ray crystal structure of an antibody fragment; an 80,000 Da fragment obtained 
from a papain digest which had been shown to crystallise readily (Porter 1959). This 
was followed by the first description of antibody structure (Fleischman, Porter et al. 
1963), shown in Figure 5-1. Further studies on gene control (Oudin 1956) and 
primary structure (R. L. Hill, R. Delaney et al. 1966, O'Donnell, Frangione et al. 
1970, Johnstone and Mole 1977) of this type of antibody provided evidence for the 
structure of antibodies. 
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Figure 5-1 – The canonical structure of an IgG1 antibody. 
The antibody structure shown in Figure 5-1 is that of an immunoglobulin γ, or IgG. 
There are five subclasses of antibody, determined by the type of C domains they 
contain. The five C domain heavy chain isotypes are α, δ, ε, μ and γ which give rise 
to the IgA, IgD, IgE, IgM and IgG isotypes. IgA and IgG both have further 
subclasses based on structural differences. IgA has three subclasses; IgA1, IgA2 and 
an IgA multimer consisting of two IgA molecules linked by a connective J-region 
(Janeway 2005). IgG contains four distinct subclasses, IgG 1-4, that differ in 
disulphide bond arrangement.  
In addition to these heavy chain isotypes, there are two distinct light chain isotypes; 
κ and λ. Whilst there is no known functional difference between the two isotypes, it 
has been shown that the relative abundance of each chain changes between species; 
the relative abundance of κ:λ is 20:1 in mice compared to 2:1 in humans, suggesting 
a difference in expression of the two genes between species (Janeway 2005). 
Each heavy chain antibody isotype has its own distinct structural properties, 
function, abundance and location within the body, and contributes in different ways 
to the immune response (Seiler, Gronski et al. 1985); IgA is associated with mucosal 
membranes and plays an important role in immunity within these membranes and 
Fc
Fab
VH
VL
CL
CH1
CH2
CH3
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their secretions; IgD is a predominantly membrane bound receptor on lymphoid cells 
responsible for cellular activation; IgE is the main antibody associated with allergic 
responses; IgM is the first antibody circulated in an immune response, and is 
commonly circulated in the body; the IgG subtype is the most abundant of all Ig 
molecules, representing 75-80% of the antibodies in any given individual, and 
contains the conserved structural features of antibodies. IgG isotypes are the only Ig 
capable of traversing the placental barrier, allowing passive immune transfer from 
mother to foetus during pregnancy.  
IgG, specifically the IgG1 subtype, will form the main focus of the work described 
here.  
All antibodies are symmetrical, and consist of paired heavy and light chains, denoted 
H and L in Figure 5-1 (Seiler, Gronski et al. 1985). The heavy chain has a molecular 
weight of approximately 50 kDa, whilst the light chain has a molecular weight of 
approximately 25 kDa (Janeway 2005). The light chains flank the amino end of the 
heavy chain, and are connected to the heavy chain via disulphide bonds, the number 
of which varies in different Ig classes, and by a number of non-covalent interactions 
(Prabakaran, Vu et al. 2008). The heavy chain is divided into two regions by a linker 
region consisting of approximately 17 amino acids (Saphire, Stanfield et al. 2002), 
separating the heavy chain into two distinct regions. Pairs of heavy/ light chain 
dimers come together to form an intact heterotetramer of approximately 150 kDa; the 
heterotetramer is connected together by a number of disulphide bonds in the hinge 
region, the number of which differs based on IgG subclass, as well as a number of 
non-covalent interactions in the CH3 domain (Prabakaran, Vu et al. 2008). 
Both heavy and light chains contain a number of domains with a shared structural 
motif (Seiler, Gronski et al. 1985), known as the immunoglobulin fold. The motif is 
a β-sandwich structure comprised of approximately 110 amino acids, with a 
molecular weight of approximately 12 kDa. The light chain contains two of these 
domains, whilst the heavy chain contains four, or five in the case of certain Ig 
subclasses. Each domain contains a strong degree of sequence homology, with the 
exception of the most N-terminal domain in both the heavy and the light chains. The 
most N-terminal 110 amino acids form the variable (V) domain, responsible for 
antigen binding. It has been suggested that IgG molecules contain approximately 
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95% sequence homology, with the 5% variance located in the V-domains (Harris, 
Shire et al. 2004). IgGs also contain a intrachain disulphide bond in each domain, 
helping to stabilise the domain structure (Wang, Singh et al. 2007).  
The V domain of both heavy and light chain contain three exposed loops, residues 
30-36, 49-65 and 95-103 in the heavy chain (Janeway 2005) and residues 28-35, 49-
59 and 92-103 in the light chain (Janeway 2005), known as the hyper variable region 
(HV); each region is denoted as HV1, HV2 or HV3 (based on ascending amino acid 
resides). These loops are also known as the complementarity-determining regions 
(CDRs), since they determine the antigen specificity of the Ig molecule (again, 
denoted CDR1, CDR2 and CDR3 based on ascending amino acid number). The 
CDR3 loop is always the most variable. It is the combination of CDRs 1-3 from both 
the heavy and light chains that provide the overall antigen binding site, rather than 
any single chain (Janeway 2005), for an antibody and is known as the antibody 
paratope. The CDR’s are flanked by conserved regions known as framework regions 
(denoted as FR 1-4 based on position) (Janeway 2005). 
The constant (C) domain of the antibody shows sequence variation, based on the 
different alleles from which the protein is transcribed, but no higher order structural 
variation.  
The constant domain is, in most antibodies, post translationally glycosylated. The 
IgG subclass contains a single conserved glycosylation site at Asn 297 of the CH2 
domain that has been shown to be vital for the receptor binding of the antibody 
(Wright and Morrison 1997, Wang, Singh et al. 2007, Prabakaran, Vu et al. 2008), 
discussed in more detail later in this chapter. The common glycan structure for 
human IgG is shown in Figure 5-2. 
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Figure 5-2 – The glycan structure of a human IgG. 
All IgG’s contain an N-linked core biantannary glycan consisting of three N-
acetylglucosamine (GlcNAc) and three mannose moeties.  To this core, additional 
galactose moieties can be added to either the Man (α1-6) or Man (α1-3) arms, with a 
possible branched fucose present at the α1-6 linkage of the primary GlcNAc moiety 
(Jefferis, Lund et al. 1990). Under some circumstances the Man (α1-3) and (α1-6) 
can have a terminal sialic acid in some rare cases (Jefferis, Lund et al. 1990). 
Each CH2 domain of the antibody contains a single glycan, and has been shown to 
influence the CH2 domain spacing (Prabakaran, Vu et al. 2008). Removal of the 
glycan leads to significant changes in the Fc function, which will be discussed later. 
The antibody molecule is divided into two sections; the upper arms which consist of 
two copies of the antigen binding domains and a constant tail domain, linked via the 
hinge region. The upper arms are known as the Fragment Antigen Binding, or Fab 
region, based on their function. The constant tail region is known as the Fragment 
Crystallisable, or Fc, region based on the ease by which is was crystallised; it was 
this region that was first crystallised by R. R. Porter in 1959 (Porter 1959).  
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In vivo role of IgG 
Antibodies molecules have two main functions within the body; to specifically bind 
the pathogenic molecules responsible for the immune response, and to recruit other 
immunogenic molecules to assist in the removal of pathogens. 
The IgG1 molecule, as shown in Figure 5-1, has evolved to fulfil both of these 
functions. As described in section 1.2, the antibody contains two antigen binding 
sites each capable of specifically binding a single, target antigen, making them 
bivalent and capable of cross-linking between two target antigens. The coming 
together of CDR 1-3 from the heavy and light chain creates a single antigen binding 
site which is unique in both sequence, and structure, leading to different Ig idiotypes 
(antibodies with a shared heavy/ light chain isotype and subclass with differences 
only in the variable regions). The structure recognised by the antigen binding site is 
known as the epitope. Epitopes fall into one of two categories, conformational/ 
discontinuous epitopes and linear/ continuous epitopes. Conformational/ 
discontinuous epitopes are those which have a specific three dimensional shape 
recognised by the antibody, resulting in an epitope that is composed of amino acids 
that are close in space and not sequence. Similarly, linear/ continuous epitopes are 
those that are recognised based on sequence and not shape. The majority of antigen 
binding sites recognise conformational epitopes; however some may be raised 
against linear epitopes if the target is a small, linear peptide (Janeway 2005). 
Once an IgG has bound target antigen via the Fab region, the antibody may trigger 
further immune responses via interactions between the Fc region and host cell 
receptors. A large number of immune cells exhibit surface proteins capable of 
recognising antigens. Others contain an Fc receptor, an extracellular protein capable 
of specifically binding to a subclass of antibody, allowing the antibody molecule to 
provide antigen recognition system for these cells (Daëron 1997). An Fc Receptor 
(FcR) family exists for every subclass of antibody and are named for the antibody 
they bind; IgG is, therefore, recognised by FcγR proteins. Binding of IgG to FcγR 
triggers one of a number of immune responses, included phagocytosis, endocytosis, 
antibody-dependent cell mediated cytotoxicity (ADCC), the release of cell mediators 
of inflammation, and B-cell activation and antibody production (Raghavan and 
Bjorkman 1996). There are three types of FcγR, denoted FcγRI, FcγRII and FcγRIII 
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(Gessner, Heiken et al. 1998). All three FcγRs contain a transmembrane domain, an 
intracellular domain and a number of extracellular domains (Raghavan and 
Bjorkman 1996). Whilst all three FcγR’s are capable of binding IgG Fc, they do so 
with different affinities: FcγRI has the highest affinity for IgG and is able to bind 
IgG at low concentrations, suggesting a role in early immune response (Shen, Guyre 
et al. 1987). FcγRII and III show a lower affinity for IgG and preferentially bind IgG 
when found in large, cross-linked antibody-antigen complexes (Raghavan and 
Bjorkman 1996).  
Antibodies are incapable of eliciting a full immune response alone, and must come 
together in large numbers in order to trigger Fc effector function. Antibodies bind 
and cross-link a number of antigen molecules creating a larger antibody-antigen 
complex which, when bound by FcγR, induces receptor cross-linking at the cell 
surface and triggers cellular signalling (Raghavan and Bjorkman 1996, Daëron 
1997). Despite affinity differences between FcγRI and FcγRII/FcγRIII, all FcγR’s 
require crosslinking in order to trigger intercellular signalling (Davies and Metzger 
1983). 
IgG Fc is also capable of binding other receptors in addition to FcγRI, FcγRII and 
FcγRIII; the Fc neonatal receptor (FcRn) (Raghavan and Bjorkman 1996, Ghetie and 
Ward 1997, Ghetie and Ward 2000) and the C1q receptor (Cooper 1985, Ward ES 
and V. 1995) may also be bound. 
The C1q receptor, like the FcγR, acts as a bridging receptor linking the humoral 
immune response with complement-dependent cytotoxicity (CDC).  
Interaction between C1 proteins, the first protein complex in the complement 
pathway, with antibodies was first characterised in the 1960s (Müller-Eberhard and 
Calcott 1966), and was investigated thoroughly in the 1970s (Augener, Grey et al. 
1971, Schumaker, Calcott et al. 1976). The C1q receptor is one peptide that makes 
up C1, a 750 kDa complex consisting of C1q, and two copies each of C1r and C1s 
(C1qr2s2). The binding of Fc triggers a rearrangement in the C1 protein which 
induces limited C1 auto-proteolysis, turning the C1 complex into an active serine 
protease (Ziccardi 1983). The active C1 complex can further activate additional 
complement proteins, C2 and C4, and begin a proteolytic cascade which eventually 
results in the destruction of the Ig-bound pathogen (Ziccardi 1983).  This series of 
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activation steps is known as the classical complement pathway. CDC can be 
activated in other, antibody-independent ways, which are not covered here. 
FcRn is another receptor capable of binding to IgG Fc. Unlike C1q and other FcγRs, 
FcRn is not responsible for eliciting effector function, but for antibody transport and 
recycling. FcRn shows specificity for the IgG class of antibody only, but unlike the 
FcγR it is capable of binding IgG alone, rather than IgG-antigen complexes 
(Raghavan and Bjorkman 1996). FcRn has been implicated in the transfer of IgG 
across the placental barrier from mother to foetus (Simister, Story et al. 1996), as 
well as in binding extracellular IgG in the gut, transporting it across the gut 
epithelium and into the blood stream (facilitating the transfer of passive immunity 
from mother to child via maternal milk (Mostov and Simister 1985)). FcRn has also 
been heavily linked to control of IgG serum lifetime (Raghavan and Bjorkman 
1996). FcRn can act as a salvage receptor, binding IgG in intracellular digestive 
vesicles and exporting the IgG back to the cell surface for release (Ghetie and Ward 
1997). The affinity of FcRn for IgG has been found to be pH dependant; at slightly 
acidic pH (6.0-6.5) the FcRn has higher affinity than at more neutral/ basic pH. This 
pH-dependent affinity is crucial to antibody reclycing, as it allows the FcRn to bind 
to IgG in the acidic intracellular vesicles, after which the IgG is transported to the 
cell surface. Upon exposure to the neutral pH of blood the FcRn loses affinity and 
releases the IgG back into circulation (Raghavan and Bjorkman 1996). 
Exploitation of Antibodies 
In 1984 Niels K. Jerne, Georges J.F. Köhler and César Milstein were awarded the 
Nobel Prize in Medicine and Physiology for “theories concerning the specificity in 
development and control of the immune system and the discovery of the principle for 
production of monoclonal antibodies" (Nobelprize.org 1984). For Kohler and 
Milstein this was awarded for their work in creating an immortalised cell line 
capable of producing a single antibody subtype with identical isotype and idiotype; a 
monoclonal antibody (mAb) (Kohler and Milstein 1975). The development of mAbs 
heralded a new age for antibodies in research and diagnostics since the selectivity, 
heterogeneity, speed of action and reproducibility enjoyed by mAbs, over polyclonal 
antibodies, made them far more suitable for routine experiments (Seiler, Gronski et 
al. 1985). For a long while the integration of mAbs in medicine was considered the 
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Holy Grail of applications, and a large amount of research was directed at addressing 
the inherent problems associated with using mAbs in medicine, discussed in section 
4.1.1.5 
Monoclonal Antibodies as therapeutics; history, current status and future 
perspectives 
The exploitation of biological agents for medicinal purposes dates back as far as 
1796, when Edward Jenner first used cowpox to immunize individuals against 
smallpox (Riedel 2005). Since these humble beginnings the use of biological agents 
in therapeutics has risen dramatically. Described as “magic bullets” in 1975, 
monoclonal antibodies were due to herald a new age in the use of biologics as 
therapeutic agents (Kohler and Milstein 1975). With their high selectivity, and 
ability to exploit a patient’s immune response for therapeutic benefit, mAbs seemed 
to be the perfect drug for a number of indications. The first mAbs produced in the 
1980s were murine based, and presented a number of challenges. Primarily, murine 
mAbs could be recognised as non-self by the patient, leading to the production of 
anti-drug antibodies (ADAs)(Buss 2012). Murine mAbs also exhibited short serum 
half-lives, as a result of weak binding to FcRn (Ober, Radu et al. 2001), and were  
poor recruiters of effector function, including complement activations and ADCC 
(Stern and Herrmann 2005). It has subsequently been shown that mAbs from 
different species can have distinct glycosylation patterns (Sheeley, Merrill et al. 
1997), which can be a key factor affecting in Fc receptor binding.  
In an attempt to address these issues a number of chimeric mAbs were created 
(Vaughan, Osbourn et al. 1998), containing ~65% human sequence in the constant 
domains, whilst the variable domains remained murine (Morrison, Johnson et al. 
1984). These chimeras showed increased recruitment of effector function, 
complement activation and ADCC activity, alongside improved serum half-lives, but 
still led to the production of ADA’s in >50% of patients (Vaughan, Osbourn et al. 
1998). A limited number of chimeric mAbs however were produced that successfully 
progressed beyond clinical trials (Vaughan, Osbourn et al. 1998) 
Chimeric mAbs are still capable of producing ADA’s due to the conserved nature of 
the V-domain. With the exception of CDR regions on VH and VL both chains are 
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homogeneous within an organism, and it was with this realisation that work began 
on creating humanised mAbs (Vaughan, Osbourn et al. 1998); mAbs containing the 
human sequence in all but the CDR regions, which would be raised in murine 
systems and then grafted onto the human mAb gene (Jones, Dear et al. 1986, 
Riechmann, Clark et al. 1988, Verhoeyen, Milstein et al. 1988). Humanising mAbs 
overcame many of the issues associated with ADA’s and the poor half-life/ induction 
of effector functions but it was a laborious process.  
Current generation mAbs are no longer humanised, but fully human, making use of 
transgenic mice capable of expressing human variable domains (Green, Hardy et al. 
1994, Lonberg, Taylor et al. 1994) and phage display technology to rapidly screen, 
select and optimise for V domains with enhanced antigen affinity (Winter, Griffiths 
et al. 1994). As with humanised mAbs, these show expected levels of serum half-life 
and effector function activity, with a diminished level of ADA production (Buss 
2012).  
In addition to producing human/ humanised mAbs, focus in recent years has shifted 
towards optimising these mAbs to make them more suitable for purpose. The Fab 
regions of the antibody contain the V domains responsible for antigen binding, are 
normally left unmodified and are normally engineered for enhanced antigen affinity 
and binding kinetics. The Fc domain is responsible for elucidating effector function 
and controlling antibody half-life, and a large degree of research has been carried out 
in order to investigate and modulate interactions with Fc receptors. 
A number of groups have studied the Fc domain in conjugation with its receptors 
(FcRn, FcγRI-III and C1q) in an attempt to map the residues important in receptor 
binding on the Fc (Idusogie, Presta et al. 2000, Shields, Namenuk et al. 2001), most 
of which were localised to the upper CH2 domain.  Research has also been 
undertaken into how glycosylation contributes to Fc function (Krapp, Mimura et al. 
2003, Prabakaran, Vu et al. 2008, Abès and Teillaud 2010). It has been observed that 
FcγR binding is highly sensitive to glysocylation at residue Asn 297, and that the 
glycan structure can lead to changes in the binding affinity (Sibéril, de Romeuf et al. 
2006, Takahashi, Kuroki et al. 2009, Abès and Teillaud 2010). The use enzymes 
which enrich for certain types of glycans (such as N-acetylglucosamyltransferase III) 
(Davies, Jiang et al. 2001), as well as cell lines engineered for certain glycan 
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structures (Yamane-Ohnuki, Kinoshita et al. 2004)  have been investigated in an 
attempt to optimise glycosylation to favour specific functions.  
Fc receptor engineering may follow one of two strategies – increasing receptor 
binding strength to enhance binding and thus increase activity, or destabilisation/ 
removal of binding affinity and thus eliminating activity. In all cases, strategic 
mutation of various residues in and around the receptor binding sites leads to 
changes in function.  
There are a number of documented examples of IgGs with enhanced receptor 
binding, and thus enhanced effector function, for ADCC,  antibody-dependent 
phagocytosis (ADP) (Shields, Namenuk et al. 2001, Lazar, Dang et al. 2006, 
Stavenhagen, Gorlatov et al. 2007, Horton, Bernett et al. 2008, Richards, Karki et al. 
2008, Zalevsky, Leung et al. 2009) and antibody-dependent CDC (Idusogie, Presta 
et al. 2000). 
The principle behind enhancing mAb-dependant effector function seems obvious, 
but there are many instances where silencing these signals is preferable. For 
example, targeting cell surface proteins on immune cells, which would result in 
ADCC, ADCP and/ or CDC, may pose a serious safety risk to the patient and it is 
therefore preferable to silence these functions (Strohl 2009). Solaris® (eculizumab) 
is one example of an effector silenced antibody designed to block the complement 
cascade pathway without inducing further immune response (Rother, Rollins et al. 
2007). A number of Fc engineered variants exist which silence Fc mediated 
activation of effector function (Bolt, Routledge et al. 1993, Alegre, Peterson et al. 
1994, Hutchins, Kull et al. 1995, Cole, Stellrecht et al. 1999, Reddy, Kinney et al. 
2000, Xu, Alegre et al. 2000, Oganesyan, Gao et al. 2008, Sazinsky, Ott et al. 2008, 
Strohl 2010, Bell and Rother 2012). 
In addition Fc variants engineered to modulate effector function, there are also a 
number of variants designed to have increased binding affinity to FcRn, and thus 
increased serum half-life (Acqua, Woods et al. 2002, Hinton, Xiong et al. 2006, 
Oganesyan, Damschroder et al. 2009, Yeung, Leabman et al. 2009, Ober 2012) . 
Increasing serum half-life can increase drug exposure and reduce patient dosing 
frequency thereby enhancing a therapeutic mAbs overall effectiveness.  
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It has been nearly 40 years since Kohler and Milstein first developed the technology 
to create mAbs. In the last 20 years particularly, antibody therapeutics have become 
the dominant force in global therapeutics. In 2012 five of the top 10 prescription 
drugs were biologics, four of which were monoclonal antibodies. The combined 
sales of these four mAbs accounted for $29.3 billion USD (Lindsley 2013). 
Antibodies are currently used to treat a range of disorders including, autoimmunity 
and inflammation, infectious diseases, metabolic disorder and cancer (Larrick 2012).  
With hundreds of potential mAb based therapeutics in development, as well as a 
number of mAbs reaching the end of their patent exclusivity, leading to the 
development of mAb biosimilars, it is more important than ever to have a number of 
robust analytical tools available for their characterisation. 
5.1.2 Characterising Biotherapeutics – Mass Spectrometry and Antibodies 
Characterising any recombinant biotherapeutic is non-trivial. They are often 
chemically modified with small modifications, such as deamidation (Liu, van Enk et 
al. 2009), or post transnationally modified with larger modifications, such as 
glycosylation. These modifications, particularly in the case of glycosylation, can 
contain an inherent heterogeneity, making structure/ function relationships more 
difficult to characterise. In addition to variable modifications, proteins have the 
potential to misfold/ rearrange during expression or in storage which can lead to 
conformational differences. There are therefore a number of different aspects to 
consider when attempting to fully characterise these complex molecules (Chen 
2011).  
Mass spectrometry has been used to characterise a number of different structural 
features of mAbs, including post-translational modifications (glycosylation) (Lewis, 
Guzzetta et al. 1994, Ashton, Beddell et al. 1995, Wang, Amphlett et al. 2005, Reid, 
Tait et al. 2010), chemical modifications (deamidation and N-terminal glutamine 
cyclisation) (Yu, Remmele et al. 2006, Zhang, Pan et al. 2009, Reid, Tait et al. 
2010), primary sequence (Downard 2000, Wang, Amphlett et al. 2005, Zhang and 
Shah 2007, Zhang, Pan et al. 2009), disulphide bond arrangement and positions 
(Zhang, Pan et al. 2009), stability (Liu, Chumsae et al. 2010), aggregation and self-
assembly (Kukrer, Filipe et al. 2010), antibody/ antigen complex formation and 
stoichiometry (Tito, Miller et al. 2001).  
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There is a growing need for methodologies to characterise the higher order structure 
of mAb therapeutics  to better understand key structure/ function relationships 
(Zhang, Cui et al. 2014). Monoclonal antibodies are difficult to study by NMR 
difficult due to their size, and the flexible linker region makes obtaining a crystal for 
X-ray diffraction difficult (Saphire, Stanfield et al. 2002). Recent advances in MS 
technology have enabled the technique to contribute to the study of higher order 
structure.  
Native MS has been used on a modified, high resolution Orbitrap
TM
 mass 
spectrometer to analyse a mAb intact (Rosati, Rose et al. 2012, Thompson, Rosati et 
al. 2014). The resolution is sufficient to identify the heterogeneity, if the sample is 
prepared correctly, from different Fc glycoforms. The mass accuracy is also 
sufficient to observe C-terminal lysine cleavage, or primary sequence mutations. 
Analysis in this way also provides direct information regarding a proteins 
conformation since charge state distributions correlate with changes in protein 
structure (Katta and Chait 1991). 
Ion mobility mass spectrometry (Section 1.1.6 Ion Mobility Mass Spectrometry) can 
be used to probe higher order protein structure, and has been successfully used to 
differentiate between structural isoforms in IgG2 (Bagal, Valliere-Douglass et al. 
2010) and to investigate the dynamics of intact IgG and IgG fragments (Pacholarz, 
Porrini et al. 2014).  
Hydrogen deuterium exchange mass spectrometry has also been used to characterise 
protein structure, proving an effective tool in highlighting disruptions in local protein 
structure between different CH3 mutants (Rose, van Berkel et al. 2013) 
5.1.3 A study of Fc engineered antibodies  
Fc engineering is becoming increasingly important in the field of biotherapeutics. 
Mass spectrometry is uniquely able to characterise the structural characteristics of 
these large, heterogeneous and dynamics biomolecules,  
Molecules to study 
Three IgG Fc’s were used in this study; two triple mutants known as a the triple 
mutant (TM) construct (Oganesyan, Gao et al. 2008) and the YTE construct (Acqua, 
Woods et al. 2002, Oganesyan, Damschroder et al. 2009). The third Fc used was the 
159 
 
TM-YTE construct (Figure 5-3) containing all six mutations present in the TM and 
YTE constructs.  
 
 
Figure 5-3 – A homology model of the IgG1 Fc domain complete with hinge.  
Residues highlighted in RED are those corresponding to the TM construct. Residues highlighted in 
BLUE are those corresponding to the YTE construct. 
The TM construct contains three mutations located in the upper CH2 domain (L234F, 
L235E, P331S) (shown in Figure 5-3) which lead to a decrease in ADCC, ADCP and 
antibody dependent-CDC. Residues 234 and 235 had been previously identified as 
having an important role in Fcγ receptor binding (Canfield and Morrison 1991, 
Chappel, Isenman et al. 1991, Armour, van de Winkel et al. 2003) whilst residue 331 
has been shown to play an important role in C1q binding (Tao, Smith et al. 1993, 
Idusogie, Presta et al. 2000). Mutagenesis of these three residues resulted in a 
reduced binding affinity to a number of FcγR’s and C1q. It should be noted, 
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however, that there was no electron density for residues 234 and 235 since these both 
lie in the lower hinge. 
The YTE construct contains three mutations located in the lower CH2 domain 
(M252Y, S254T, T256E) (Figure 5-3) which result in a 10-fold increase in the 
binding of Fc to FcRn at pH 6.0, resulting in a 4-fold increase in the serum half-life 
on mAbs engineered with these mutations (Acqua, Woods et al. 2002, Dall’Acqua, 
Cook et al. 2006).  
Analysis of the Fc-TM and Fc-YTE crystal structures suggests some structural 
differences between the two, shown in Figure 5-4. 
 
 
Figure 5-4 – A comparison of the X-ray crystal structures of the Fc-TM (PDB: 3C2S), Fc-YTE 
(PDB: 3FJT) and Fc-WT (PDB: 3AVE). 
Fc-TM is shown in cyan, Fc-YTE is shown in magenta and Fc-WT is shown in Grey. Glycans have 
been omitted from this structure, but were present on the full crystal. Figure generated using structural 
alignment in Pymol  
CH2
CH3
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A comparison of the three crystal structures suggests that Fc-TM has a larger CH2 
interdomain space than that of Fc-YTE or Fc-WT. This may be related to function, 
or may be an artefact of the crystal structure.  
Despite this subtle difference, a closer inspection of the sites of amino acid 
substitution in the three constructs suggests that these residues adopt a similar 
conformation between the different constructs (Figure 5-5 and Figure 5-6) indicating 
no significant changes to protein conformation in either construct at this site. 
 
Figure 5-5 – An enhanced image of the TM mutation sites in the upper CH2 domain shown in Figure 
5-4. 
Residues 234 (L  F) and 235 (L  E) only showed electron density in the WT structure, and are 
located at the top of the CH2 domain. Residue 331 (P  S) is highlighted in the figure. All three 
amino acids are predicted to overlay, suggesting no conformational change. Fc-TM is shown in cyan, 
Fc-YTE is shown in magenta and Fc-WT is shown in Grey. Figure generated using structural 
alignment in Pymol 
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Figure 5-6 - An enhanced image of the YTE mutation sites in the lower CH2 domain shown in Figure 
5-4. 
Residues 252 (MY), 254 (ST), and 256 (TE are located at the bottom of the CH2 domain. All 
three amino acids overlay, suggesting no conformational change. Fc-TM is shown in cyan, Fc-YTE is 
shown in magenta and Fc-WT is shown in Grey. Figure generated using structural alignment in 
Pymol 
When an Fc variant was generated containing both TM and YTE modifications (a 
TM-YTE construct containing all six substitutions) there was an observed shift in the 
thermal stability of the CH2 domain observed by DSC. A summary of the data is 
shown in Figure 5-7. 
Y
T
E
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Figure 5-7 – A box and whisker plot illustrating the differences in the thermal stability of the CH2 
domain for Wild Type (WT) TM, YTE and TMYTE constructs.  
Data is based on the average Tm1 shifts (known to refer to the melting of the CH2 domain) of 44 fully 
human IgG1 mAbs – 12 IgG-WT, 21 IgG-TM, 6 IgG-YTE and 5 IgG-TMYTE. Box shows the first to 
third quartile, bisected by the mean average value. Whiskers show the upper and lower limits.  
Both IgG-TM and IgG-YTE show a similar reduction in thermal stability of 
approximately 6-7
o
C in the CH2 domain upon mutation; Tm1 changed from 70.1
o
C 
in WT to 64.1
o
C in IgG-TM and 62.2
o
C IgG-YTE constructs, based on the mean Tm 
from sampled data.. This destabilisation is compounded in IgG-TMYTE, which 
shows a CH2 Tm of approximately 58
o
C (12
o
C change) based on the mean Tm from 
sampled data. The effects of the two sets of mutations are not purely additive, 
suggesting a cooperativity between the sets of two mutations. As previously 
described, there is no direct structural information underpinning these changes in 
thermal stability between the individual TM and YTE constructs compared to the 
wild type.  
Experimental Aims 
This study aims to use a combination of recently introduced mass spectrometry 
based techniques to characterise the structural differences between different IgG 
constructs engineered for different effector functions, and to attempt to rationalise 
the observed thermal destabilisation in IgG-TMYTE. The hypothesis is that there 
will be observable structural differences between the wild type and the mutants 
relating to the thermal stability differences observed in Figure 5-7. 
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It was the aim of this study to use ion mobility mass spectrometry to identify the 
conformation of the Fc-WT, and to compare this with the conformations of the three 
engineered Fc variants to provide insight into conformational changes across the 
domain. It was also the aim of the study to use hydrogen/ deuterium exchange MS to 
investigate the conformational changes between the Fc WT and the different 
engineered variants, and to use this as a measure of local conformational change 
within the Fc domain. 
5.2 Results and Discussions 
5.2.1 Preparation of the Fc  
Enzyme digestion strategy 
Antibodies may be digested into separate Fab/ Fc Fragments using a number of 
different strategies, depending on the desired outcome. It was decided that analysis 
of the isolated Fc domain would be the most appropriate for two reasons. Firstly this 
would ensure that there was no variation in HDX kinetics as a result of differences in 
the V-regions, since one of the four IgG1s sourced contained a different V-region, 
based on sample availability. The second reason was specific to the ion mobility 
experiments. Given the inherent flexibility of IgG1, by virtue of the hinge region, it 
was believed that this flexibility would mask any Fc structural differences caused by 
the mutations which could be observed by IMS. To have the best chance of 
observing conformational differences, only the Fc’s were used. A number of 
digestion strategies were considered for obtaining isolated Fc regions.  
Pepsin has long been considered as a key proteolytic enzyme for obtaining antibody 
fragments. Pepsin cleaves on the carboxy-terminal side of the hinge disulphide 
bridge, generating a number of hinge and upper CH2 fragments along with the 
disulphide linked Fabs, known as the F(ab’)2 fragment. The Fc is released, but also 
undergoes a number of additional cleavage steps in the CH2 region, generating a 
partial Fc (pFc’) fragment (Figure 5-8) (Janeway 2005) 
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Figure 5-8 – The fragments generated by Pepsin partial digestion; F(ab’)2 and pFc’. Dashed red lines 
on the Fc construct show additional sites of digestion. 
Pepsin was therefore ruled out since it cleaved at the site of TM mutation (upper 
CH2) and would therefore provide an incomplete Fc structure. 
A novel protease, Immunglobulin-degrading enzyme S (IdeS), was also ruled out for 
the same reason. IdeS (von Pawel-Rammingen, Johansson et al. 2002) is a protease 
which cleaves a specific site within the hinge on IgG’s on the carboxy-terminal side 
of the disulphide bridge. Unlike pepsin, IdeS shows specificity for the target 
sequence shown in Figure 5-9. 
 
Figure 5-9 - A focused image of the IgG1 hinge sequence, illustrating the IdeS cleavage site.  
IdeS cleave on the C-terminal side of L234 and L235, two residues mutated in the Fc-TM construct.  
Whilst IdeS does not lead to ragged digestion, like pepsin, it still cleaves below the 
disulphide, yielding an incomplete Fc. IdeS digestion would also remove two of the 
three residues substituted in the TM construct. 
Papain has been considered as being an enzyme of choice for proteolytic cleavage of 
IgG into Fab and Fc fragments. Papain cleaves at the amino-terminal side of the 
disulphide bridge in the hinge, generating a complete Fc fragment, complete with 
disulphide bonds, and Fab fragments. Papain does have however a number of 
undesirable characteristics associated with digestion. Due to its nonspecific nature, 
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papain digestion can result in microheterogeneity within the Fc fragments as a result 
of differences in digestion site in the hinge, making fragment identification difficult. 
In addition, papain is a thiol protease and requires the presence of reducing agents in 
order to function. It has been observed that, if the conditions are not completely 
optimised, the presence of cysteine can lead to cleavage of the interchain disulphide 
bonds (Adamczyk, Gebler et al. 2000). Termination of papain digestion occurs via 
addition of iodoacetamide, an alkylation agent. It has been observed in other 
experiments performed that this can lead to derivitisation of the partially cleaved 
disulphide bridges, which would cause problems to assessing structure/ function 
performance of the antibody Fcs. 
The enzyme chosen for these experiments was endoproteinase Lys C. Like IdeS, 
endoproteinase Lys C has a specific digestion site; it cleaves on the C-terminal side 
of lysine (Jekel, Weijer et al. 1983). Under carefully controlled conditions this can 
be used for the partial digestion of antibodies, this leads to the digestion of a single 
position within the mAb hinge (Figure 5-10). 
 
Figure 5-10 –Tthe digestion site of endoproetinase lys C.  
Like IdeS, endoproteinase Lys C has a specific cleavage site. Unlike IdeS, endoproteinase lys C 
cleave on the N-terminal side of the disulphide bridge, retaining the intact Fc and all the TM 
mutations. 
As shown in Figure 5-10, endoproteinase lys C appears to be a perfect enzyme for 
the digestion of an IgG to obtain a homogeneous Fc fragment that retains the full 
structure of the Fc. The endoproteinase lys C reaction is terminated by the addition 
of diisopropyl fluorophosphate (DIPF); a specific inhibitor which binds covalently to 
the catalytic serine and prevents further digestion. As a protease inhibitor, DIPF 
should ensure there is no derivitisation of the antibody during the digestion. 
Protein Purification 
The in-house method for purification of IgG’s and Fc fragments involved large scale 
use of protein A (Duhamel, Schur et al. 1979). Protein A has, for many years, been 
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used as the affinity matrix of choice for purification of antibodies (Hober, Nord et al. 
2007). The facilities at MedImmune are equipped for a larger scale (10’s of 
millilitres to 10’s of lires scale) the antibody Fcs, and so steps were taken to develop 
a smaller, analytical scale purification method more suitable to a few millilitres of 
sample.   
For the affinity matrix, CaptureSelect
TM
 affinity columns were purchased from 
Genovis and used to purify the Fc fragments (see methods). At the time of analysis, 
the YTE had yet to be sourced, and only experimental data for the WT, TM and 
TMYTE samples is presented here. In order to test the applicability of the 
CaptureSelect
TM
 affinity matrix the three samples were bound and eluted from the 
column following the method outlined above. The acid-released eluent was subject 
to LC-MS analysis, the chromatograms for which are shown in Figure 5-11. 
 
Figure 5-11 – Chromatogram showing the elution’s from the CaptureSelect column following acid 
release. 
Two major peaks can be observed; the first (red) corresponds with low signal noise as a result of 
solvent/ salt elutions. The second (blue) corresponds to the full length IgG 
All three samples show a single large peak eluting between 1 and 1.25 mins, which 
corresponds to salts and other low m/z species. Both the WT and the TM mutant 
show a prominent peak eluting between 3 and 3.5 minutes. The 3-3.5min peak is 
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present in the TMYTE sample but at much lower intensity. The deconvoluted MS 
spectra associated with the 3-3.5 min peak are shown in Figure 5-12. 
 
Figure 5-12 - The deconvoluted MS spectra of the IgG-WT, IgG-TM and IgG-TMYTE eluted from 
the blue peak shown in Figure 4-11. 
The three peaks deconvolute to give masses of approximately 147 kDa, plus 
additional glycan species (see Figure 5-15 and Figure 5-17), corresponding to the 
intact antibody. Based on observations shown in Figure 5-11, this would suggest that 
the IgG-TMYTE shows a different binding affinity to the CaptureSelect columns 
than either the IgG-WT or the IgG-TM. Either the pH 2.8 glycine wash is too weak 
to successfully remove the IgG from the CaptureSelect
TM
 or the CaptureSelect
TM
 did 
not bind the IgG. In order to test this hypothesis, the three IgG’s were bound to the 
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resin and washed with PBS. The eluent was then analysed using LC-MS; results are 
shown in Figure 5-13.  
 
Figure 5-13 – A chromatogram showing the elution profiles of IgG-WT, IgG-TM and IgG-TMYTE 
after binding to CaptureSelectTM affinity matrix and washed with PBS (10mM sodium phosphate, 
150mM NaCl, pH 7.4) 
Figure 5-13 shows that, with a PBS wash, IgG-WT and IgG-TM have minor elution 
peaks at 3-3.5 mins, corresponding to the IgG. The IgG-TMYTE, by comparison, 
has a much larger elution peak, supporting the suggestion that it is unable to bind to 
the CaptureSelect resin
TM
. The small peaks present in the PBS wash for the IgG-WT 
and IgG-TM are believed to be as a result of overloading the column, rather than the 
induced dissociate of the protein from the resin. 
This data suggests that CaptureSelect
TM
 affinity matrix is incompatible with the TM-
YTE mutation. The matrix itself consists of an immobilised V domain from an 
antibody raised against human IgG Fc. Whilst the CaptureSelect
TM
 matrix does have 
broad cross-species applicability, including human IgG1, the data here suggests that 
as a result of the TMYTE mutations the matrix no longer has affinity with the IgG-
Fc. There are two possible explanations for this. Engineering of the double mutant 
may reduce the affinity of the CaptureSelect
TM
 for the antibody, making the 
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observation in Figure 5-13 specific to the Fc-TMYTE and thus suggesting a 
conformational change in the Fc-TMYTE, or the YTE mutation itself changes the 
epitope of the CaptureSelect
TM
 matrix. 
Following the unsuccessful attempt to use the low-volume CaptureSelect
TM
 affinity 
matrix, IgG’s were digested and subjected to purification using the MabSelect SuRe 
protein A affinity matrix. Full IgG’s were not screened using this resin prior to 
digestion as they were with the CaptureSelect
TM
 matrix since all antibodies provided 
had been previously purified using the MabSelect SuRe protein A affinity matrix 
during the production  process. 
Following elution, the Fc-WT, Fc-TM, Fc-YTE and Fc-TMYTE fractions were 
analysed using LC-MS to confirm identity; the chromatograms are shown in Figure 
5-14. 
 
Figure 5-14 – LC-MS chromatogram for the four IgG-Fc samples. All four indicate two eluting 
species. 
The chromatograms for all four samples show two major elution peaks; the first is 
highlighted in red and the second in blue in Figure 5-14. The corresponding 
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deconvoluted MS spectra for the red species are shown in Figure 5-15, whilst the 
deconvoluted spectra for the red peak is shown in Figure 5-18) 
 
 
Figure 5-15 – The deconvoluted MS spectra of the FcWT, Fc-TM, Fc-YTE and Fc-TM-YTE. F-WT, 
Fc-TM and Fc-TMYTE show good agreement between experimental and expected 
Figure 5-15 corresponds to the red LC peak highlighted in Figure 5-14. Considering 
the Fc-WT, Fc-TM and Fc-TMYTE samples, all four show clear evidence of being 
Fc. There is a strong agreement between the observed molecular weights expected 
based on the primary sequence for these three samples, indicating that they are the 
Fc’s. There are also a number of peaks separated by 162 Da in the Fc-WT, Fc-TM 
and Fc-TMYTE spectra, indicating glycan patterning consistent with that observed 
in IgG Fc’s (an increase in the galactose moieties on either the Man (α1-6) or Man 
(α1-3) arms). The data presented in Figure 5-15 corresponds to the non-reduced Fc, 
and therefore contains two copies of each glycan. Each increase of 162 Da 
corresponds to the addition of a single galactose to one of the two glycans, but it is 
impossible to identify which glycan has had the addition. For the addition for 324 
Da, corresponding to two galactose moieties, there is some ambiguity as to whether 
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this corresponds to equal glycosylation across the two glycans (leading to G1F/ G1F) 
or both glacatose attaching to the same glycan (leading to G2F/G0F). 
In all cases the dominant glycoform is the G0F/G0F, which is the expected major 
glycoform. There is a high degree of certainty that the digestion and purification 
method has yielded correct Fc fragments for these three samples. The Fc-YTE data, 
however, does not agree with the other samples, nor with the expected data. The 
glycan profile shows the addition of 147 Da, consistent with a fucosylation, followed 
by a number of 162 Da additions, which is consistent with the addition of a number 
of galactose moieties. This glycan pattern, alongside the observed molecular weight, 
supports the theory that it is an IgG Fc, however the glycan profile (the relative 
intensities of the glycans) is inconsistent with that of the other three IgG1 samples. 
Assuming glycans are similar between the Fc-WT shown in Figure 5-15 and “Fc-
YTE” sample, this would mean that the G0F glycoform mass for the “Fc-YTE” is 
53379 Da, a 71 Da mass error compared to the theoretical. This suggests that the 
sample provided was not that of an IgG-YTE or, if it was, not of the IgG1 subtype as 
previously thought.  
Following this observation the IgG YTE sample was replaced with a new IgG-YTE 
from a different production batch. This YTE was subject to the same digestion and 
purification steps as before, and characterised using same LC-MS methods. Figure 
5-17 shows the same data shown in Figure 5-15, with the incorrect “Fc-YTE” data 
being replaced by that obtained from new Fc-YTE.  
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Figure 5-16 – LC-MS chromatogram for the four IgG-Fc samples. Following the second digestion 
and purification step, the Fc-YTE indicate only a single eluting species compared to the Fc-WT, Fc-
TM and Fc-TMYTE. 
Following a second preparation and purification of Fc-YTE (Fc-YTE preparation 2) 
the LC chromatogram looks similar to that presented in Figure 5-14, with the 
obvious exception of the missing peak highlighted in blue in the other species.  
The deconvoluted MS spectra for the Fc-YTE preparation 2 elution peak (red) is 
shown in Figure 5-17.  
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Figure 5-17 – The deconvoluted MS spectra for the Fc-YTE from preparation 2.  
The deconvoluted MS spectra for Fc-YTE preparation 2 in Figure 5-17 shows 
significantly improved agreement with that of the Fc-WT, Fc-TM and Fc-TMYTE 
shown in Figure 5-15 illustrating once again previous “Fc-YTE” was not the correct 
sample. Figure 5-17 shows a glycan pattern consistent with previous data, and the 
expected data, along with an accurate mass that agrees with the theoretical mass to 
within 2 Da.  
Deconvoluted MS spectra relating to the species highlighted in blue for Fc-WT, Fc-
TM and Fc-TMYTE are shown Figure 5-18. All three spectra show the presence of 
two distinct molecules with molecular weight of 47115±1 Da and 47228±1 Da in all 
species. The strong agreement between the molecular weights, and retention times, 
between the three samples supports the suggestion that these are the same molecules. 
The IgG-WT, IgG-TM and IgG-TMYTE provided have identical V domain 
sequences with variations only in their Fc domains. The blue species present in the 
chromatogram in Figure 5-16 corresponds to the Fab region of the Fc which has co-
eluted with the Fc. The theoretical mass of the Fab fragment of these three samples is 
47116.6 Da, which agrees well with the masses shown here. 
It is likely that some Fab protein was non-specifically bound to the protein A column 
used during the purification of these three samples. Given that these three samples 
were run at the same time, it would suggest that an extra wash step would be  
required to remove any non-specifically bound proteins during our purification.  
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The new Fc-YTE sample was run on a different occasion and contains little/ no Fab 
carryover. The reasons for this are not obvious, but may be as a result of minor 
changes to the elution protocol/ different buffers used between days.  
 
Figure 5-18 – The deconvoluted MS spectra of the elution species highlighted in blue in Figures 5-14 
and 5-16 
Figure 5-18, as mentioned, shows a second species with a molecular weight 113 Da 
larger than the theoretical mass of the Fab. Given that the focus of this study is on 
structural studies associated with the Fc region, no further investigation was 
performed on the Fab. 
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Having successfully identified and purified an authentic Fc-YTE sample an 
additional experiment was conducted to investigate Fc-YTE affinity with 
CaptureSelect
TM
 matrix. The results are shown in Figure 5-19. 
 
Figure 5-19 – A) The Fc peak for purified Fc-YTE obtained following the acid elution from a protein 
A affinity column. B) The result following a weak, neutral pH elution from and Fc-YTE/ Fab mixture 
incubated on CaptureSelect
TM
 affinity matrix 
Figure 5-19 shows that, following incubation with CaptureSelect
TM
 affinity matrix, 
the Fc-YTE elutes under the same conditions as the Fab fragment, indicating that, as 
previously observed for the Fc-TMYTE, Fc-YTE does not bind to the 
CaptureSelect
TM
. This observation suggests that the lack of affinity Fc-YTE and Fc-
TMYTE is likely due to disruptions in the CaptureSelect
TM
 epitope, rather than a 
conformational rearrangement induced by a combination of the TM and YTE 
mutations.  
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5.2.2 Native MS 
Following confirmation of the sample identities, and successful purification of Fc 
from the Fc/ Fab mixture, the different antibody Fc’s were analysed using native 
MS. It has been observed that changes in charge state distribution can be indicative 
of differences in conformation (Katta and Chait 1991, Benesch, Sobott et al. 2003, 
Heck and van den Heuvel 2004, Wyttenbach and Bowers 2011, Konijnenberg, 
Butterer et al. 2013), and it was possible that global changes in Fc conformation, as a 
result of TM/ YTE mutations, would result in changes in the charge distribution. 
None of the amino acids introduced as part of the TM or YTE mutations are 
positively charged, and therefore we would only expect to see a shift in the positive 
MS spectra as a result of conformational change. The results obtained are shown in 
Figure 5-20. 
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Figure 5-20 – A - the native MS spectra of the four Fc constructs, Fc-WT, Fc-YTE, Fc-TM and Fc-TM-YTE, labelled with their 11+  14+ charge states. 
Species labelled X, most prevalent in the Fc-YTE spectra, corresponds to native Fab fragments. B – A focused image of the 12+ charge state, illustrating the major 
glycoforms present. Fc-YTE and Fc WT also show evidence of a minor G0 glycoform, consistent with the observations from the LC-MS experiment 
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The native MS of all four Fc samples indicate few differences between the samples. 
All four Fc’s show similar charge states, 11+  14+, with a broadly similar charge 
state distribution, centred on the 12
+
 charge state, consistent with previous studies on 
IgG Fc domains (Pacholarz, Porrini et al. 2014). This suggests that the four 
molecules adopt similar conformations in solution.  
Resolution obtained on the MS spectra was sufficient to observe the different 
glycoforms present on the Fc. The peaks are separated by a mass difference of 162 
Da, which is consistent with the addition of a single glycan moiety. This observation 
is consistent with that presented in Figure 5-15 and Figure 5-17. 
The Fc-TMYTE sample shows two peaks, labelled X in Figure 20, which are also 
present in low levels in the Fc-TM and Fc-WT samples. These peaks were identified 
as belonging to the Fab fragment, and were therefore ignored for the purposes of 
analysis and processing.  
5.2.3 Ion mobility MS 
Ion mobility mass spectrometry was then used probe to the conformation of the 
proteins, as described in Section 1.1.6 Ion Mobility Mass Spectrometry 
Comparison of the conformation of different glycoforms in the Fc-WT 
X-ray diffraction studies have suggested that different the inter-domain spacing is 
affected by different Fc glycoforms (Krapp, Mimura et al. 2003). This was 
investigated here using IMS, since any changes as a result of different glycosylation 
profiles would need to be considered when obtaining IMS measurements. The results 
for the Fc-WT construct are shown in Figure 5-21. 
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Figure 5-21 – A comparison of the arrival time distributions of the four observed glycoforms for the 
Fc-WT construct. 
No differences are observed in either drift time, or arrival time distribution, suggesting that the glycan 
has no observable effects on the conformation of the Fc observed by IMS 
Figure 5-21 shows no significant differences in the arrival time distribution (ATD) 
for the Fc-WT sample as a result of differences in glycosylation. Ion mobility 
provides a measure of the collision cross section (CCS) of a protein, determined by 
the broadly spherical shape it adopts when tumbling through the mobility cell. The 
longest dimension of a proteins structure is most representative of the diameter of 
this spherical shape, and thus is the most important dimension used to determine 
CCS. Small changes in protein conformation which do not affect this value are 
unlikely to be observed since they result in little change to the overall shape of the 
sphere. The structure of the Fc, complete with atomic measurements, is shown in 
Figure 5-22. As can be seen in Figure 5-22, the longest dimension is that that which 
spans the full height of the Fc with hinge, referred to as the HingeCH3 dimension, 
with a length of 104.5 Å (shown in magenta). This structure represents just one 
possible hinge conformation, since there are no interactions that anchor the hinge to 
the core CH2 domain, affording complete flexibility. A CH2CH3 dimension, 
measuring 78.2 Å, was also determined spanning the full height of the Fc core 
without the hinge to illustrate that, even without hinge or with hinge lying flat 
against the core, the dimension spanning the two CH2 domains remains the smallest 
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dimension. It is likely that any changes in this space, particularly changes in domain 
spacing of approximately 5 Å which have been  previously reported (Krapp, Mimura 
et al. 2003), are unlikely to be observable using the IMS approach. 
 
Figure 5-22 – A homology model of the Fc-WT construct complete with hinge in a hinge-up view.  
Three atomic measurements are shown on the figure. Black shows the CH2CH3 atomic distance, 
magenta shows the HingeCH3 atomic distance, red show the CH2 spanning atomic distance. All 
measurements are shown in Å. 
A comparison of the Fc constructs by IMS 
Having shown that the glycosylation profile did not significantly affect the ATD of 
the protein, the 11
+
 charge state for all four Fc variants was analysed for differences. 
All glycoforms in the 11
+
 charge state were combined for this analysis. Results are 
shown in Figure 5-23. 
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Figure 5-23 - The arrival time distributions for the 11
+
 charge state of the Fc constructs. 
Drift times show small changes between samples that are within the experimental error of the 
instrument 
Small differences were observed in drift times between the four Fc constructs, but 
repeated experiments indicate that these differences were within experimental error 
and are not significant. This suggests there were no measureable global changes in 
conformation associated with any of the constructs.  This is not a surprising 
observation and is supported by previous X-ray diffraction studies by Oganeysan et 
al which suggested there were no large conformational changes associated with these 
mutations (Oganesyan, Gao et al. 2008, Oganesyan, Damschroder et al. 2009).  
Table 5-1 shows a comparison of the arrival time distributions, measured as peak 
width at half maximum (PWHM). 
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 Drift time chromatogram width at 50% 
Fc-WT 1.07 ± 0.12 
Fc-TM 1.11 ± 0.09 
Fc-YTE 0.94 ± 0.11 
Fc-TMYTE 1.21 ± 0.14 
Table 5-1 - A comparison of the FWHM from the drift time chromatograms.  
The width of the ATD can be considered to be representative of the dynamics of the 
protein, and related to the flexibility of the conformation adopted by a protein. The 
data suggest that Fc-TMYTE may have a slightly more flexible conformation that 
either Fc-TM or Fc-YTE. The data also suggest that Fc-YTE has a more rigid 
structure than that of the Fc-WT. These observations may echo the minor CH2 
domain spacing differences highlighted in Figure 5-5, suggesting minor changes in 
domain flexibility. Concentration-dependent peak broadening was observed when 
analysing these proteins. Whilst peak broadening occurred when concentration 
changed as a factor of 10 (Figure 5-24), smaller fluctuations in spray conditions 
which influence the protein concentration in the droplet may play a role in the 
observations presented in Table 5-1 and may also play a part in the larger errors 
shown in Table 5-1. 
 
Figure 5-24 – An example of the peak broadening observes as a factor of concentration. 
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Following the analysis of the 11
+
 charge state, all four charge states of the Fc-WT, 
Fc-TM, Fc-YTE and Fc-TMYTE were compared. In order to provide better clarity 
regarding the different conformations, CCS estimates for each of the drift times were 
calculated. The calibration curve used is shown in Figure 5-25, and calibration was 
performed using established methods (Scarff, Thalassinos et al. 2008, Williams and 
Scrivens 2008, Thalassinos, Grabenauer et al. 2009). 
 
Figure 5-25 – The calibration curve used for the calculation of CCS values for the four Fc constructs 
Figure 5-26 shows the arrival time distributions obtained for the four Fc constructs, 
complete with CCS estimates calculated for the different conformers. 
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Figure 5-26 – The drift times, and CCS estimates, for the four Fc constructs.
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Fc-WT Fc-YTE
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Figure 5-26 shows that, with increasing charge the calculated protein CCS increases 
as the Fc begins to unfold. At higher charge states this results in the unfolding of the 
protein into multiple conformations, which is consistent with previous reports on the 
behaviour of proteins in the gas phase (Scarff, Thalassinos et al. 2008).  
Similar to the results obtained from the 11
+
 charge state, the 12
+
 charge state shows 
only a single observable conformation. The ATD, however, shows tailing for the 12
+
 
charge state when compared with the 11
+
, suggesting that the Fc is beginning to 
adopt more extended conformations.  
The 13
+
 charge state for all species shows major peaks corresponding to a ~3660 Å
2
 
species, a ~3840 Å
2
 species and a ~4060 Å
2
 species (as observed in the wild type). 
The peak width of the 3840 Å
2
 species suggests at least two conformations which 
cannot be resolved; this observation is supported by the observation of a broad 
~3811 Å
2
 peak present in the Fc-TM and Fc-TMYTE 13
+ 
ATD not present in the Fc-
WT or Fc-YTE. This suggests that, as a result of TM mutations the Fc-TM and Fc-
TMYTE follow a slightly different unfolding mechanism, as they can more readily 
adopt an extended conformation not seen to the same degree in either Fc-construct 
without the TM mutations.  
The 14
+
 charge state also contains three dominant conformations; a 3850 Å
2
 species, 
a 4080 Å
2
 species observed only in the Fc-WT, Fc-TM and Fc-YTE, and a 4270 Å
2
 
species. The lack of an observed 4080 Å
2
 species the 14
+
 Fc-TMYTE data suggests 
the protein is able to completely unfold into the more extended conformation, rather 
than adopting a partially unfolded intermediary conformation. 
Data for the four Fc constructs shows that whilst the proteins exhibit species with 
similar CCS values, and therefore potentially similar conformations, there are 
differences observed in intensities of the more extended conformations between the 
mutants, suggesting possible differences in stability between the constructs. Fc-WT 
consistently shows the highest relative intensity for the most compact conformation 
at all charge states, suggesting it is the most stable. The Fc-TM, Fc-YTE and Fc-
TMYTE show higher observed intensity for intermediate conformations (3800 Å
2
 
species in the 13
+
 and 4080 Å
2 
in the
 
14
+
 ATDs) compared to wild type, with the Fc-
TMYTE showing the highest relative intensity of all three for this intermediate state, 
as well as the highest intensity for the most extended conformation observed (4040 
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Å
2 
in the 13
+
 and 4270 Å
2
 in the 14
+
). This would suggest that Fc-WT is the most 
stable construct, with Fc-TMYTE being the least stable; this observation agrees with 
data obtained from DSC shown in Figure 5-7. Fc-YTE appears more resistant to gas 
phase unfolding that Fc-TM based on Figure 25, which is not in agreement with the 
DSC data presented in Figure 5-7 and may suggest different mechanisms of 
unfolding for Fc’s between solution and gas phase.  
Ion mobility has shown a number of minor structural differences between the four Fc 
constructs, but no major structural changes at the lowest energy state. With 
increasing charge there are observable stability differences between the four Fcs. In 
order to investigate the conformational and dynamics differences on a more local 
level the four Fc’s were analysed using HDX-MS. 
5.2.4 Hydrogen Deuterium Exchange MS 
In order to obtain data on the whole Fc it was essential to obtain as close to 100% 
sequence coverage as possible. It was also important to obtain sequence coverage 
across the regions of mutation; the upper CH2 and hinge for the TM mutation sites, 
and the lower CH2 for the YTE mutation sites. The sequence coverage maps for the 
four Fc regions are shown in Figure 5-27 for Fc-WT, Figure 5-28 the Fc-TM, Figure 
5-29 for Fc YTE and Figure 5-30 for Fc-TMYTE. 
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Figure 5-27 – The peptide coverage map for the Fc-WT construct. Mutation sites are highlighted with 
red boxes. Blue boxes located under sequence correspond to peptides identified using ProteinLynx 
Global Server. Sequence coverage corresponds to the number of residues identified, based on the total 
residues in the protein. Total sequence coverage was 94.2% 
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Figure 5-28 - The peptide coverage map for the Fc-TM construct. Mutation sites are highlighted with 
red boxes. Blue boxes located under sequence correspond to peptides identified using ProteinLynx 
Global Server. Sequence coverage corresponds to the number of residues identified, based on the total 
residues in the protein. Total sequence coverage was 95.1% 
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Figure 5-29 - The peptide coverage map for the Fc-YTE construct. Mutation sites are highlighted 
with red boxes. Blue boxes located under sequence correspond to peptides identified using 
ProteinLynx Global Server. Sequence coverage corresponds to the number of residues identified, 
based on the total residues in the protein. Total sequence coverage was 94.2% 
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Figure 5-30 - The peptide coverage map for the Fc-TMYTE construct. Mutation sites are highlighted 
with red boxes. Blue boxes located under sequence correspond to peptides identified using 
ProteinLynx Global Server. Sequence coverage corresponds to the number of residues identified, 
based on the total residues in the protein.Total sequence coverage was 96.9% 
Based on the criteria outlined earlier, all four peptide maps were suitable. All four 
peptide maps showed approximately 95% sequence coverage. Sequence coverage 
shows a high degree of redundancy within the data; there are a number of 
overlapping peptides across the protein which give higher confidence in the assigned 
sequence. There was also a degree of redundancy at the sites of mutation.  
The region of the largest concern was that of the hinge. Peptides from the hinge were 
observed at a low abundance. It is possible a number of close proximity cleavages 
within the hinge resulted in over digestion of the hinge to low amino acid fragments. 
To ensure that key peptides of the hinge had been correctly assigned, these peptides 
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were selected for follow-up, targeted MS/MS fragmentation and manual fragment 
assignment. Results are shown in Figure 5-31.  
 
Figure 5-31 – The MS/MS analysis of two important peptides from the hinge region of the Fc 
constructs. A – The peptide found in the Fc-WT and Fc-YTE sample has a C-terminal leucine, whilst 
B – shows the same peptide with a C-terminal phenylalanine 
Figure 5-31 shows the same peptide found in the Fc-WT/ Fc-YTE (A) and Fc-
TM/Fc-TMYTE (B) proteins, based on presence of the L234F mutation. Both 
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MS/MS spectra show strong b- and y- ions, supporting the assignment made by 
PLGS and confirming the presence of these low abundance peptides. 
Following identification of these key peptides, an HDX time course was run on the 
peptides and exchange tracked across the Fc. The exchange data was normalised 
against the Fc-WT and relative protection/ deprotection of Fc-TM, Fc-YTE and Fc-
TMYTE is summarised in Figure 5-32. 
 
Figure 5-32 – Deuteurim uptake across the fc domain plotted as a heat trace the homology models of 
the Fc-TM, Fc-YTE and Fc-TMYTE. No data was fit for the hinge region. 
No hinge data is modelled in Figure 5-32, as the Fc-WT structure used to normalise 
the data (crystal structure: 3AVE) had no hinge coverage to map against. The hinge 
exchange data is shown in Figure 5-33. 
Figure 5-32 shows that both TM and YTE mutations introduce extra conformational 
freedom to the protein, since both mutants show an increase in the levels of 
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deuteration uptake across the protein (increased deprotection). No region of Fc in 
either of the Fc-TM or Fc-YTE shows increased protection, indicating that the 
mutations introduced only serve to destabilise the protein structure and/ or increase 
its dynamics. This observation is is consistent with DSC and IMS data presented 
earlier. 
Whilst the main site of thermal destabilisation, indicated by DSC is located in the 
CH2 domain for Fc-TM, Fc-YTE and Fc-TMYTE HDX shows the mutations have 
wide ranging effects on the overall dynamics of the protein. Both Fc-TM and Fc-
YTE proteins have an observed increase in the deuteration in the CH3 domain and at 
sites within the CH2 both proximal and distal from the sites of mutation.  
Fc-TMYTE shows a mostly additive effect in deuteration caused by local 
conformational changes across the protein , particularly within the CH3 domain 
where the uptake plot shows an additive Fc-TM/ Fc-YTE pattern. There is a site 
within the CH2 domain, located between the TM mutations L234F and L235E and 
YTE mutations M252Y, S254T and T256E, which appears to have a significantly 
increased level of deuterium uptake than any other region in the Fc.  
Relative deuterium uptake plots are shown below for the peptides spanning the 
mutation sites. 
One peptide spanning the hinge region (THTCPPCPAPEL) is found in all four 
constructs, the most C-terminal residue being L234 (the first amino acid of TM 
mutation site). HDX data shown in Figure 5-33 shows that all four mutants show a 
high rate of deuterium exchange in the hinge. This is unsurprising given solvent 
accessibility of the hinge relative to the rest of the protein. Fc-TM and Fc-TMYTE 
show a slightly elevated initial uptake, suggesting that the two constructs which 
share the mutated L234F both exhibit a similar increase in deuterium uptake.  
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Figure 5-33 – The deuterium incorporation plot for a conserved hinge peptide found across all four 
Fc constructs. Residue 12, lysine (L), was mutated to phenylalanine (F) in Fc-TM and Fc-TMYTE 
constructs. Error bars show the standard deviation from repeated data sets 
Three peptides were identified spanning the TM mutation site located in the upper 
CH2, and these are shown in Figure 5-34. 
WT TM YTE TM/YTE
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Figure 5-34 – The deuterium incorporation plots for three peptides which span the TM mutation sites.  
A) A conserved peptide in the TM and TMYTE which covers the L234, and L235 residue, B) and C) 
are both peptides found which cover the P331. In both B and C residue 13, proline (P), was mutated 
to serine (S) in Fc-TM and Fc-TMYTE constructs. Error bars show the standard deviation from 
repeated data sets 
Figure 5-34 illustrates similarities between Fc-TM and Fc-TMYTE deuterium uptake 
in peptides spanning the regions of mutation. This is most clearly seen in Figure 
33B, which highlights the differences in Fc-TM and Fc-TMYTE relative to Fc-WT, 
but can also be seen in the latter time points of Figure 33C where the Fc-TM and Fc-
YTE also show increased deuterium uptake relative to Fc-YTE.  
A single peptide (ISRTPEVTC) was found that contained residues S254 and T256 
from the YTE mutation site. The deuterium uptake is shown in Figure 5-35 
 
B
A
C
WT TM YTE TM/YTE
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Figure 5-35 – The deuterium incorporation plot for a peptide spanning the YTE mutation site 
Residues 2, serine (S), and 4, threonine (T) were mutated to threonine (T) and glutamate (E) in Fc-
YTE and Fc-TMYTE constructs. Error bars show the standard deviation from repeated data sets 
Figure 5-35 illustrates that across the YTE mutation site again the two mutant 
variants, Fc-YTE and Fc-TMYTE, show a similar deuterium incorporation profile 
which is different to that observed for Fc-WT and Fc-TM, with the two mutants 
showing an increase in deuterium uptake. 
Figures 4.32-4.34 illustrate potential conformational differences between Fc 
constructs which contain the amino acid substitutions and those which do not. The 
substitutions, in all cases, appear to increase the relative uptake of deuterium at the 
site consistent with an increase in conformational flexibility. 
Data presented in Figures 34 and 35 all show a biphasic trend in deuterium uptake; 
there is an initial increase in deuterium uptake, followed by a plateau and a second 
increase. Different amino acids, based on the local chemical environment, will 
exchange at different rates, and the observed trend in deuterium uptake in these 
figures is suggestive of different exchange rates across the peptides. This suggests 
possible differences in relative stability of the structural elements across the peptide. 
The region between the two sets of mutations, residues 236-251, show an increased 
degree of deuterium uptake in Figure 5-31, suggesting a possible site of cooperative 
destabilisation in the Fc-TMYTE protein. The deuterium incorporation plots for the 
four peptides in this region are shown in Figure 36. 
WT TM YTE TM/YTE
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Figure 5-36 – Deuterium uptake plots for the four peptides located at the inner CH2 interface, 
between YTE and TM mutation sites. Error bars show the standard deviation from repeated data sets 
Each of the four peptides shown in Figure 5-36 show that both Fc-TM and Fc-YTE 
have increased proton exchange relative to wild type, with Fc-YTE having the 
greater relative exchange, and thus a potentially more destabilised structure, than Fc-
TM. The Fc-TMYTE shows the greatest degree of proton exchange. The degree of 
proton exchange observed in Fc-TMYTE appears to be greater than the additive 
effect of individual Fc-TM and Fc-YTE mutations, particularly at intermediate time 
points (1 minute  100 minutes) where the combined Fc-TM and Fc-YTE data is 
less than that observed for Fc-TMYTE. This data suggests that the peptides 
identified above may contribute to the observed synergistic thermal destabilisation 
observed in the Fc-TMYTE mutants. 
WT TM YTE TM/YTE
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In order attempt to quantify these differences, data from Figure 5-36 was fitted to a 
number of exponentials. In order to ensure that the simplest model which adequately 
fitted the data was used, an F-test was applied. Results are shown in Figure 5-37. 
 
Figure 5-37 – The rates of deuterium exchange for the fast, intermediate and slow kinetics steps for 
peptide LFPPKPKDTL 
Figure 5-37 indicates that proton exchange in peptide LFPPKPKDTL can be 
characterised by three distinct rates; fast exchanging amides (k > 3.00), intermediate 
exchanging amides (k = 0.05- 3.00), and slow exchanging amides (k = < 0.05) (the 
exchange rates of which are shown in Figure 5-37). Fc-TMYTE data was the only 
data set, confirmed by F-test, which could be best fitted to three rates of exchange 
(fast, intermediate and slow) compared to Fc-WT, Fc-TM and Fc-TMYE which were 
adequately fitted to two rate of exchange. This illustrates that Fc-TMYTE shows not 
WT TM YTE TM/YTE
fast
inter
slow
R2 all ≥0.99
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only differences in proton exchange, but also suggests that the Fc-TMYTE has local 
unfolding or a reduced degree of structure in this region of the protein.  
In order to validate the proposed cooperative destabilisation, Figure 5-38 shows a 
cooperativity plot, creating by comparing the effects of additive deuterium exchange 
(Fc-TM + Fc-YTE deuterium uptake) relative to the cooperative deuterium exchange 
(Fc-TMYTE deuterium uptake. Ω calculated by using the equation ω = ((Fc-TM – 
Fc-WT) + (Fc-YTE –Fc-WT)) / (Fc-TMYTE – Fc-WT). Deviation from the central 
line (ω = 1.0) suggests either a greater than additive (ω = 0 - 1.0) or a less than 
additive (ω = 1.0 – 2.0) effect on deuterium exchange.  
 
Figure 5-38 – The deuterium incorporation (Dinc) cooperativity index, determined by the ratio of 
additive (Fc-TM + Fc-YTE) deuterium uptake and cooperative (Fc-TMYTE) deuterium uptake.  
Data points are determined by the mid-point of the slow (0.166 minutes), intermediate (10 minutes) 
and fast (60 minutes) kinetics rates described in Figure 5-37. Figure generated by Dr Phillips. 
Figure 5-38 suggests that there is no cooperativity in the Fc-TMYTE construct for 
the fast and slow exchange rates, since both data points lie within experimental error 
from the line ω = 1. The intermediate exchange rate shows a deviation from the line 
ω = 1 greater than error, and falls at approximately 0.7 ω, indicating a greater than 
cooperative effect on exchange.  
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5.3 Conclusions 
The aim of this study was to rationalise the conformational destabilisation observed 
by DSC for IgG Fcs engineered with different effector functions/ serum half-life and 
to identify any other differences in protein structure and/or dynamics using MS 
based approaches.  
Native IM-MS is a powerful tool for the identification of structural changes on a 
whole protein level. Changes in the charge distribution/ ATD are indicative of 
changes in the conformation and/or dynamics of a protein. 
HDX is a powerful tool for not only looking at global conformational changes, but 
also identifying local sites within the protein that undergo change. Measuring the 
rates of exchange on a peptide level provides information on subtle changes to the 
conformation which cannot be detected using native IM-MS. This approach has in 
the past been laborious to perform with a high degree of error, but the development 
of on-line deuteration/ digestion/ analysis systems has helped improve the 
reproducibility and sensitivity of the technique.  
By using a combination of native IM-MS and HDX is has been possible to study 
different engineered Fc variants in a great degree of detail.  
The Fc variants exhibit no observable changes in their global conformation by IMS 
as a result of the mutations. This suggests that the conformational changes observed 
are too subtle to be seen on a whole-domain level. It was possible to observe the 
differences in gas phase stability by studying the arrival time distribution of the 
different charge states. The IM-MS data supported the DSC observations of a 
reduction of stability with the introduction of the mutations. 
The global pattern of HDX change across the protein also supported the DSC and 
IMMS data; no regions in the engineered Fcs shows increased protection as a result 
of mutation indicating the mutations in the Fc-TM, Fc-YTE and Fc-TMYTE 
destabilised the protein across the molecules. 
The deuterium exchange at the site of mutation showed agreement between the Fc-
TM and Fc-YTE, and between the Fc-YTE and Fc-TMYTE. This suggests that, at 
these sites, there is no additional destabilisation as a result of all six mutations. 
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A site on the inner CH2 domain surface located between residues 236-251, which is 
between the two sets of mutations, was shown to have increased deuterium exchange 
in the Fc-TMYTE compared to the Fc-TM and Fc-YTE. Analysis of the region 
shows not only an additional exchange rate present in the Fc-TMYE not present in 
any other construct, but also a quantifiable increase in the exchange greater than the 
additive effects of the individual Fc-TM and Fc-YTE combined. The combination of 
the two sets of mutations leads to the synergistic destabilisation of this region which 
may be responsible for the observed thermal destabilised seen by DSC and IM-MS. 
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5.1 Conclusions 
The use of mass spectrometry in protein structural biology is becoming increasingly 
common. Mass spectrometry offers a number of improvements in speed and 
sensitivity compared to alternative structural techniques. This research made use of 
mass spectrometry to investigate the structural difference in three different biological 
systems. 
5.1.1 Prolyl oligopeptidase and dipeptidyl peptidase IV 
There were a number of theories regarding mechanism of substrate entry to the 
activate site of PREP. A number of bacterial proteins had been crystalised in an 
open, domain separated conformation and it was proposed that whole domain 
separation could occur in the mammalian protein. Using shape selective mass 
spectrometry it was possible to observe only a single conformation of PREP, 
suggesting that more subtle conformational changes were  occurring to allow 
substrate entry, which is consistent with MD simulations and electron microscopy 
data. More extended conformations of PREP were observed at higher charge states, 
and a comparison between the estimated CCS values of these both open and closed 
conformations agreed well with those calculated from X-ray crystal structures, 
suggesting that the open conformation on PREP may represent a non-physiological 
conformation. 
DPPIV, an enzyme in the same family, was also studied using IM-MS. DPP IV is 
larger than PREP, and it was proposed that small interdomain rearrangements 
allowed substrate entry. The observations presented in this study were consistent 
with this theory, as only a single conformation of DPP IV could be observed. DPP 
IV also showed no evidence of multiple  conformations at higher charge states, 
consistent with the protein being unable undergo domain separation as has been seen 
in PREP. 
5.1.2 Haemoglobin 
Data published by Scarff et al shortly after the release of the first generation ion 
mobility instrument was revisited, with a number of experimental changes made in 
light of recent advances in native MS and IM-MS. The data indicates that, at higher 
source temperatures, minor differences in the conformation of the protein appear 
larger than they do at lower temperatures by virtue of a worsening of the strength of 
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the CCS data calibration curve. Higher source pressures, such as those above 5 
mBar, were shown to dramatically affect desolvation. As with source temperature, 
higher pressures were shown to have a negative impact on the CCS data calibration 
curve.  
Having re-optimised the instrument settings, HbA and HbS CCS estimates were 
obtained experimentally and compared with those calculated from X-ray crystal data. 
The values obtained in this study showed an improved agreement with the 
computational values, illustrating the strength and accuracy that can be obtained in 
when using native protein standards for CCS estimates, compared with those 
obtained using denatured proteins. The PSA method, a new computational method 
developed by the Bowers group, was also used for CCS estimates, and compared 
well with the TM method. This serves to highlight the strength of the PSA method as 
a fast and accurate alternative for generating theoretical CCS values to the 
computationally demanding TM method. 
HbA and HbS CCS values were then compared to one another, and to a third Hb 
variant: HbC. It was found that HbA and HbS have a far more similar CCS that first 
observed, whilst HbC had a significantly smaller CCS value, suggesting a more 
compact conformation. With increasing charge, all three proteins showed an increase 
in CCS, consistent with the protein unfolding, with HbS and HbC adopting a more 
extended conformation at lower charge states than HbA. This was indicative of 
stability differences between the proteins, and was further studied by collisionally 
activating the protein. 
The results of the activation showed that all three Hb variants adopt that same 
extended conformations, but the intensities of the extended conformations varied, 
with HbA proving to be the most stable. 
5.1.3 Fc's engineered for therapeutic antibodies 
Monoclonal antibody therapeutics represent a large portion of the new generation of 
therapeutic agents. Whilst mass spectrometry is used routinely for the 
characterisation of glycosylation and sample identity, it is becoming more commonly 
used to investigate higher order structure. In this study, a combination of IM-MS and 
HDX has been used to characterise the Fc domain, responsible for host cell receptor 
binding, in four differently engineered Fcs. 
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The TM mutant, engineered for decreased complement recruitment, and the YTE 
mutant, engineered for increased serum half-life, were both found to have 
diminished CH2 thermal stability by DSC. A TMYTE double mutant was observed 
to have a further decreased thermal stability in the same domain, and it was believed 
that the combination of mutants was leading to a synergistic destabilisation greater 
than the sum of the two sets of mutations. 
IM-MS was used to study the global conformation, whilst HDX was used to study 
the local conformation. The IM-MS results indicated that there were no global 
conformational changes, nor were there any apparent changes to the global protein 
dynamics. Given the inclusion of the hinge domain in the Fc samples, a loose stretch 
of 14 amino acids capable of free motion in solution, it is possible that any changes 
in conformation were concealed by natural hinge motion.  
The HDX data showed a number of sites across the Fc domain with increased 
deuterium uptake, consistent with an increase in the dynamics of the protein. Data at 
the sites of mutation agreed between the single and double mutants, indicating that 
mutations at one site did not interfere with the other. HDX also revealed a small 
region of the Fc domain located between the TM and YTE mutation sites, in the 
inner CH2 domain face, which showed a greater than additive degree of deuterium 
uptake in Fc-TMYTE when compared to Fc-TM and Fc-YTE. Further analysis of 
this site suggested that there is a different regime of exchange kinetics, consistent 
with a change in the conformational dynamics in Fc-TMYTE compared to Fc-TM or 
Fc-YTE. Given the location of the site, it seems possible that this region is 
responsible for the observed differences in thermal stability. 
5.1.4 Final remarks 
This work has shown the strength of mass spectrometry as a tool for probing subtle, 
and larger, changes in protein conformation. Using a combination of approaches it 
has been used to study protein conformation, stability, and dynamics, and has 
successfully highlighted the differences between proteins differing in only a few 
amino acids.  
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Appendix A-1: The sequence alignment for the homology model of the Fc-TM construct 
 
Appendix A-2: The sequence alignment for the homology model of the Fc-TMYTE construct 
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Appendix A-3: The sequence alignment for the homology model of the Fc-WT construct 
 
Appendix A-4: The sequence alignment for the homology model of the Fc-YTE construct 
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Appendix B 
In addition to the research described in detail in Chapters 1-5, research has also been 
carried out on the use of mass spectrometry approaches to characterise glycosylation 
patterns in proteins. Glycosylation is the enzymatic attachment of carbohydrates to 
specific sites on a protein. More than 50% of all proteins are thought to be modified 
in this way. Glycosylation is a key process in the cell and can control the promotion 
of correct protein folding, the recognition of cell types by the immune system, and 
primitive protection against viruses and bacteria. Glycans can form large chains and 
antennary structures, which can give rise to a large amount of heterogeneity in a 
sample, often due to single sites of glycosylation playing host to a series of different 
glycans. The characterisation of oligosaccharides presents a significant analytical 
challenge since it requires the determination of ring size, isomer, linkage position, 
sequence and anomeric configuration of linkage for each species in what is often a 
complex mixture of carbohydrate molecules. Existing approaches for characterising 
glycans are time consuming and labour intensive.  Rapid methods are required not 
only for glycoproteomic research but also for pharmaceutical studies. These involve 
the recombinant synthesis of glycoproteins using, for example, insect cell lines. 
Measurement is required for synthesis optimisation, quality control and effect 
measurement. The Warwick group has enjoyed a successful and productive 
collaboration with Professor David Harvey (a visiting Professor in the School of Life 
Sciences and a major international expert in the use of mass spectrometry to 
characterise glycans) for a number of years. The collaboration has resulted in a 
number of publications and the approach, based on ion mobility separation and 
development of improved enrichment and ionisation approaches has been shown to 
have significant advantages. 
I have, during the period of my post graduate research worked closely with Professor 
Harvey and Professor Scrivens in support of this research carrying out experimental 
work and providing data interpretation in support of a number of projects. This work 
has resulted in four publications to date of which I am a co-author. Since these 
projects, although valuable and interesting, did not form part of my core research 
program I have not described the work in detail in this thesis. I do however attach 
copies of the publications in appendix B as a record of the activities. 
